Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
regulation of glial cell differentiation (GO:0045685),3/6,0.0022241766503380937,1,0,0,10,61.08368476639271,EPHA4;CDK1;TNFRSF8
carboxylic acid transport (GO:0046942),8/51,0.0035689878336031453,1,0,0,3.1372549019607843,17.6799160576913,SLC16A6;SLC1A4;SLC16A9;SLC6A20;SLC16A3;SLC7A2;SLC38A5;SLC38A4
monocarboxylic acid transport (GO:0015718),8/53,0.004550781167453931,1,0,0,3.0188679245283017,16.279113586719326,SLCO1B1;STARD5;SLC10A1;SLCO1B3;SLC16A6;SLC16A9;SLC16A3;SLC27A5
positive regulation of telomerase RNA localization to Cajal body (GO:1904874),4/15,0.005444864346461733,1,0,0,5.333333333333333,27.803106327047363,SHQ1;TCP1;RUVBL1;CCT8
sensory perception of pain (GO:0019233),5/24,0.005938776132475564,1,0,0,4.166666666666667,21.359384188084036,CHRNA4;KCNA2;OPRM1;RETREG1;NIPSNAP1
positive regulation of calcium ion transmembrane transport (GO:1904427),5/25,0.007123209459613566,1,0,0,4,19.777587553293714,PDPK1;GPER1;DRD1;CASQ1;LACRT
lipoprotein biosynthetic process (GO:0042158),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,WDR45B;ALOX12B;ATG7
DNA topological change (GO:0006265),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,TOP2A;ERCC3;TOP1MT
membrane lipid metabolic process (GO:0006643),4/18,0.010832993829611394,1,0,0,4.444444444444444,20.111816967158788,POGLUT1;AGMO;CYP1B1;ALOX12B
regulation of telomerase RNA localization to Cajal body (GO:1904872),4/18,0.010832993829611394,1,0,0,4.444444444444444,20.111816967158788,SHQ1;TCP1;RUVBL1;CCT8
DNA conformation change (GO:0071103),4/18,0.010832993829611394,1,0,0,4.444444444444444,20.111816967158788,TOP2A;ERCC3;TOP1MT;KAT6A
regulation of NLRP3 inflammasome complex assembly (GO:1900225),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,CPTP;PYDC2;NLRC3
negative regulation of interleukin-1 beta secretion (GO:0050713),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,NLRP7;CPTP;PYDC2
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,NFKBIL1;TRIB1;LACRT
rhodopsin mediated signaling pathway (GO:0016056),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,RHO;PDE6A;CNGB1
bile acid and bile salt transport (GO:0015721),5/30,0.01555659746473132,1,0,0,3.333333333333333,13.877568186921728,SLCO1B1;STARD5;SLC10A1;SLCO1B3;SLC27A5
steroid hormone mediated signaling pathway (GO:0043401),4/20,0.015846713681637082,1,0,0,4,16.579172555417852,RHOXF1;NR6A1;MED30;GPER1
action potential (GO:0001508),7/54,0.017451462104601394,1,0,0,2.592592592592592,10.495675155296674,KCNE2;CATSPER4;CHRNA4;GPER1;KCNA2;CACNA1A;SCN7A
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),5/31,0.017804675725432068,1,0,0,3.225806451612903,12.994497338628113,PDPK1;GPER1;DRD1;CASQ1;LACRT
negative regulation of DNA metabolic process (GO:0051053),6/43,0.01929988711082831,1,0,0,2.7906976744186043,11.016714508655674,ZRANB3;ERCC4;DPPA3;GPER1;ENPP7;ATR
regulation of systemic arterial blood pressure (GO:0003073),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,PRCP;KLK2;SLC2A5
negative regulation of ATPase activity (GO:0032780),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,PAM16;TLR9;VCPKMT
epithelial structure maintenance (GO:0010669),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,TLR9;LACRT;PBLD
positive regulation of cardiocyte differentiation (GO:1905209),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,MYOCD;GPER1;NKX2-5
negative regulation of interleukin-1 secretion (GO:0050711),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,NLRP7;CPTP;PYDC2
positive regulation of calcium ion transport into cytosol (GO:0010524),5/32,0.020257193169988103,1,0,0,3.125,12.185141656980141,PDPK1;GPER1;DRD1;CASQ1;LACRT
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),4/22,0.022111430851613167,1,0,0,3.6363636363636362,13.860583894809807,KCNE2;CAV3;CCDC22;CTSC
negative regulation of multi-organism process (GO:0043901),5/33,0.02292040460454417,1,0,0,3.0303030303030303,11.441599195115412,NFKBIL1;ARHGDIB;TRIB1;LACRT;KRT6A
protein polymerization (GO:0051258),6/45,0.023716628785101824,1,0,0,2.6666666666666665,9.97754357432181,TRIM6;GSN;UBE2S;CASQ1;WASF3;TTC17
"Notch receptor processing, ligand-dependent (GO:0035333)",3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,NOTCH3;PSEN1;DLL1
cardiocyte differentiation (GO:0035051),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,KDM6B;MYOCD;NKX2-5
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,ATF7IP;NKX2-5;GTF2F2
chromosome condensation (GO:0030261),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,TOP2A;ERN2;GPER1;AKAP8L
positive regulation of ERBB signaling pathway (GO:1901186),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,GPER1;NUP62;AGR2;CNOT9
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,EPHA4;PSME3;PSME1;CTSC
apoptotic nuclear changes (GO:0030262),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,TOP2A;ERN2;GPER1;DNASE2
cellular response to amyloid-beta (GO:1904646),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,CACNB1;EPHA4;CACNA1A;PSEN1
cellular macromolecular complex assembly (GO:0034622),5/34,0.02579993741840051,1,0,0,2.941176470588235,10.757009449120288,SHQ1;MIA;CSNK2B;CTAGE9;PDE4DIP
lipid biosynthetic process (GO:0008610),8/72,0.026917281476999108,1,0,0,2.222222222222222,8.033303921239105,SREBF1;SRD5A1;LPCAT1;ACSM6;HSD17B8;TRERF1;AGPAT3;CBR4
peptide cross-linking (GO:0018149),6/47,0.028763410125455306,1,0,0,2.553191489361702,9.060385994914286,LCE1A;LCE2C;LCE4A;FN1;PI3;IVL
regulation of extracellular matrix disassembly (GO:0010715),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,CARMIL2;FAP;CLASP2
negative regulation of interleukin-1 beta production (GO:0032691),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,NLRP7;CPTP;PYDC2
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,KCNE2;CAV3;SCN4B
glycoside metabolic process (GO:0016137),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,AKR1B10;NAGA;CBR4
positive regulation of smooth muscle contraction (GO:0045987),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,MYOCD;CTTN;GPER1
protein acylation (GO:0043543),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,ABHD17B;KAT6A;ZDHHC5;ZDHHC12;LACRT
actin polymerization or depolymerization (GO:0008154),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,CAP1;GSN;DSTN;WASF3;TTC17
organic hydroxy compound transport (GO:0015850),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,SLCO1B1;STARD5;SLC10A1;SLCO1B3;SLC27A5
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,FRS2;PTPRF
negative regulation of chromosome organization (GO:2001251),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,TOP2A;ERCC4
vitamin K metabolic process (GO:0042373),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,VKORC1;CBR1
cellular response to monoamine stimulus (GO:0071868),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GNG2;DRD1
glomerular epithelial cell differentiation (GO:0072311),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PTPRO;PROM1
renal filtration cell differentiation (GO:0061318),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PTPRO;PROM1
centromeric sister chromatid cohesion (GO:0070601),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,NAA50;BUB1
GDP-mannose metabolic process (GO:0019673),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GMPPB;GMDS
response to catecholamine (GO:0071869),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GNG2;DRD1
neutral amino acid transport (GO:0015804),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,SLC1A1;SLC1A4;SLC6A20;SLC38A5
response to amyloid-beta (GO:1904645),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,CACNB1;EPHA4;CACNA1A;PSEN1
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,KLRK1;STAP1;RASGRP1;HLA-E
L-amino acid transport (GO:0015807),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,SLC1A1;SLC1A4;SLC6A20;SLC38A5
signal transduction in response to DNA damage (GO:0042770),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,MAD2L2;USP10;GADD45A;MDM4
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",5/37,0.03578300819815846,1,0,0,2.7027027027027026,9.000762512391741,PCNA;ERCC3;RFC2;ERCC4;GTF2H3
"phototransduction, visible light (GO:0007603)",3/15,0.03614002285058795,1,0,0,4,13.281417446154263,RHO;PDE6A;CNGB1
substrate-dependent cell migration (GO:0006929),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,NRP1;ANKS1A;NTN1
cardiac muscle cell differentiation (GO:0055007),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,KDM6B;MYOCD;NKX2-5
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,GCDH;ACOX2;ETFB
establishment of protein localization to endoplasmic reticulum (GO:0072599),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,SEC61G;RAB3GAP2;SRP68
DNA replication (GO:0006260),11/120,0.03797813093409151,1,0,0,1.833333333333333,5.996365442200597,POLA2;RMI2;RFC2;ERCC4;TREX1;TOP1MT;CDK1;TNFAIP1;BRCA1;ATR;MCM2
negative regulation of response to external stimulus (GO:0032102),10/107,0.04158500168313311,1,0,0,1.8691588785046727,5.9439546040877795,EPHA4;NLRP7;NFKBIL1;GPER1;RORC;PYDC2;NLRC3;DRD1;TRIB1;LACRT
Notch receptor processing (GO:0007220),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,NOTCH3;PSEN1;DLL1
protein deacylation (GO:0035601),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,HDAC3;SIRT5;LYPLAL1
negative regulation of striated muscle cell differentiation (GO:0051154),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,CAV3;FRS2;NKX2-5
negative regulation of transcription regulatory region DNA binding (GO:2000678),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,MAD2L2;MSX2;PSEN1
steroid biosynthetic process (GO:0006694),8/79,0.043440838071242584,1,0,0,2.0253164556962022,6.35211202212957,CYP27A1;SQLE;ACOX2;SRD5A1;HSD17B8;TSPOAP1;TRERF1;SLC27A5
regulation of neurotransmitter secretion (GO:0046928),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,PREPL;GPER1;SLC30A1;CPLX3
negative regulation of organelle assembly (GO:1902116),4/27,0.04362093265098386,1,0,0,2.962962962962963,9.280646332348267,CAV3;BRCA1;CEP97;NBDY
DNA metabolic process (GO:0006259),23/314,0.04376901950217327,1,0,0,1.464968152866242,4.583634883495429,ZRANB3;TOP2A;RMI2;PCNA;GADD45A;CHRNA4;RFC2;TREX1;BRCA1;TNFAIP1;GTF2H3;INIP;POLA2;TATDN2;ERCC3;ERCC4;TOP1MT;CDK1;DNASE2;ASF1A;ATR;ZNF365;MCM2
"substrate-dependent cell migration, cell extension (GO:0006930)",2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,NRP1;NTN1
response to misfolded protein (GO:0051788),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,UBE2W;STUB1
positive regulation of extracellular matrix disassembly (GO:0090091),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,CARMIL2;CLASP2
negative regulation of membrane protein ectodomain proteolysis (GO:0051045),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,TIMP4;PTPN3
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,GNG2;DRD1
amino acid import across plasma membrane (GO:0089718),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,SLC1A1;SLC7A2
skin development (GO:0043588),9/94,0.045354951622954415,1,0,0,1.9148936170212765,5.923217722110746,LCE1A;LCE2C;LCE4A;PDGFA;ALOX12B;DHCR24;DLL1;ASPRV1;IVL
"nucleotide-excision repair, DNA incision (GO:0033683)",5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,PCNA;ERCC3;RFC2;ERCC4;GTF2H3
positive regulation of phosphate metabolic process (GO:0045937),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,NRP1;ILK;BCL10;PSEN1
regulation of protein localization to plasma membrane (GO:1903076),7/67,0.04938993805127162,1,0,0,2.08955223880597,6.285391018194011,DPP10;LRRC15;PDPK1;GPER1;AGR2;PIK3R1;LDLRAP1
positive regulation of natural killer cell mediated immunity (GO:0002717),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,KLRK1;RASGRP1;HLA-E
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",8/82,0.05220786888704381,1,0,0,1.951219512195122,5.7610186351061445,PCNA;USP10;GADD45A;CDK1;CASP2;MDM4;BRCA1;CNOT9
positive regulation of cell cycle arrest (GO:0071158),8/82,0.05220786888704381,1,0,0,1.951219512195122,5.7610186351061445,PCNA;FAP;GADD45A;CDK1;CASP2;MDM4;BRCA1;CNOT9
cellular response to peptide (GO:1901653),5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,CACNB1;EPHA4;GPER1;CACNA1A;PSEN1
negative regulation of proteolysis (GO:0045861),5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,EPHA4;DNAJC1;NLRP7;TIMP4;PTPN3
monocarboxylic acid biosynthetic process (GO:0072330),7/68,0.05279047635145934,1,0,0,2.0588235294117645,6.0558739225566685,CYP27A1;ACOX2;ACSM6;CHST14;HSD17B8;SLC27A5;CBR4
regulation of embryonic development (GO:0045995),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,POGLUT1;CDK1;DLL1;CLASP2
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,GPER1;NUP62;AGR2;CNOT9
Golgi to lysosome transport (GO:0090160),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,EHD3;CCDC91
aminoglycoside antibiotic metabolic process (GO:0030647),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,AKR1B10;CBR4
positive regulation of protein localization to Cajal body (GO:1904871),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,TCP1;CCT8
daunorubicin metabolic process (GO:0044597),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,AKR1B10;CBR4
protein K6-linked ubiquitination (GO:0085020),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,UBE2S;BRCA1
regulation of store-operated calcium entry (GO:2001256),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,HOMER3;CASQ1
doxorubicin metabolic process (GO:0044598),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,AKR1B10;CBR4
membrane lipid catabolic process (GO:0046466),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,NAGA;CYP1B1
peptidyl-diphthamide metabolic process (GO:0017182),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,DPH1;DPH7
regulation of protein localization to Cajal body (GO:1904869),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,TCP1;CCT8
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,DPH1;DPH7
tRNA aminoacylation for mitochondrial protein translation (GO:0070127),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,YARS2;WARS2
actin filament polymerization (GO:0030041),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,GSN;WASF3;TTC17
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,NFKBIL1;TRIB1;LACRT
regulation of cardiac muscle cell membrane repolarization (GO:0099623),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,KCNE2;CAV3;SCN4B
regulation of smooth muscle cell migration (GO:0014910),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,NRP1;PDGFA;TRIB1
transcription initiation from RNA polymerase II promoter (GO:0006367),13/160,0.05814883760924165,1,0,0,1.625,4.622717758327802,NOTCH3;WWTR1;GTF2A2;TAF10;RORC;GTF2H3;GTF2F2;MED15;NR6A1;MED30;ERCC3;CDK1;POLR2F
phospholipid metabolic process (GO:0006644),7/70,0.06002223966632419,1,0,0,2,5.626080248664981,PLPPR3;ACP6;LPCAT1;PLBD1;AGPAT2;AGPAT3;ENPP7
protein palmitoylation (GO:0018345),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,GOLGA7B;ABHD17B;ZDHHC5;ZDHHC12
regulation of developmental growth (GO:0048638),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,CTTN;AGR2;SIX1;DLL1
membrane depolarization (GO:0051899),5/43,0.06205452849740553,1,0,0,2.325581395348837,6.4645157873716,CHRNA4;CATSPER4;CACNA1A;SCN7A;BEST2
positive regulation of protein localization to plasma membrane (GO:1903078),5/43,0.06205452849740553,1,0,0,2.325581395348837,6.4645157873716,DPP10;PDPK1;GPER1;AGR2;PIK3R1
peptidyl-lysine modification (GO:0018205),10/115,0.06223696205916553,1,0,0,1.7391304347826086,4.829228192011538,TOP2A;SENP6;PCNA;MTA1;NUP210;NUP50;NUP62;VCPKMT;SIRT5;IVL
regulation of neurogenesis (GO:0050767),6/57,0.06427597956822549,1,0,0,2.1052631578947367,5.77804060142804,CASZ1;GPER1;SIX1;OPRM1;DLL1;TRIM32
protein import into mitochondrial matrix (GO:0030150),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,DNAJC19;GRPEL1;PAM16
negative regulation of response to biotic stimulus (GO:0002832),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,NFKBIL1;TRIB1;LACRT
gamma-aminobutyric acid signaling pathway (GO:0007214),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,GABRA2;GABRR3;GABRA1
striated muscle cell differentiation (GO:0051146),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,KDM6B;MYOCD;NKX2-5
negative regulation of immune system process (GO:0002683),5/44,0.06726261217595207,1,0,0,2.2727272727272725,6.134433491895637,NLRP7;GPER1;NFKBIL1;TLR9;BCL10
negative regulation of NIK/NF-kappaB signaling (GO:1901223),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ADGRG3;NLRC3
negative regulation of cytokine production involved in inflammatory response (GO:1900016),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,NLRP7;NLRC3
sphingomyelin metabolic process (GO:0006684),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SAMD8;ENPP7
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,MICA;HLA-E
small nucleolar ribonucleoprotein complex assembly (GO:0000491),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SHQ1;RUVBL1
regulation of skeletal muscle cell differentiation (GO:2001014),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,MYOCD;KLHL41
positive regulation of establishment of protein localization to telomere (GO:1904851),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,TCP1;CCT8
glycine transport (GO:0015816),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SLC6A20;SLC38A5
omega-hydroxylase P450 pathway (GO:0097267),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CYP1B1;CYP2C19
protein modification by small protein conjugation or removal (GO:0070647),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SENP6;ZNF747
negative regulation of chromatin silencing (GO:0031936),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ASF1A;PHF8
proline transport (GO:0015824),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SLC1A4;SLC6A20
7-methylguanosine mRNA capping (GO:0006370),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,ERCC3;POLR2F;GTF2H3;GTF2F2
response to zinc ion (GO:0010043),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,MT1A;MT1M;SLC30A1;CRIP1
7-methylguanosine RNA capping (GO:0009452),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,ERCC3;POLR2F;GTF2H3;GTF2F2
positive regulation of telomere maintenance via telomerase (GO:0032212),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,TCP1;CCT8;MAP3K4;ATR
positive regulation of transcription factor import into nucleus (GO:0042993),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,HDAC3;TLR9;PIK3R1;LACRT
regulation of phosphorylation (GO:0042325),10/119,0.07467856020884321,1,0,0,1.680672268907563,4.360608806670558,NRP1;SRPX2;NUP210;NUP50;NUP62;FN1;STAP1;ILK;BCL10;PSEN1
error-prone translesion synthesis (GO:0042276),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,MAD2L2;PCNA;RFC2
regulation of calcium ion transmembrane transport (GO:1903169),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,CACNB1;CAV3;CASQ1
autophagy of nucleus (GO:0044804),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,WDR45B;ATG13;ATG7
growth hormone receptor signaling pathway (GO:0060396),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,GH2;CSH1;PIK3R1
organelle disassembly (GO:1903008),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,CDK1;MTIF2;RETREG1
positive regulation of protein localization to cell periphery (GO:1904377),5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,DPP10;PDPK1;GPER1;AGR2;PIK3R1
nuclear envelope disassembly (GO:0051081),5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,NUP210;NUP50;AKAP8L;NUP62;CDK1
regulation of tumor necrosis factor production (GO:0032680),6/61,0.08348906656118887,1,0,0,1.9672131147540983,4.884668055906092,ARG2;NFKBIL1;TLR9;NLRC3;RASGRP1;HLA-E
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,ERCC3;ERCC4;GTF2H3
thyroid gland development (GO:0030878),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SIX1;NKX2-5
cellular response to growth hormone stimulus (GO:0071378),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,GH2;PIK3R1
positive regulation of steroid metabolic process (GO:0045940),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,LDLRAP1;APOA5
regulation of cytoplasmic translational elongation (GO:1900247),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,DPH1;DPH7
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,TOP2A;APOBEC3C
negative regulation of inclusion body assembly (GO:0090084),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,DNAJB1;SACS
astrocyte development (GO:0014002),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PSEN1;DLL1
epithelial cell morphogenesis (GO:0003382),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,POF1B;RILPL1
negative regulation of cell activation (GO:0050866),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,GPER1;PDGFA
regulation of establishment of protein localization to telomere (GO:0070203),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,TCP1;CCT8
IRES-dependent viral translational initiation (GO:0075522),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PTBP1;EIF3F
positive regulation of smooth muscle cell migration (GO:0014911),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,NRP1;DOCK5
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,BRCA1;CNOT9
quinone metabolic process (GO:1901661),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,AKR1B10;CBR4
DNA repair (GO:0006281),20/288,0.08697905350329747,1,0,0,1.3888888888888888,3.391788824508127,ZRANB3;RMI2;GTF2H2C;PCNA;GADD45A;CHRNA4;RFC2;TREX1;ACTR5;BRCA1;PARP9;GTF2H3;INIP;MAD2L2;MTA1;ERCC3;ERCC4;CDK1;ASF1A;ATR
mitochondrial translation (GO:0032543),9/107,0.08740344947079064,1,0,0,1.6822429906542054,4.099997152379927,MRPS17;MRPS33;MTERF4;MRPS23;GATC;MTIF2;MRPS30;MRPS6;MRPL46
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,TCP1;CCT8;MAP3K4;ATR
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",6/62,0.08873881335310585,1,0,0,1.9354838709677418,4.687854010251747,PCNA;GADD45A;CDK1;CASP2;MDM4;CNOT9
amino acid transport (GO:0006865),5/48,0.0904238200779985,1,0,0,2.0833333333333335,5.006765728864707,SLC1A4;SLC6A20;SLC7A2;SLC38A5;SLC38A4
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,PCNA;GADD45A;CDK1;CASP2;MDM4;CNOT9
regulation of natural killer cell mediated cytotoxicity (GO:0042269),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,KLRK1;RASGRP1;MICA
regulation of catecholamine secretion (GO:0050433),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,SYT4;CHRNA4;KCNA2
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,ERCC3;ERCC4;GTF2H3
protein O-linked glycosylation via serine (GO:0018242),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,GALNT12;POGLUT1;GALNT9
negative regulation of protein complex assembly (GO:0031333),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,ANKRD27;CPTP;NLRC3;PYDC2
protein heterooligomerization (GO:0051291),5/49,0.0967823010309069,1,0,0,2.0408163265306123,4.765900289809773,TRPS1;MCCC1;TMCC1;HSD17B8;CBR4
regulation of release of sequestered calcium ion into cytosol (GO:0051279),5/49,0.0967823010309069,1,0,0,2.0408163265306123,4.765900289809773,PDPK1;GPER1;CASQ1;DRD1;LACRT
nitric oxide biosynthetic process (GO:0006809),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ARG2;CYP1B1
regulation of histone deacetylation (GO:0031063),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ING2;AKAP8L
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,TCP1;CCT8
regulation of inclusion body assembly (GO:0090083),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DNAJB1;SACS
positive regulation of extracellular matrix organization (GO:1903055),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,CARMIL2;CLASP2
protein localization to pre-autophagosomal structure (GO:0034497),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,WDR45B;ATG13
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ADAMTS3;DLL1
calcineurin-NFAT signaling cascade (GO:0033173),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,PPP3CC;LACRT
positive regulation of protein deacetylation (GO:0090312),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ING2;AKAP8L
biotin metabolic process (GO:0006768),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,MCCC1;ACACB
positive regulation of histone deacetylation (GO:0031065),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ING2;AKAP8L
"synaptic transmission, GABAergic (GO:0051932)",2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,GABRA2;GABRA1
regulation of cardiac muscle cell differentiation (GO:2000725),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,MYOCD;FRS2
regulation of chromatin silencing (GO:0031935),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,HIRA;ASF1A
urate metabolic process (GO:0046415),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SLC16A9;SLC17A1
cellular response to DNA damage stimulus (GO:0006974),22/329,0.10225103559980289,1,0,0,1.3373860182370818,3.0496739107533024,ZRANB3;TOP2A;GADD45A;CHRNA4;CCDC13;RFC2;USP10;TREX1;BRCA1;ALKBH7;GTF2H3;CRIP1;INIP;IRF3;ERCC3;ERCC4;CDK3;CDK1;CASP2;ASF1A;MICA;ATR
regulation of muscle cell differentiation (GO:0051147),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,PTBP1;MYOCD;CDH15;KLHL41
natural killer cell activation (GO:0030101),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,KLRK1;IFNA1;IFNA8;ULBP3
sodium ion transmembrane transport (GO:0035725),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,SCN7A;SLC17A1;KCNK1;SCN4B
secondary alcohol biosynthetic process (GO:1902653),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,SQLE;ERG28;DHCR24;APOA5
neuronal action potential (GO:0019228),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,GPER1;KCNA2;SCN7A
melanosome organization (GO:0032438),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,TRAPPC6A;RAB38;LYST
glycolipid metabolic process (GO:0006664),6/65,0.10553500656937817,1,0,0,1.8461538461538463,4.1514693512884095,POGLUT1;CPTP;NAGA;ST8SIA6;ARSD;ENPP7
cellular macromolecule biosynthetic process (GO:0034645),24/367,0.10938273015598082,1,0,0,1.307901907356948,2.8942590880740413,MRPS17;CREBZF;RMI2;RFC2;TREX1;MRPS33;GCNT1;RPS6;RPS3A;BRCA1;TNFAIP1;GSPT2;MRPS6;YARS2;POLA2;RPS15A;ERCC4;TOP1MT;NUP62;CDK1;POLR2F;EIF4G2;ATR;MCM2
cellular response to light stimulus (GO:0071482),6/66,0.1114753492102168,1,0,0,1.8181818181818181,3.9890032651653162,PCNA;ERCC4;RHO;PDE6A;CNGB1;ATR
sodium-independent organic anion transport (GO:0043252),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,SLCO1B1;SLCO1B3;SLCO5A1;MFSD10
regulation of sodium ion transmembrane transporter activity (GO:2000649),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,NETO1;CAV3;SCN4B;PTPN3
negative regulation of G0 to G1 transition (GO:0070317),4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,UXT;BRCA1;DUX4;E2F6
negative regulation of NF-kappaB transcription factor activity (GO:0032088),7/82,0.11553692430953495,1,0,0,1.7073170731707317,3.6846721375201086,PKHD1;NLRP7;NFKBIL1;TLR9;CYP1B1;NLRC3;PYDC2
membrane protein intracellular domain proteolysis (GO:0031293),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,NOTCH3;PSEN1;DLL1
positive regulation of endopeptidase activity (GO:0010950),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,EPHA4;PSME3;PSME1
positive regulation of nervous system development (GO:0051962),5/52,0.11715876376056604,1,0,0,1.9230769230769231,4.123510209226117,SRPX2;SLITRK2;GPER1;OPRM1;TRIM32
response to UV (GO:0009411),8/98,0.11716919712760449,1,0,0,1.6326530612244896,3.500630627798508,ZRANB3;PCNA;ERCC3;ERCC4;TRIM32;MAP3K4;IVL;ATR
regulation of oligodendrocyte differentiation (GO:0048713),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TNFRSF8;ZNF365
positive regulation of establishment of protein localization (GO:1904951),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TCP1;CCT8
mitochondrion transport along microtubule (GO:0047497),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,UXT;MGARP
exit from mitosis (GO:0010458),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,UBE2S;CLASP2
nitric oxide metabolic process (GO:0046209),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,ARG2;CYP1B1
regulation of skeletal muscle tissue development (GO:0048641),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,DLL1;KLHL41
positive regulation of peptidase activity (GO:0010952),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,PSME3;PSME1
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,AGR2;PIK3R1
transcription from mitochondrial promoter (GO:0006390),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,MTERF2;MTERF4
endosome transport via multivesicular body sorting pathway (GO:0032509),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TMEM50B;LYST
DNA deamination (GO:0045006),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,APOBEC3C;EXOSC6
calcineurin-mediated signaling (GO:0097720),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,PPP3CC;LACRT
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TLR9;RASGRP1
regulation of protein kinase activity (GO:0045859),11/147,0.11883496557521814,1,0,0,1.4965986394557822,3.1877844239018156,WWTR1;LRRC15;CAV3;MMD;PDPK1;JTB;MAPRE3;SPDYE5;TRIB1;LRRC66;SOCS4
membrane depolarization during action potential (GO:0086010),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,CATSPER4;CACNA1A;SCN7A;SCN4B
retina homeostasis (GO:0001895),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,POTEJ;POC1B;LCN1;CNGB1
establishment of protein localization to membrane (GO:0090150),7/83,0.12107906826619484,1,0,0,1.686746987951807,3.5612482964696746,GOLGA7B;RFTN2;C16ORF70;RILPL1;ZDHHC12;RAB3GAP2;SEC63
regulation of epithelial to mesenchymal transition (GO:0010717),6/68,0.12385227423087532,1,0,0,1.7647058823529411,3.685880753701308,MAD2L2;WWTR1;SDHAF2;ELL3;PBLD;CLASP2
protein sumoylation (GO:0016925),6/68,0.12385227423087532,1,0,0,1.7647058823529411,3.685880753701308,TOP2A;PCNA;MTA1;NUP210;NUP50;NUP62
regulation of neuron differentiation (GO:0045664),7/84,0.12675522288040375,1,0,0,1.6666666666666665,3.442495718671272,CASZ1;MMD;ZC4H2;SIX1;NKX2-5;DLL1;TRIM32
regulation of potassium ion transmembrane transporter activity (GO:1901016),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,KCNE2;NETO1;CAV3
negative regulation of epithelial to mesenchymal transition (GO:0010719),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,MAD2L2;SDHAF2;PBLD
negative regulation of protein catabolic process (GO:0042177),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,MAD2L2;MDM4;TIMP4;PTPN3
regulation of G0 to G1 transition (GO:0070316),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,UXT;BRCA1;DUX4;E2F6
positive regulation of neurogenesis (GO:0050769),6/69,0.13028256049309653,1,0,0,1.7391304347826086,3.5444341652133744,MMD;GPER1;ZC4H2;OPRM1;NKX2-5;TRIM32
sensory perception (GO:0007600),5/54,0.13177730633611895,1,0,0,1.8518518518518516,3.7530404709585476,CHRNA4;KCNA2;OPRM1;RETREG1;NIPSNAP1
cell morphogenesis involved in differentiation (GO:0000904),5/54,0.13177730633611895,1,0,0,1.8518518518518516,3.7530404709585476,NRP1;POF1B;RILPL1;FN1;ILK
positive regulation of sodium ion transport (GO:0010765),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,NKX2-5;SCN4B
DNA replication-independent nucleosome organization (GO:0034724),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,HIRA;ASF1A
viral translation (GO:0019081),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PTBP1;EIF3F
maintenance of gastrointestinal epithelium (GO:0030277),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,TLR9;PBLD
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,TLR9;RASGRP1
response to UV-B (GO:0010224),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,CRIP1;IVL
positive regulation of muscle contraction (GO:0045933),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,MYOCD;CTTN
positive regulation of lamellipodium assembly (GO:0010592),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,CARMIL2;WASF2
glomerular visceral epithelial cell differentiation (GO:0072112),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PTPRO;PROM1
amyloid precursor protein metabolic process (GO:0042982),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PSEN1;LDLRAP1
sterol biosynthetic process (GO:0016126),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,SQLE;ERG28;DHCR24;APOA5
phosphatidic acid biosynthetic process (GO:0006654),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,ACP6;LPCAT1;AGPAT2;AGPAT3
regulation of ATPase activity (GO:0043462),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,DNAJB1;PAM16;TNNT3;VCPKMT
bile acid biosynthetic process (GO:0006699),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,CYP27A1;ACOX2;SLC27A5
regulation of transcription regulatory region DNA binding (GO:2000677),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,MAD2L2;TRIM6;MSX2
internal peptidyl-lysine acetylation (GO:0018393),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,NAA50;KAT6A;RUVBL1
T cell activation involved in immune response (GO:0002286),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,TNFSF18;IFNA1;IFNA8
regulation of rhodopsin mediated signaling pathway (GO:0022400),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,RHO;PDE6A;CNGB1
regulation of RNA splicing (GO:0043484),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,RBM38;PTBP1;PIK3R1;CLK4;JMJD6
positive regulation of DNA biosynthetic process (GO:2000573),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,RFC2;TCP1;CCT8;MAP3K4;ATR
Notch signaling pathway (GO:0007219),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,NOTCH3;GMDS;PSEN1;ZNF423;DLL1
"DNA-templated transcription, initiation (GO:0006352)",13/186,0.14053179803192992,1,0,0,1.3978494623655913,2.7430300471977467,NOTCH3;WWTR1;GTF2A2;TAF10;RORC;GTF2H3;GTF2F2;MED15;NR6A1;MED30;ERCC3;CDK1;POLR2F
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),14/204,0.14383363469368182,1,0,0,1.3725490196078431,2.661507006562017,GOLT1B;PDPK1;USP10;TRADD;CARD9;NLRC3;BCL10;ATP2C1;NLRP7;CLEC6A;NUP62;TLR9;CCDC22;TRIM32
positive regulation of programmed cell death (GO:0043068),17/257,0.14683152594026255,1,0,0,1.3229571984435797,2.5380529443924913,TOP2A;TNFAIP8;CSRNP3;GADD45A;TRADD;RPS6;BCL10;PSEN1;SHQ1;ERCC3;RPS6KA2;GPER1;CYP1B1;TNFRSF8;CASP2;ATG7;PHLDA3
regulation of cholesterol metabolic process (GO:0090181),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,SREBF1;SQLE;LDLRAP1;ACACB
phosphatidic acid metabolic process (GO:0046473),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,ACP6;LPCAT1;AGPAT2;AGPAT3
negative regulation of cell projection organization (GO:0031345),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,EPHA4;PTPRO;TNFRSF8;ZNF365
regulation of protein localization (GO:0032880),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,AFDN;MMD;STX6;PLEKHM2
phagosome acidification (GO:0090383),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,RAB38;ATP6V1D;ATP6V1C1
cellular response to topologically incorrect protein (GO:0035967),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,UBE2W;STUB1;HSPA14
glycoprotein biosynthetic process (GO:0009101),6/72,0.15049803689681743,1,0,0,1.6666666666666665,3.1563420645887432,SERP1;FUT7;ALG5;GCNT1;GAL3ST3;DDOST
divalent metal ion transport (GO:0070838),7/88,0.1507542789330227,1,0,0,1.5909090909090908,3.0101655491711536,CHRNA4;CATSPER4;NIPAL3;CACNA1A;SLC30A1;PSEN1;ATP2C1
nucleoside salvage (GO:0043174),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PUDP;PRTFDC1
mitotic cell cycle arrest (GO:0071850),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,FAP;GADD45A
regulation of Golgi organization (GO:1903358),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,EHD3;PDE4DIP
regulation of phosphate metabolic process (GO:0019220),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,SRPX2;PSEN1
acyl-CoA biosynthetic process (GO:0071616),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,HSD17B8;CBR4
modified amino acid transport (GO:0072337),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,SLC1A4;SLC25A32
Golgi to vacuole transport (GO:0006896),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,EHD3;CCDC91
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,MAD2L2;BRCA1
regulation of gastrulation (GO:0010470),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,POGLUT1;CLASP2
regulation of histone modification (GO:0031056),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,MYOCD;AKAP8L
estrogen metabolic process (GO:0008210),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CYP1B1;HSD17B8
regulation of signal transduction by p53 class mediator (GO:1901796),10/138,0.1534135194799526,1,0,0,1.4492753623188406,2.7168380604772677,RMI2;SETD9;RFC2;ERCC4;KAT6A;TAF10;CSNK2B;MDM4;BRCA1;ATR
IRE1-mediated unfolded protein response (GO:0036498),5/57,0.15514033768438892,1,0,0,1.7543859649122806,3.2691669601382802,TATDN2;SERP1;SEC61G;TLN1;SEC63
positive regulation of protein localization to nucleus (GO:1900182),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,TCP1;CDK1;CCT8;PARP9
translesion synthesis (GO:0019985),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,MAD2L2;PCNA;USP10;RFC2
peptidyl-threonine modification (GO:0018210),7/89,0.15706487379765424,1,0,0,1.5730337078651684,2.9118369551802306,GALNT12;PDPK1;DAPK2;CSNK2B;CDK1;GALNT9;PSKH1
B cell activation (GO:0042113),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,ADGRG3;IFNA1;CHRNA4;BTK;IFNA8;NHEJ1
transcription-coupled nucleotide-excision repair (GO:0006283),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,PCNA;ERCC3;RFC2;ERCC4;POLR2F;GTF2H3
positive regulation of sprouting angiogenesis (GO:1903672),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,SRPX2;PDPK1;DLL1
positive regulation of protein tyrosine kinase activity (GO:0061098),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,EPHA4;STAP1;UNC119
regulation of NIK/NF-kappaB signaling (GO:1901222),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,ADGRG3;ILK;NLRC3
cardiac muscle cell action potential involved in contraction (GO:0086002),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,KCNE2;CAV3;SCN4B
protein export from nucleus (GO:0006611),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,XPO6;NUP62;DUSP16
transcription elongation from RNA polymerase I promoter (GO:0006362),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,ERCC3;POLR2F;GTF2H3
cellular calcium ion homeostasis (GO:0006874),9/123,0.16278961618226181,1,0,0,1.4634146341463412,2.6565316245543467,PKHD1;CCL14;SCGN;GPER1;RMDN3;SLC30A1;PSEN1;PDE6A;ATP2C1
response to light stimulus (GO:0009416),5/58,0.16328476821631294,1,0,0,1.7241379310344829,3.1245854451901107,ZRANB3;ERCC3;ERCC4;RHO;TRIM32
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),5/58,0.16328476821631294,1,0,0,1.7241379310344829,3.1245854451901107,GPER1;NUP62;AGR2;CNOT9;PTPN3
sodium ion transport (GO:0006814),5/58,0.16328476821631294,1,0,0,1.7241379310344829,3.1245854451901107,SCN7A;SLC5A2;SLC17A1;KCNK1;SCN4B
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),10/140,0.16350553449103974,1,0,0,1.4285714285714284,2.587012055885183,PKHD1;ADGRG3;MAD2L2;NLRP7;NFKBIL1;TLR9;CYP1B1;PYDC2;NLRC3;TRIB1
nitrogen compound transport (GO:0071705),6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,SLC1A4;SLC6A20;SLC17A1;SLC7A2;SLC38A5;SLC38A4
protein transmembrane import into intracellular organelle (GO:0044743),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,DNAJC19;GRPEL1;PAM16;PEX5
regulation of multicellular organismal development (GO:2000026),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,DEAF1;CDK1;ELL3;CLASP2
axon guidance (GO:0007411),11/158,0.16821183822925043,1,0,0,1.3924050632911391,2.4820054015992006,LGI1;EPHA4;GRB7;NRP1;PTPRO;TNR;TNFRSF8;FRS2;PIK3R1;SPTAN1;NTN1
lipid transport (GO:0006869),7/91,0.17003916876293382,1,0,0,1.5384615384615385,2.725733021512411,SLCO1B1;STARD5;CAV3;SLC10A1;SLCO1B3;APOA5;SLC27A5
negative regulation of kinase activity (GO:0033673),7/91,0.17003916876293382,1,0,0,1.5384615384615385,2.725733021512411,LRRC15;WWTR1;CAV3;PDPK1;TRIB1;LRRC66;SOCS4
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SLC5A8;PARP9
regulation of B cell differentiation (GO:0045577),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TLR9;BTK
embryonic axis specification (GO:0000578),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RIPPLY1;CXXC4
L-alpha-amino acid transmembrane transport (GO:1902475),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SLC1A1;SLC7A2
ventricular cardiac muscle cell action potential (GO:0086005),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,KCNE2;CAV3
regulation of centriole replication (GO:0046599),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NUP62;BRCA1
negative regulation of muscle cell differentiation (GO:0051148),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PTBP1;DLL1
negative regulation of RNA metabolic process (GO:0051253),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PTBP1;SHQ1
JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,GH2;CSH1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,GSN;TRADD
cell junction assembly (GO:0034329),5/59,0.17159602546898528,1,0,0,1.694915254237288,2.987478396269761,FBLIM1;CDH10;ILK;CDH15;TLN1
negative regulation of hydrolase activity (GO:0051346),8/108,0.17280406327587397,1,0,0,1.4814814814814814,2.6008843089787628,FARP1;KLRK1;CSRNP3;SH2D4A;PAM16;VCPKMT;FZD10;SYTL2
protein dephosphorylation (GO:0006470),9/125,0.1739138981897665,1,0,0,1.4399999999999997,2.518840713931456,PTPRT;PPP3CC;SDHAF2;PPP2R2C;EYA2;PTPRO;DUSP16;PTPRF;PTPN3
regulation of striated muscle contraction (GO:0006942),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,CAV3;TNNT3;NKX2-5
collagen fibril organization (GO:0030199),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,ADAMTS3;COL2A1;CYP1B1
positive regulation of histone modification (GO:0031058),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,ING2;AKAP8L;BRCA1
sprouting angiogenesis (GO:0002040),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,NRP1;RSPO3;DLL1;JMJD6
regulation of T cell activation (GO:0050863),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,TNFSF18;IFNL2;GSN;SIRPB1
mitotic nuclear envelope disassembly (GO:0007077),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,NUP210;NUP50;NUP62;CDK1
positive regulation of JNK cascade (GO:0046330),6/76,0.17945756311992533,1,0,0,1.5789473684210524,2.712341867627267,GADD45A;CARD9;TLR9;FZD10;RASGRP1;MAP3K4
mitochondrial gene expression (GO:0140053),4/45,0.18643368284604128,1,0,0,1.7777777777777777,2.98609722860718,MRPS17;MTERF4;GATC;MRPS6
response to ionizing radiation (GO:0010212),6/77,0.18702582489369443,1,0,0,1.5584415584415583,2.612740629548293,MTA1;GADD45A;ERCC4;BRCA1;INIP;NHEJ1
regulation of actin cytoskeleton reorganization (GO:2000249),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,NRP1;ARHGDIB;STAP1
fatty-acyl-CoA biosynthetic process (GO:0046949),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,TECR;HSD17B8;CBR4
bile acid metabolic process (GO:0008206),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,CYP27A1;ACOX2;SLC27A5
regulation of sodium ion transmembrane transport (GO:1902305),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,CAV3;SCN4B;PTPN3
positive regulation of epithelial cell apoptotic process (GO:1904037),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,GSN;GPER1
negative regulation of NF-kappaB import into nucleus (GO:0042347),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PYDC2;CCDC22
positive regulation of secretion (GO:0051047),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ALOX12B;LACRT
regulation of membrane depolarization (GO:0003254),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CAV3;PTPN3
regulation of dopamine secretion (GO:0014059),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CHRNA4;KCNA2
leukocyte tethering or rolling (GO:0050901),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PODXL2;GCNT1
cytoplasmic sequestering of transcription factor (GO:0042994),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NFKBIL1;CCDC22
epithelial cell development (GO:0002064),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,POF1B;RILPL1
leukocyte adhesion to vascular endothelial cell (GO:0061756),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PODXL2;GCNT1
hexose transport (GO:0008645),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SLC2A5;SLC5A2
peptidyl-lysine methylation (GO:0018022),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SETD3;VCPKMT
negative regulation of DNA replication (GO:0008156),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ENPP7;ATR
regulation of steroid metabolic process (GO:0019218),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,RORC;STUB1
positive regulation of triglyceride metabolic process (GO:0090208),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SREBF1;APOA5
regulation of SMAD protein import into nucleus (GO:0060390),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,WWTR1;PBLD
genitalia development (GO:0048806),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,DNAJC19;SRD5A1
detection of visible light (GO:0009584),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,RHO;CNGB1
neurotransmitter transport (GO:0006836),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,GABRA2;SLC17A6
regulation of interferon-alpha production (GO:0032647),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,IRF3;NLRC3
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,NKX2-5;GTF2F2
visual perception (GO:0007601),6/78,0.19471584243590756,1,0,0,1.5384615384615385,2.5172523099552775,DNAJC19;COL2A1;OPA3;CABP4;CYP1B1;CNGB1
positive regulation of ion transport (GO:0043270),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,FFAR1;DRD1;NKX2-5;SCN4B
regulation of fibroblast proliferation (GO:0048145),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,FN1;PDGFA;NLRC3;TRIM32
transcription elongation from RNA polymerase II promoter (GO:0006368),7/95,0.19731095294472298,1,0,0,1.4736842105263155,2.3917516785909614,GTF2A2;ERCC3;TAF10;POLR2F;GTF2H3;GTF2F2;ELL3
positive regulation of apoptotic process (GO:0043065),19/307,0.19931135085934243,1,0,0,1.2377850162866448,1.996407485033504,TOP2A;TNFAIP8;CSRNP3;GADD45A;TRADD;RPS6;BCL10;PSEN1;SHQ1;FAP;ERCC3;RPS6KA2;GPER1;CYP1B1;TNFRSF8;CASP2;BLID;ATG7;PHLDA3
ion transport (GO:0006811),18/289,0.19973411560636045,1,0,0,1.2456747404844288,2.0064932830185316,GABRA2;GABRA1;GABRP;CHRNA4;SLC1A1;AQP6;WWP1;HTR3B;ATP2C1;GABRR3;SLC5A8;SLC17A6;CASQ1;SLC12A6;SLC17A1;ATP6V1D;ATP6V1C1;CNGB1
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,ARG2;NFKBIL1;NLRC3
zinc ion homeostasis (GO:0055069),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,MT1A;MT1M;SLC30A1
cellular zinc ion homeostasis (GO:0006882),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,MT1A;MT1M;SLC30A1
termination of RNA polymerase I transcription (GO:0006363),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,ERCC3;POLR2F;GTF2H3
sarcomere organization (GO:0045214),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,TNNT3;CASQ1;KLHL41
vesicle-mediated transport to the plasma membrane (GO:0098876),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,ANKRD27;EXOC5;CCDC22
cation transport (GO:0006812),6/79,0.20252260341125683,1,0,0,1.5189873417721518,2.425676623110086,SLC1A1;SLC1A4;SLC6A20;SLC38A5;CNGB1;RHD
protein localization to plasma membrane (GO:0072659),9/130,0.20317246774459144,1,0,0,1.3846153846153846,2.206661629625701,GOLGA7B;DPP10;C16ORF70;EHD3;CAV3;RILPL1;FCHO2;TSPAN33;CLASP2
protein glycosylation (GO:0006486),9/130,0.20317246774459144,1,0,0,1.3846153846153846,2.206661629625701,POGLUT1;FUT7;SERP1;ALG5;MOGS;ST8SIA6;PARP9;GALNT9;DDOST
translational termination (GO:0006415),7/96,0.20438472217151854,1,0,0,1.4583333333333333,2.3154704536306197,MRPS17;MRPS33;MRPS23;MRPS30;MRPS6;MRPL46;GSPT2
oligosaccharide metabolic process (GO:0009311),5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,GALNT12;NAGA;ST8SIA6;GAL3ST3;GALNT9
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,USP10;NLRC3;PYDC2;CCDC22
polyol metabolic process (GO:0019751),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,MINPP1;PLCZ1;IMPA2;PLCH2
positive regulation of tumor necrosis factor production (GO:0032760),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,TLR9;TNFRSF8;RASGRP1;HLA-E
postreplication repair (GO:0006301),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,PCNA;USP10;RFC2;BRCA1
fatty acid biosynthetic process (GO:0006633),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,TECR;ACSM6;HSD17B8;CBR4
inositol phosphate metabolic process (GO:0043647),4/47,0.20718336704116536,1,0,0,1.7021276595744679,2.679406036964871,MINPP1;PLCZ1;IMPA2;PLCH2
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,NKX2-5;GTF2F2
microtubule nucleation (GO:0007020),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TUBGCP3;CLASP2
cardiac muscle cell contraction (GO:0086003),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,KCNE2;SCN4B
DNA packaging (GO:0006323),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,KAT6A;GATAD1
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TMEM102;MPV17L
negative regulation of lipid biosynthetic process (GO:0051055),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,GPER1;BRCA1
negative regulation of reactive oxygen species metabolic process (GO:2000378),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SIRT5;BRCA1
spindle assembly checkpoint (GO:0071173),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MAD2L2;BUB1
negative regulation of stress fiber assembly (GO:0051497),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,WASF2;CLASP2
peptidyl-lysine trimethylation (GO:0018023),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SETD3;VCPKMT
rRNA catabolic process (GO:0016075),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ERN2;EXOSC6
regulation of protein localization to membrane (GO:1905475),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,GSN;LDLRAP1
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,KLRK1;RASGRP1
serine family amino acid metabolic process (GO:0009069),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SLC25A32;CDO1
purine-containing compound metabolic process (GO:0072521),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SLC16A9;SLC17A1
platelet-derived growth factor receptor signaling pathway (GO:0048008),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,NRP1;PDGFA
mitotic spindle assembly checkpoint (GO:0007094),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MAD2L2;BUB1
mitotic spindle checkpoint (GO:0071174),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MAD2L2;BUB1
nucleic acid metabolic process (GO:0090304),6/80,0.21044099394584637,1,0,0,1.4999999999999998,2.337824968427116,PTBP1;PCBP1;TREX1;POLR2F;DNASE2;GTF2F2
phosphatidylcholine biosynthetic process (GO:0006656),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,CSNK2B;LPCAT1;CEPT1
oxoacid metabolic process (GO:0043436),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,MINPP1;PODXL2;SULT4A1
ceramide biosynthetic process (GO:0046513),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,SAMD8;ALOX12B;ST8SIA6
regulation of potassium ion transmembrane transport (GO:1901379),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,DPP10;KCNE2;CAV3
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,TLR9;RASGRP1;HLA-E
phagosome maturation (GO:0090382),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,RAB38;ATP6V1D;ATP6V1C1
substrate adhesion-dependent cell spreading (GO:0034446),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,NRP1;FN1;ILK
global genome nucleotide-excision repair (GO:0070911),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,ERCC3;ERCC4;GTF2H3
positive regulation of JAK-STAT cascade (GO:0046427),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,TNFSF18;GH2;CYP1B1;PARP9;CRLF1
positive regulation of endocytosis (GO:0045807),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,LDLRAP1;DOCK2;APOA5;DLL1;SIRPB1
negative regulation of neuron differentiation (GO:0045665),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,EPHA4;PTPRO;TNFRSF8;DLL1;ZNF365
regulation of MAPK cascade (GO:0043408),13/203,0.21721330783374762,1,0,0,1.2807881773399015,1.9556039898526423,GDF10;EPHA4;CAV3;FN1;PDGFA;ALOX12B;RASGRP1;PKHD1;SBK2;RRAS;GPER1;TLR9;TRIB1
regulation of mitochondrion organization (GO:0010821),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,SREBF1;TMEM102;RUVBL1;MGARP
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,CASP2;BRCA1;CRIP1;PHLDA3
cellular response to mechanical stimulus (GO:0071260),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,GADD45A;CASP2;TNFRSF8;BCL10
sensory perception of light stimulus (GO:0050953),6/81,0.21846581133310103,1,0,0,1.4814814814814814,2.253519624534179,DNAJC19;COL2A1;OPA3;CABP4;CYP1B1;CNGB1
protein targeting (GO:0006605),9/133,0.22164004840978987,1,0,0,1.3533834586466165,2.0391436915940395,GOLGA7B;DNAJC19;TMEM50B;SEC61G;ZDHHC12;HOMER3;MGARP;SRP68;SEC63
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),8/116,0.22432316253884624,1,0,0,1.379310344827586,2.0616104508948703,TNFSF18;GH2;EPHA4;NRP1;UNC119;PARP9;LACRT;CRLF1
cellular response to type I interferon (GO:0071357),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,IFNA1;IRF3;XAF1;IFNA8;HLA-E
regulation of JAK-STAT cascade (GO:0046425),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,GH2;LRRC15;CYP1B1;LRRC66;SOCS4
DNA synthesis involved in DNA repair (GO:0000731),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,RMI2;PCNA;RFC2;USP10;BRCA1
type I interferon signaling pathway (GO:0060337),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,IFNA1;IRF3;XAF1;IFNA8;HLA-E
steroid metabolic process (GO:0008202),7/99,0.2261619520902503,1,0,0,1.414141414141414,2.1021267756043183,CYP27A1;SRD5A1;UGT2B15;CYP1B1;DHCR24;CYP2C19;TRERF1
small GTPase mediated signal transduction (GO:0007264),7/99,0.2261619520902503,1,0,0,1.414141414141414,2.1021267756043183,RIT1;RRAS;GRAP2;RAB38;RGL1;RUNDC3A;NTN1
regulation of spindle organization (GO:0090224),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,SENP6;NUP62
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,IFNA1;IFNA8
negative regulation of fibroblast proliferation (GO:0048147),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,NLRC3;TRIM32
regulation of mitochondrial membrane permeability (GO:0046902),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,TMEM102;ALKBH7
positive regulation of actin cytoskeleton reorganization (GO:2000251),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,NRP1;STAP1
positive regulation of p38MAPK cascade (GO:1900745),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,GADD45A;MAP3K4
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,IFNA1;IFNA8
regulation of epithelial cell differentiation (GO:0030856),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,DLL1;DSPP
DNA ligation (GO:0006266),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,TOP2A;PCNA
intracellular pH reduction (GO:0051452),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,RAB38;ATP6V1D;ATP6V1C1
positive regulation of cytokine-mediated signaling pathway (GO:0001961),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,TRIM6;PARP9;AGPAT2
protein acetylation (GO:0006473),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,NAA50;KAT6A;LACRT
"chemical synaptic transmission, postsynaptic (GO:0099565)",3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,GABRA2;GABRA1;CHRNA4
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,NUP210;NUP50;NUP62
regulation of cell-substrate adhesion (GO:0010810),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,FZD4;PTPRO;AGR2
tRNA export from nucleus (GO:0006409),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,NUP210;NUP50;NUP62
regulation of postsynaptic membrane potential (GO:0060078),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,GABRA2;GABRA1;CHRNA4
transcription initiation from RNA polymerase I promoter (GO:0006361),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,ERCC3;POLR2F;GTF2H3
positive regulation of catalytic activity (GO:0043085),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,DAOA;PSEN1;NHEJ1
transcription from RNA polymerase I promoter (GO:0006360),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,ERCC3;POLR2F;GTF2H3
positive regulation of organelle organization (GO:0010638),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,TMED9;RAB3GAP2;MGARP
axonogenesis (GO:0007409),14/223,0.22717657130788282,1,0,0,1.2556053811659191,1.8608419761202477,LGI1;GRB7;NRP1;PTPRO;FRS2;PRELP;PIK3R1;NTN1;SLITRK2;SLITRK4;TLR9;TNR;TNFRSF8;SPTAN1
RNA methylation (GO:0001510),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,MEPCE;MTERF4;TRMT13;FTSJ1
organic hydroxy compound biosynthetic process (GO:1901617),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,CYP27A1;SQLE;ACOX2;SLC27A5
regulation of reactive oxygen species metabolic process (GO:2000377),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,GADD45A;CYP1B1;SIRT5;BRCA1
establishment of protein localization to mitochondrion (GO:0072655),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,DNAJC19;GRPEL1;PAM16;MGARP
positive regulation of response to DNA damage stimulus (GO:2001022),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,PCNA;EYA2;BRCA1;ATR
intracellular steroid hormone receptor signaling pathway (GO:0030518),5/66,0.23381942521025603,1,0,0,1.5151515151515151,2.201827497975576,RHOXF1;NR6A1;MED30;GPER1;BRCA1
positive regulation of protein ubiquitination (GO:0031398),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,MTA1;CAV3;STUB1;BRCA1;BCL10;CCDC22
protein maturation (GO:0051604),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,ADAMTS3;CASP2;STUB1;PSEN1;TSPAN33;ASPRV1
regulation of ion transport (GO:0043269),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,CHRNA4;KCNA2;KCNJ16;DRD1
wound healing (GO:0042060),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,PDGFA;PRCP;LACRT;KRT6A
regulation of JUN kinase activity (GO:0043506),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,TLR9;FZD10;MAP3K4
regulation of alcohol biosynthetic process (GO:1902930),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,SREBF1;SQLE;ACACB
regulation of axon extension (GO:0030516),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,EPHA4;CTTN;NTN1
positive regulation of cell development (GO:0010720),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,GPER1;OPRM1;TRIM32
regulation of interleukin-1 beta secretion (GO:0050706),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,NLRP7;CPTP;PYDC2
regulation of interferon-beta production (GO:0032648),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,IRF3;TLR9;NLRC3
cellular divalent inorganic cation homeostasis (GO:0072503),7/101,0.24110527590989309,1,0,0,1.3861386138613863,1.9718121345751627,PKHD1;CCL14;MT1A;MT1M;RMDN3;SLC30A1;ATP2C1
epidermal cell differentiation (GO:0009913),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,LCE1A;LCE2C;ERCC3;LCE4A;IVL
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,HEXIM2;MYOCD;GADD45A;MAPRE3;CCNL2
cellular response to UV (GO:0034644),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,PCNA;ERCC4;ACTR5;CRIP1;ATR
error-free translesion synthesis (GO:0070987),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PCNA;RFC2
regulation of sprouting angiogenesis (GO:1903670),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PDPK1;DLL1
regulation of long-term synaptic potentiation (GO:1900271),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,EPHA4;SCGN
positive regulation of STAT cascade (GO:1904894),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GH2;CYP1B1
purine ribonucleoside bisphosphate metabolic process (GO:0034035),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PODXL2;SULT4A1
cellular response to zinc ion (GO:0071294),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,MT1A;MT1M
regulation of transcription factor import into nucleus (GO:0042990),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HDAC3;PIK3R1
positive regulation of interferon-alpha production (GO:0032727),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,IRF3;TLR9
fatty-acyl-CoA metabolic process (GO:0035337),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HSD17B8;CBR4
macromolecule biosynthetic process (GO:0009059),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,ADAMTS3;EIF4G2
positive regulation of immunoglobulin production (GO:0002639),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,TLR9;HLA-E
negative regulation of calcium ion transport (GO:0051926),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CAV3;SLC30A1
protein heterotetramerization (GO:0051290),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HSD17B8;CBR4
regulation of cAMP biosynthetic process (GO:0030817),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CAP1;GPER1
response to interferon-beta (GO:0035456),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,TRIM6;XAF1
positive regulation of axon extension (GO:0045773),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,NRP1;NTN1
negative regulation of neuron projection development (GO:0010977),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,EPHA4;PTPRO;TNFRSF8;ZNF365
regulation of telomere maintenance via telomerase (GO:0032210),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,TCP1;CCT8;MAP3K4;ATR
arachidonic acid metabolic process (GO:0019369),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,CBR1;CYP1B1;ALOX12B;CYP2C19
positive regulation of developmental growth (GO:0048639),4/51,0.2504443908625444,1,0,0,1.5686274509803921,2.171793530456325,SYT4;AGR2;NTN1;DLL1
cholesterol metabolic process (GO:0008203),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,SQLE;DHCR24;LDLRAP1;APOA5;TRERF1
peptidyl-threonine phosphorylation (GO:0018107),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,PDPK1;DAPK2;CSNK2B;CDK1;PSKH1
negative regulation of protein kinase B signaling (GO:0051898),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PKHD1;GPER1;PHLDA3
anatomical structure homeostasis (GO:0060249),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PCNA;ERCC4;ZNF365
endothelial cell migration (GO:0043542),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,NRP1;FAP;CYP1B1
tRNA transport (GO:0051031),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,NUP210;NUP50;NUP62
cholesterol biosynthetic process (GO:0006695),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,SQLE;DHCR24;APOA5
regulation of sodium ion transport (GO:0002028),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,NKAIN1;NKX2-5;SCN4B
carboxylic acid transmembrane transport (GO:1905039),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,SLC25A32;SLC38A5;SLC38A4
negative regulation of tumor necrosis factor production (GO:0032720),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,ARG2;NFKBIL1;NLRC3
Golgi organization (GO:0007030),8/121,0.25904531858348734,1,0,0,1.322314049586777,1.7861186874223587,GOLGA8S;RAB2A;GOLGA8DP;TMED9;CDK1;STX6;PLEKHM2;CLASP2
regulation of calcium ion transport (GO:0051924),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,CAV3;HOMER3;FFAR1;CASQ1
B cell differentiation (GO:0030183),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,ADGRG3;IFNA1;IFNA8;NHEJ1
positive regulation of cell-substrate adhesion (GO:0010811),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,NRP1;DOCK5;AGR2;FN1
regulation of innate immune response (GO:0045088),5/69,0.26222604197239524,1,0,0,1.4492753623188406,1.9399252051607478,IFNA1;NLRC3;PARP9;IFNA8;HLA-E
regulation of cellular response to stress (GO:0080135),7/104,0.26407942160983944,1,0,0,1.346153846153846,1.7924110906796216,DNAJB1;ING2;NUP210;NUP50;NUP62;OPRM1;ATR
proteoglycan metabolic process (GO:0006029),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,CHST14;GAL3ST3
natural killer cell activation involved in immune response (GO:0002323),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,IFNA1;IFNA8
negative regulation of actin filament bundle assembly (GO:0032232),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,WASF2;CLASP2
neuromuscular junction development (GO:0007528),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,CACNB1;ZC4H2
regulation of toll-like receptor signaling pathway (GO:0034121),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,NFKBIL1;TLR9
inositol phosphate-mediated signaling (GO:0048016),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,PPP3CC;LACRT
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,STAP1;CEP97
cellular response to estradiol stimulus (GO:0071392),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,GPER1;CCDC62
cellular response to steroid hormone stimulus (GO:0071383),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,GPER1;MGARP
entrainment of circadian clock by photoperiod (GO:0043153),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,MTA1;CRTC1
mitochondrial RNA metabolic process (GO:0000959),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,MTERF2;MTERF4
positive regulation of DNA-directed DNA polymerase activity (GO:1900264),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFC2
regulation of glomerular filtration (GO:0003093),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPRO
macropinocytosis (GO:0044351),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DOCK2
positive regulation of interferon-gamma secretion (GO:1902715),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RASGRP1
neuron projection maintenance (GO:1990535),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PSEN1
mesodermal cell fate commitment (GO:0001710),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EYA2
regulation of lymphocyte apoptotic process (GO:0070228),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BTK
COPI coating of Golgi vesicle (GO:0048205),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED9
regulation of extent of cell growth (GO:0061387),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CTTN
embryonic skeletal joint development (GO:0072498),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,COL2A1
positive regulation of aspartic-type peptidase activity (GO:1905247),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EPHA4
mitochondrial ribosome assembly (GO:0061668),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MTERF4
monoterpenoid metabolic process (GO:0016098),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CYP2C19
spinal cord motor neuron differentiation (GO:0021522),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ZC4H2
lipoprotein metabolic process (GO:0042157),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,APOA5
prepulse inhibition (GO:0060134),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DRD1
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,UXT
negative regulation of catecholamine secretion (GO:0033604),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SYT4
"regulation of phagocytosis, engulfment (GO:0060099)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STAP1
positive regulation of activin receptor signaling pathway (GO:0032927),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CSNK2B
ventricular cardiac muscle cell development (GO:0055015),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NKX2-5
snRNA modification (GO:0040031),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MEPCE
establishment of endothelial intestinal barrier (GO:0090557),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,AFDN
positive regulation of receptor binding (GO:1900122),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRP1
regulation of adiponectin secretion (GO:0070163),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RAB11FIP5
ceramide transport (GO:0035627),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CPTP
regulation of cardiac muscle cell apoptotic process (GO:0010665),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NKX2-5
muscle tissue development (GO:0060537),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,POGLUT1
Golgi transport vesicle coating (GO:0048200),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED9
renal system process involved in regulation of blood volume (GO:0001977),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPRO
histone H4-K12 acetylation (GO:0043983),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,JADE2
collagen biosynthetic process (GO:0032964),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ADAMTS3
positive regulation of cardiac muscle tissue development (GO:0055025),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MYOCD
regulation of protein targeting (GO:1903533),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SREBF1
negative regulation of neurological system process (GO:0031645),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TNFRSF8
regulation of skeletal muscle contraction (GO:0014819),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CAV3
retinal ganglion cell axon guidance (GO:0031290),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRP1
male genitalia development (GO:0030539),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SRD5A1
peroxisomal membrane transport (GO:0015919),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PEX5
"regulation of wound healing, spreading of epidermal cells (GO:1903689)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CLASP2
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GTF2H3
queuosine metabolic process (GO:0046116),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PDCL2
regulation of ribonucleoprotein complex localization (GO:2000197),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,AKAP8L
COPI-coated vesicle budding (GO:0035964),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED9
glandular epithelial cell development (GO:0002068),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLL1
ammonium transmembrane transport (GO:0072488),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RHD
regulation of glial cell apoptotic process (GO:0034350),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLL1
negative regulation of cell size (GO:0045792),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CAV3
regulation of phosphatidylinositol biosynthetic process (GO:0010511),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PDGFA
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HLA-E
embryonic skeletal joint morphogenesis (GO:0060272),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,COL2A1
alpha-beta T cell activation (GO:0046631),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HLA-E
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BCL10
interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TUBGCP3
Golgi disassembly (GO:0090166),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CDK1
type B pancreatic cell development (GO:0003323),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLL1
positive regulation of axon guidance (GO:1902669),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NRP1
neurotransmitter loading into synaptic vesicle (GO:0098700),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC17A6
"positive regulation of protein import into nucleus, translocation (GO:0033160)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PSEN1
regulation of keratinocyte apoptotic process (GO:1902172),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GSN
ribonucleoside biosynthetic process (GO:0042455),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PDCL2
dosage compensation by inactivation of X chromosome (GO:0009048),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BRCA1
negative regulation of calcium ion-dependent exocytosis (GO:0045955),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SYT4
positive regulation of microglial cell activation (GO:1903980),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STAP1
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HSF4
telencephalon cell migration (GO:0022029),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FOXB1
negative regulation of systemic arterial blood pressure (GO:0003085),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRCP
glycosyl compound catabolic process (GO:1901658),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NAGA
polyphosphate metabolic process (GO:0006797),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MINPP1
lipoprotein catabolic process (GO:0042159),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LYPLAL1
negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,KCNE2
queuosine biosynthetic process (GO:0008616),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PDCL2
morphogenesis of an endothelium (GO:0003159),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CSNK2B
negative regulation of meiotic nuclear division (GO:0045835),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ERCC4
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LYST
astrocyte differentiation (GO:0048708),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DLL1
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RAB11FIP5
negative regulation of myeloid cell apoptotic process (GO:0033033),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MAEA
sterol import (GO:0035376),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STARD5
regulation of cytokine production involved in immune response (GO:0002718),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BTK
regulation of mRNA export from nucleus (GO:0010793),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,AKAP8L
astrocyte activation (GO:0048143),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PSEN1
regulation of NFAT protein import into nucleus (GO:0051532),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LACRT
regulation of sarcomere organization (GO:0060297),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CAV3
regulation of DNA-directed DNA polymerase activity (GO:1900262),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFC2
L-amino acid import (GO:0043092),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC1A1
cholesterol import (GO:0070508),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STARD5
positive regulation of protein localization to centrosome (GO:1904781),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NUP62
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EPHA4
neuron remodeling (GO:0016322),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANKS1A
apoptotic process (GO:0006915),14/231,0.2672701409403699,1,0,0,1.2121212121212122,1.5993883251494772,GADD45A;DAPK2;TRADD;DHCR24;BRCA1;MRPS30;TNFAIP1;DUX4;FAP;IRF3;ERCC3;CASP2;PHLDA2;MCM2
regulation of potassium ion transport (GO:0043266),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,DPP10;KCNE2;DRD1
carbohydrate biosynthetic process (GO:0016051),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,GALNT12;ST8SIA6;GALNT9
plasma membrane organization (GO:0007009),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,SERP1;CAV3;PLSCR2
epithelial cell migration (GO:0010631),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,NRP1;FAP;CYP1B1
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,GNG2;FZD4;PDE6A
regulation of ubiquitin protein ligase activity (GO:1904666),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,MAD2L2;UBE2S;CDK1
cardiac muscle tissue development (GO:0048738),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,KDM6B;MYOCD;NKX2-5
mitochondrial translational elongation (GO:0070125),6/87,0.2685502192059934,1,0,0,1.379310344827586,1.813403236377029,MRPS17;MRPS33;MRPS23;MRPS30;MRPS6;MRPL46
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),6/87,0.2685502192059934,1,0,0,1.379310344827586,1.813403236377029,PSMA6;CAV3;PSME3;PSME1;CDK1;CCDC22
regulation of canonical Wnt signaling pathway (GO:0060828),13/213,0.26916035984924336,1,0,0,1.220657276995305,1.6020491331898241,INVS;WWTR1;PTPRO;ILK;PSEN1;MAD2L2;PSMA6;SDHAF2;PSME3;RUVBL1;PSME1;ANKRD10;NKX2-5
snRNA transcription (GO:0009301),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,GTF2A2;POLR2F;PHAX;GTF2F2;ELL3
snRNA transcription from RNA polymerase II promoter (GO:0042795),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,GTF2A2;POLR2F;PHAX;GTF2F2;ELL3
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,TNFSF18;GH2;PARP9;CRLF1
tumor necrosis factor-mediated signaling pathway (GO:0033209),8/123,0.27337366492441967,1,0,0,1.3008130081300813,1.6870447917730367,TNFSF18;PSMA6;PSME3;TRADD;PSME1;TNFRSF8;ILK;TNFRSF13C
T cell activation (GO:0042110),6/88,0.2771694338705115,1,0,0,1.3636363636363635,1.7497176615936614,IFNA1;NLRC3;IFNA8;DDOST;MICA;NHEJ1
regulation of protein targeting to mitochondrion (GO:1903214),6/88,0.2771694338705115,1,0,0,1.3636363636363635,1.7497176615936614,SREBF1;LRRC46;RUVBL1;ACSM6;ATG13;OR13C4
chemical synaptic transmission (GO:0007268),17/289,0.2794068430649466,1,0,0,1.176470588235294,1.5001015770102055,GABRA2;GABRA1;GABRP;CHRNA4;SLC1A1;CACNA1A;SLC1A4;OPRM1;HTR3B;GABRR3;CACNB1;PLP1;UNC119;SLC17A6;MYCBPAP;SLC12A6;TSPOAP1
positive regulation of cellular component organization (GO:0051130),7/106,0.27972134756360467,1,0,0,1.320754716981132,1.6825904736403015,TMED9;SRPX2;SLITRK2;PLEKHM2;APOA5;DLL1;ATR
actomyosin structure organization (GO:0031032),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,EPB41L1;TNNT3;TNFAIP1;CASQ1;KLHL41
phosphatidylcholine metabolic process (GO:0046470),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,CSNK2B;LPCAT1;PLBD1;CEPT1;APOA5
histone acetylation (GO:0016573),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,NAA50;KAT6A;TAF10;RUVBL1;JADE2
positive regulation of growth (GO:0045927),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,LGI1;GH2;AGR2;TRIM32;EIF4G2
protein peptidyl-prolyl isomerization (GO:0000413),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,FKBP10;FKBP7;FKBP3
regulation of DNA repair (GO:0006282),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,PCNA;EYA2;BRCA1
phospholipid biosynthetic process (GO:0008654),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,SAMD8;LPCAT1;AGPAT3
regulation of carbohydrate catabolic process (GO:0043470),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,NUP210;NUP50;NUP62
positive regulation of cellular component movement (GO:0051272),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,NTN1;TRIM32
epoxygenase P450 pathway (GO:0019373),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CYP1B1;CYP2C19
regulation of ruffle assembly (GO:1900027),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CARMIL2;STAP1
cellular response to hexose stimulus (GO:0071331),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,GPER1;SLC2A5
histone lysine demethylation (GO:0070076),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,KDM6B;PHF8
mitochondrial fission (GO:0000266),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MTFP1;MTFR1
positive regulation of lamellipodium organization (GO:1902745),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CARMIL2;WASF2
protein O-linked glycosylation via threonine (GO:0018243),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,GALNT12;GALNT9
embryonic skeletal system morphogenesis (GO:0048704),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,COL2A1;SIX1
establishment of endothelial barrier (GO:0061028),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,AFDN;MARVELD2
positive regulation of defense response to virus by host (GO:0002230),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,TRIM6;PARP9
cellular response to misfolded protein (GO:0071218),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,UBE2W;STUB1
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,HEXIM2;MYOCD
cellular response to copper ion (GO:0071280),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MT1A;MT1M
embryonic skeletal system development (GO:0048706),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,DEAF1;SIX1
photoperiodism (GO:0009648),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,MTA1;CRTC1
"synaptic transmission, glutamatergic (GO:0035249)",2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,SLC17A6;SLC1A4
protein targeting to mitochondrion (GO:0006626),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,DNAJC19;GRPEL1;PAM16;MGARP
negative regulation of cellular component organization (GO:0051129),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,DNAJB1;CARMIL2;FAP;SACS
cytoplasmic translation (GO:0002181),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,RPS3A;HSPA14;FTSJ1;GSPT2
positive regulation of response to stimulus (GO:0048584),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,ARG2;ACOX2;ILK;C2CD2L
mitochondrial translational termination (GO:0070126),6/89,0.2858516905884061,1,0,0,1.348314606741573,1.6884703375813395,MRPS17;MRPS33;MRPS23;MRPS30;MRPS6;MRPL46
cell-cell junction organization (GO:0045216),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,AFDN;MARVELD2;CDH10;CDH15;TLN1
negative regulation of cell cycle (GO:0045786),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,HEXIM2;MYOCD;GPER1;RPS6KA2;PTPN3
regulation of gene silencing by RNA (GO:0060966),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,NUP210;NUP50;NUP62;POLR2F
regulation of posttranscriptional gene silencing (GO:0060147),4/55,0.2953729340320737,1,0,0,1.4545454545454544,1.773842236930121,NUP210;NUP50;NUP62;POLR2F
potassium ion import (GO:0010107),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,KCNE2;KCNJ16;SLC12A6
mitochondrion disassembly (GO:0061726),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,WDR45B;ATG7;ATG13
positive regulation of innate immune response (GO:0045089),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,TRIM6;TLR9;HLA-E
positive regulation of DNA repair (GO:0045739),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,PCNA;EYA2;BRCA1
nucleotide-excision repair (GO:0006289),7/108,0.29558593657898286,1,0,0,1.296296296296296,1.5799203089302307,GTF2H2C;PCNA;ERCC3;RFC2;ERCC4;POLR2F;GTF2H3
"DNA-templated transcription, elongation (GO:0006354)",7/108,0.29558593657898286,1,0,0,1.296296296296296,1.5799203089302307,GTF2A2;ERCC3;TAF10;POLR2F;GTF2H3;GTF2F2;ELL3
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),10/163,0.2988597106982444,1,0,0,1.2269938650306749,1.4819398904135106,GOLT1B;CLEC6A;TRADD;NUP62;CARD9;TLR9;BCL10;CCDC22;ATP2C1;TRIM32
nucleic acid phosphodiester bond hydrolysis (GO:0090305),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,PCNA;ERCC3;RFC2;ERCC4;GTF2H3
chloride transport (GO:0006821),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,GABRA2;GABRA1;SLC1A1;SLC4A10;SLC12A6
regulation of entry of bacterium into host cell (GO:2000535),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KRT6A
negative regulation of muscle hypertrophy (GO:0014741),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CAV3
replication fork protection (GO:0048478),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZRANB3
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MPV17L
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LACRT
coenzyme A biosynthetic process (GO:0015937),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PPCDC
regulation of hormone biosynthetic process (GO:0046885),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TRERF1
regulation of interleukin-13 production (GO:0032656),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HLA-E
AV node cell action potential (GO:0086016),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SCN4B
flavin-containing compound metabolic process (GO:0042726),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FLAD1
negative regulation of glial cell apoptotic process (GO:0034351),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DLL1
regulation of extracellular matrix organization (GO:1903053),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FAP
regulation of cardiac muscle cell membrane potential (GO:0086036),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EHD3
ornithine transport (GO:0015822),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC7A2
ribonucleoside bisphosphate biosynthetic process (GO:0034030),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PPCDC
sulfur amino acid biosynthetic process (GO:0000097),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CDO1
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PROM1
glycoside catabolic process (GO:0016139),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NAGA
positive regulation of cellular senescence (GO:2000774),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ARG2
riboflavin metabolic process (GO:0006771),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FLAD1
positive regulation of histone H4 acetylation (GO:0090240),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BRCA1
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SEC63
cytoplasmic sequestering of NF-kappaB (GO:0007253),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCDC22
reproductive system development (GO:0061458),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SRD5A1
regulation of natural killer cell chemotaxis (GO:2000501),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KLRK1
nucleic acid transport (GO:0050657),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NXF2
death-inducing signaling complex assembly (GO:0071550),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TRADD
retrograde axonal transport (GO:0008090),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MGARP
negative regulation of cardiac muscle cell differentiation (GO:2000726),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FRS2
negative regulation of telomere capping (GO:1904354),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ERCC4
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYOCD
L-alanine transport (GO:0015808),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC1A4
regulation of sterol transport (GO:0032371),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,APOA5
regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TLR9
terpenoid metabolic process (GO:0006721),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CYP2C19
activation of MAPKKK activity (GO:0000185),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GADD45A
chitin metabolic process (GO:0006030),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CHIA
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDGFA
box C/D snoRNP assembly (GO:0000492),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RUVBL1
negative regulation of calcium ion import (GO:0090281),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC30A1
positive regulation of B cell differentiation (GO:0045579),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BTK
regulation of interleukin-18 production (GO:0032661),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TLR9
glycosphingolipid catabolic process (GO:0046479),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NAGA
phosphorylated carbohydrate dephosphorylation (GO:0046838),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IMPA2
L-cysteine metabolic process (GO:0046439),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CDO1
negative regulation of cell adhesion mediated by integrin (GO:0033629),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CYP1B1
regulation of smooth muscle cell differentiation (GO:0051150),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYOCD
vascular endothelial growth factor signaling pathway (GO:0038084),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NRP1
glycosylceramide metabolic process (GO:0006677),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NAGA
regulation of histone H3-K9 acetylation (GO:2000615),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BRCA1
inositol phosphate dephosphorylation (GO:0046855),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IMPA2
cellular lipid biosynthetic process (GO:0097384),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ERG28
positive regulation of inositol phosphate biosynthetic process (GO:0060732),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GPER1
positive regulation of triglyceride catabolic process (GO:0010898),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,APOA5
negative regulation of cardiocyte differentiation (GO:1905208),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FRS2
negative regulation of B cell apoptotic process (GO:0002903),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BCL10
female genitalia development (GO:0030540),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SRD5A1
negative regulation of axon regeneration (GO:0048681),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EPHA4
negative regulation of epidermal cell differentiation (GO:0045605),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DLL1
cell differentiation in spinal cord (GO:0021515),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZC4H2
purine nucleoside bisphosphate biosynthetic process (GO:0034033),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PPCDC
negative regulation of glycoprotein biosynthetic process (GO:0010561),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ITM2B
regulation of cell projection organization (GO:0031344),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FAM110C
regulation of microglial cell activation (GO:1903978),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STAP1
positive regulation of type I interferon-mediated signaling pathway (GO:0060340),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TRIM6
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RSPO3
regulation of protein localization to centrosome (GO:1904779),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NUP62
negative regulation of cardiac muscle tissue development (GO:0055026),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FRS2
chitin catabolic process (GO:0006032),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CHIA
regulation of transcription involved in cell fate commitment (GO:0060850),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RORC
neuron fate specification (GO:0048665),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DLL1
marginal zone B cell differentiation (GO:0002315),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DLL1
folic acid transport (GO:0015884),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC25A32
membrane invagination (GO:0010324),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FCHO2
cAMP catabolic process (GO:0006198),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PDE4A
regulation of Cdc42 protein signal transduction (GO:0032489),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NRP1
leucine metabolic process (GO:0006551),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MCCC1
regulation of calcium ion import (GO:0090279),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,CAV3;SLC30A1
NAD biosynthetic process (GO:0009435),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,SLC5A8;PARP9
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GOLGA7B;ZDHHC12
peptidyl-L-cysteine S-palmitoylation (GO:0018230),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GOLGA7B;ZDHHC12
lymphocyte activation involved in immune response (GO:0002285),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,IFNA1;IFNA8
outflow tract septum morphogenesis (GO:0003148),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NRP1;NKX2-5
regulation of transcription from RNA polymerase III promoter (GO:0006359),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ZNF76;BRCA1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ERCC3;GTF2H3
regulation of cytokine production involved in inflammatory response (GO:1900015),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NLRP7;NLRC3
regulation of membrane protein ectodomain proteolysis (GO:0051043),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,TIMP4;PTPN3
negative regulation of protein import into nucleus (GO:0042308),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,WWTR1;PBLD
C21-steroid hormone metabolic process (GO:0008207),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,SRD5A1;TSPOAP1
viral genome replication (GO:0019079),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PCBP1;UBP1
negative regulation of GTPase activity (GO:0034260),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,KLRK1;FZD10
positive regulation of RNA splicing (GO:0033120),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PIK3R1;PRDX6
ncRNA catabolic process (GO:0034661),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ERN2;EXOSC6
ion transmembrane transport (GO:0034220),13/219,0.3021725614056588,1,0,0,1.187214611872146,1.4208074321744444,GABRA2;GABRA1;GABRP;KCNE2;CHRNA4;AQP6;WWP1;HTR3B;ATP2C1;GABRR3;CASQ1;ATP6V1D;ATP6V1C1
protein lipidation (GO:0006497),8/127,0.3026458393583639,1,0,0,1.2598425196850394,1.5057537059644543,ABHD17B;WDR45B;ZDHHC5;GP2;ZDHHC12;LYPD2;ALOX12B;ATG7
negative regulation of protein kinase activity (GO:0006469),7/109,0.3035915104348741,1,0,0,1.2844036697247707,1.5311019042060257,WWTR1;LRRC15;CAV3;PDPK1;TRIB1;LRRC66;SOCS4
anion transport (GO:0006820),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,SLCO1B1;SLCO1B3;SLC17A6;SLC17A1
chordate embryonic development (GO:0043009),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,DEAF1;BRCA1;LMX1B;NKX2-5
negative regulation of cellular catabolic process (GO:0031330),4/56,0.30677317565166196,1,0,0,1.4285714285714284,1.6880666371405524,CPTP;TIMP4;EIF4G2;PTPN3
signal transduction by p53 class mediator (GO:0072331),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,USP10;ZNF385C;MDM4
regulation of type I interferon-mediated signaling pathway (GO:0060338),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,TRIM6;IFNA1;IFNA8
regulation of proteasomal protein catabolic process (GO:0061136),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,KCNE2;PSME3;PSME1
positive regulation of phagocytosis (GO:0050766),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,STAP1;DOCK2;SIRPB1
ERBB2 signaling pathway (GO:0038128),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,GRB7;STUB1;PIK3R1
Golgi to plasma membrane transport (GO:0006893),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,C16ORF70;EXOC5;CCDC22
DNA replication-independent nucleosome assembly (GO:0006336),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,HIRA;RUVBL1;ASF1A
regulation of coenzyme metabolic process (GO:0051196),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,NUP210;NUP50;NUP62
mitotic nuclear division (GO:0140014),5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,HIRA;UBE2S;NUP62;TUBGCP3;CLASP2
positive regulation of cell migration (GO:0030335),13/221,0.3134222374811857,1,0,0,1.176470588235294,1.3649458776349923,TNFSF18;GRB7;NRP1;LRRC15;DOCK5;CARMIL2;FN1;PDGFA;FAM110C;GPER1;DRD1;TRIM32;CLASP2
anterograde trans-synaptic signaling (GO:0098916),14/240,0.31501062151878817,1,0,0,1.1666666666666665,1.3476737418873355,GABRA2;GABRA1;GABRP;CHRNA4;SLC1A1;CACNA1A;OPRM1;HTR3B;GABRR3;CACNB1;PLP1;UNC119;MYCBPAP;SLC12A6
chloride transmembrane transport (GO:1902476),4/57,0.31821716196314576,1,0,0,1.4035087719298245,1.6070473403738648,GABRA2;GABRA1;SLC1A1;SLC12A6
I-kappaB kinase/NF-kappaB signaling (GO:0007249),4/57,0.31821716196314576,1,0,0,1.4035087719298245,1.6070473403738648,TRADD;NFKBIL1;TLR9;NLRC3
cellular response to catecholamine stimulus (GO:0071870),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,GNG2;DRD1
negative regulation of viral transcription (GO:0032897),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,POU2F3;TRIM32
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PCNA;RFC2
cell-cell adhesion mediated by cadherin (GO:0044331),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CDH10;CDH15
cellular nitrogen compound biosynthetic process (GO:0044271),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,ARG2;CYP1B1
cellular response to ammonium ion (GO:0071242),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,OPRM1;DRD1
regulation of smooth muscle contraction (GO:0006940),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,MYOCD;CTTN
rRNA methylation (GO:0031167),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,EMG1;MTERF4
negative regulation of transcription factor import into nucleus (GO:0042992),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,NFKBIL1;PYDC2
positive regulation of cell junction assembly (GO:1901890),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,NRP1;NPHP1
negative regulation of canonical Wnt signaling pathway (GO:0090090),9/148,0.32185346752169186,1,0,0,1.2162162162162162,1.3787743461346562,INVS;MAD2L2;WWTR1;PSMA6;SDHAF2;PSME3;PTPRO;PSME1;NKX2-5
autophagy of mitochondrion (GO:0000422),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,WDR45B;ATG7;ATG13
tRNA aminoacylation (GO:0043039),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,GATC;YARS2;WARS2
peptidyl-proline modification (GO:0018208),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,FKBP10;FKBP7;FKBP3
regulation of cholesterol biosynthetic process (GO:0045540),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,SREBF1;SQLE;ACACB
positive regulation of cytokine biosynthetic process (GO:0042108),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,TLR9;TNFRSF8;BCL10
regulation of viral transcription (GO:0046782),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,POLR2F;GTF2F2;TRIM32
negative regulation of cell differentiation (GO:0045596),9/150,0.33592380981134945,1,0,0,1.2,1.3090450814951031,GDF10;MAD2L2;PTBP1;MYOCD;SDHAF2;CCDC85B;GPER1;DLL1;PBLD
regulation of DNA methylation (GO:0044030),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DPPA3
regulation of vascular associated smooth muscle cell migration (GO:1904752),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DOCK5
neuron projection extension involved in neuron projection guidance (GO:1902284),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NRP1
positive regulation of extracellular matrix assembly (GO:1901203),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CLASP2
"regulation of synaptic transmission, dopaminergic (GO:0032225)",1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DRD1
lipoprotein transport (GO:0042953),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UNC119
regulation of establishment of protein localization to mitochondrion (GO:1903747),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SREBF1
positive regulation of cell aging (GO:0090343),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ARG2
late endosome to vacuole transport (GO:0045324),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TMEM50B
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CACNB1
defense response to protozoan (GO:0042832),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LYST
cellular response to prostaglandin E stimulus (GO:0071380),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GNG2
microtubule nucleation by microtubule organizing center (GO:0051418),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TUBGCP3
sulfur amino acid catabolic process (GO:0000098),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BLMH
integrin activation (GO:0033622),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FN1
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DRD1
negative regulation of protein homooligomerization (GO:0032463),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PEX5
ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KCNE2
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MICA
T-helper 17 cell differentiation (GO:0072539),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RORC
endodermal cell fate commitment (GO:0001711),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NANOG
amyloid fibril formation (GO:1990000),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GSN
positive regulation of interleukin-8 biosynthetic process (GO:0045416),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BCL10
positive regulation of chromatin binding (GO:0035563),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PARP9
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CAV3
positive regulation of DNA recombination (GO:0045911),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRDM9
negative regulation of monooxygenase activity (GO:0032769),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CAV3
coronary vasculature morphogenesis (GO:0060977),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NRP1
cellular cation homeostasis (GO:0030003),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CLDN16
regulation of PERK-mediated unfolded protein response (GO:1903897),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AGR2
cellular response to UV-B (GO:0071493),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CRIP1
spleen development (GO:0048536),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NKX2-5
axon extension involved in axon guidance (GO:0048846),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NRP1
protein desumoylation (GO:0016926),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SENP6
estrogen biosynthetic process (GO:0006703),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HSD17B8
negative regulation of voltage-gated potassium channel activity (GO:1903817),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KCNE2
central nervous system myelination (GO:0022010),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PLP1
"negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UBAC2
peptidyl-lysine hydroxylation (GO:0017185),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,JMJD6
positive regulation of IRE1-mediated unfolded protein response (GO:1903896),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AGR2
regulation of chemokine secretion (GO:0090196),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CHIA
positive regulation of tumor necrosis factor biosynthetic process (GO:0042535),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TNFRSF8
negative regulation of centriole replication (GO:0046600),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BRCA1
negative regulation of biosynthetic process (GO:0009890),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GPER1
angiogenesis involved in wound healing (GO:0060055),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRCP
protein localization to endosome (GO:0036010),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NRP1
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EPHA4
early endosome to Golgi transport (GO:0034498),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EHD3
amyloid precursor protein catabolic process (GO:0042987),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PSEN1
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TMEM50B
inositol phosphate catabolic process (GO:0071545),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IMPA2
fatty acid alpha-oxidation (GO:0001561),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HACL1
phospholipid scrambling (GO:0017121),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PLSCR2
cGMP-mediated signaling (GO:0019934),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GUCY1B2
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NBDY
negative regulation of neuron projection regeneration (GO:0070571),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EPHA4
actin filament network formation (GO:0051639),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CARMIL2
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKAR1B
regulation of response to oxidative stress (GO:1902882),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ACOX2
negative regulation of cilium assembly (GO:1902018),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CEP97
regulation of amyloid fibril formation (GO:1905906),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PSEN1
positive regulation of chemokine secretion (GO:0090197),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CHIA
mitochondrial tRNA modification (GO:0070900),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TRMU
positive regulation of lipoprotein lipase activity (GO:0051006),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,APOA5
snoRNA 3'-end processing (GO:0031126),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EXOSC6
mammary gland epithelial cell differentiation (GO:0060644),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FOXB1
U4 snRNA 3'-end processing (GO:0034475),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EXOSC6
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,APOBEC3C
peptidyl-lysine monomethylation (GO:0018026),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SETD3
ribosome disassembly (GO:0032790),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MTIF2
nose development (GO:0043584),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SMCHD1
histone H3-K36 demethylation (GO:0070544),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PHF8
lipoprotein localization (GO:0044872),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,UNC119
arginine catabolic process (GO:0006527),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ARG2
DNA cytosine deamination (GO:0070383),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,APOBEC3C
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RSPO3
regulation of receptor binding (GO:1900120),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PTPRF
kidney mesenchyme development (GO:0072074),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SIX1
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CAV3
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,CDH10;CDH15;ATP2C1
telomere organization (GO:0032200),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,PCNA;ERCC4;ZNF365
positive regulation of receptor-mediated endocytosis (GO:0048260),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,ATAD1;LDLRAP1;APOA5
negative regulation of STAT cascade (GO:1904893),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,LRRC15;LRRC66;SOCS4
regulation of cellular metabolic process (GO:0031323),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,CYP1B1;STUB1;ACACB
positive regulation of protein localization to membrane (GO:1905477),6/95,0.33896434675202747,1,0,0,1.263157894736842,1.3665604407859686,DPP10;PPP3CC;PDPK1;GPER1;AGR2;PIK3R1
response to dsRNA (GO:0043331),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,IFNA1;IFNA8
camera-type eye development (GO:0043010),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CYP1B1;PRSS56
"positive regulation of DNA-templated transcription, elongation (GO:0032786)",2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,GTF2F2;ELL3
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,HEXIM2;MYOCD
neuromuscular synaptic transmission (GO:0007274),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CHRNA4;TSPOAP1
DNA replication initiation (GO:0006270),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,POLA2;MCM2
positive regulation of vascular endothelial growth factor production (GO:0010575),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CYP1B1;BRCA1
chaperone mediated protein folding requiring cofactor (GO:0051085),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,DNAJB1;HSPA14
negative regulation of interleukin-6 production (GO:0032715),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,TLR9;NLRC3
fatty acid derivative biosynthetic process (GO:1901570),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,HSD17B8;CBR4
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ING2;TRIM32
regulation of cell cycle G1/S phase transition (GO:1902806),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PSME3;PSME1
regulation of cellular senescence (GO:2000772),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ARG2;ING2
negative regulation of ubiquitin protein ligase activity (GO:1904667),5/77,0.34100404859306127,1,0,0,1.2987012987012985,1.397221985795033,MAD2L2;PSMA6;PSME3;PSME1;CDK1
regulation of extrinsic apoptotic signaling pathway (GO:2001236),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,TRADD;GPER1;PSME3;BCL10
sterol metabolic process (GO:0016125),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,CYP27A1;SQLE;CYP1B1;LDLRAP1
keratinocyte differentiation (GO:0030216),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,LCE1A;LCE2C;LCE4A;IVL
cell morphogenesis (GO:0000902),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,CAP1;CDH10;PTPRO;CDH15
protein modification by small protein conjugation (GO:0032446),22/398,0.34443639477960497,1,0,0,1.1055276381909547,1.178322029873554,TOP2A;PCNA;NUP210;FBXO25;WWP1;BCL10;UBR1;BRCA1;TNFAIP1;ASB12;BACH2;KLHL41;PCNP;UBE2W;MTA1;UBE2S;NUP50;NUP62;PEX5;STUB1;CCDC22;TRIM32
cellular metal ion homeostasis (GO:0006875),6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,CCL14;PKHD1;RMDN3;SLC30A1;CLDN16;ATP2C1
regulation of cellular response to heat (GO:1900034),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,DNAJB1;NUP210;NUP50;NUP62;ATR
negative regulation of inflammatory response (GO:0050728),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,NLRP7;GPER1;RORC;NLRC3;PYDC2
regulation of protein modification process (GO:0031399),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,FN1;PPP1R14D;ATG7
cellular response to radiation (GO:0071478),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,GADD45A;ERCC4;RHO
negative regulation of protein secretion (GO:0050709),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,FAM3D;OPRM1;RAB11FIP5
regulation of ion transmembrane transporter activity (GO:0032412),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,CAV3;SCN4B;PTPN3
ceramide metabolic process (GO:0006672),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,SAMD8;FUT7;ALOX12B
epithelium development (GO:0060429),7/115,0.35239484145081534,1,0,0,1.2173913043478262,1.269742811049461,CBR1;PCNA;CDK1;SIX1;NKX2-5;DLL1;KRT6A
protein targeting to ER (GO:0045047),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,RPS15A;SEC61G;RPS6;RPS3A;SRP68;SEC63
heterotypic cell-cell adhesion (GO:0034113),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,ITGAD;IZUMO1
regulation of spindle assembly (GO:0090169),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SENP6;CEP97
response to copper ion (GO:0046688),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,MT1A;MT1M
lamellipodium organization (GO:0097581),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CTTN;PTPRO
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CAV3;CCDC22
cyclic nucleotide metabolic process (GO:0009187),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,GUCY1B2;PDE8A
misfolded or incompletely synthesized protein catabolic process (GO:0006515),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,UBE2W;STUB1
regulation of interleukin-10 production (GO:0032653),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,TLR9;DLL1
regulation of lamellipodium assembly (GO:0010591),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CARMIL2;WASF2
cellular response to epidermal growth factor stimulus (GO:0071364),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PDPK1;PDE8A
regulation of apoptotic signaling pathway (GO:2001233),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,TMEM102;DAPK2
long-chain fatty acid transport (GO:0015909),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,LCN1;ACACB
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PODXL2;SULT4A1
peptidyl-tyrosine dephosphorylation (GO:0035335),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PTPRO;PTPRF
positive regulation of embryonic development (GO:0040019),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,SIX1;CLASP2
anaphase-promoting complex-dependent catabolic process (GO:0031145),5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,PSMA6;UBE2S;PSME3;PSME1;CDK1
cell-cell junction assembly (GO:0007043),5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,POF1B;MARVELD2;CDH10;CDH15;TLN1
cellular response to organic cyclic compound (GO:0071407),8/135,0.3629382263971019,1,0,0,1.1851851851851851,1.201212011156535,GNG2;GPER1;RORC;CYP1B1;MGARP;DRD1;BRCA1;CCDC62
actin cytoskeleton reorganization (GO:0031532),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,NRP1;GSN;CTTN;ATP2C1
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,TNFSF18;GH2;PARP9;CRLF1
regulation of cellular ketone metabolic process (GO:0010565),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,PSMA6;PSME3;PSME1;SIRT5
negative regulation of viral life cycle (GO:1903901),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,APOBEC3C;TRIM6;GSN;TRIM32
protein targeting to membrane (GO:0006612),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,GOLGA7B;PEX5;ZDHHC12;SEC63
regulation of DNA replication (GO:0006275),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,PCNA;PDGFA;ENPP7;ATR
negative regulation of protein metabolic process (GO:0051248),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,MAD2L2;EIF2AK1;MDM4
regulation of ATP metabolic process (GO:1903578),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,NUP210;NUP50;NUP62
histone H3 acetylation (GO:0043966),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,TAF10;KAT6A;JADE2
protein localization to cell periphery (GO:1990778),7/117,0.36885988926259045,1,0,0,1.1965811965811965,1.1933963891623318,GOLGA7B;DPP10;EHD3;CAV3;FCHO2;TSPAN33;CLASP2
type B pancreatic cell differentiation (GO:0003309),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DLL1
very-low-density lipoprotein particle remodeling (GO:0034372),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOA5
inositol metabolic process (GO:0006020),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IMPA2
secretory granule organization (GO:0033363),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LYST
regulation of immunoglobulin secretion (GO:0051023),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HLA-E
adult heart development (GO:0007512),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NKX2-5
alanine transport (GO:0032328),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC1A4
negative regulation of leukocyte chemotaxis (GO:0002689),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,STAP1
RNA destabilization (GO:0050779),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MEX3D
L-fucose metabolic process (GO:0042354),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT7
acidic amino acid transport (GO:0015800),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC1A1
positive regulation of production of molecular mediator of immune response (GO:0002702),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TLR9
ornithine metabolic process (GO:0006591),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ARG2
response to UV-C (GO:0010225),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MAP3K4
negative regulation of response to reactive oxygen species (GO:1901032),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDE8A
actin filament reorganization (GO:0090527),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSN
lactation (GO:0007595),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FOXB1
epithelial cell apoptotic process (GO:1904019),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSN
neuron maturation (GO:0042551),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ANKS1A
positive regulation of triglyceride biosynthetic process (GO:0010867),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SREBF1
regulation of amyloid precursor protein biosynthetic process (GO:0042984),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ITM2B
anoikis (GO:0043276),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DAPK2
long-chain fatty acid biosynthetic process (GO:0042759),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ALOX12B
regulation of SNARE complex assembly (GO:0035542),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ANKRD27
sterol catabolic process (GO:0016127),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TRERF1
negative regulation of catenin import into nucleus (GO:0035414),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,WWTR1
regulation of interferon-gamma secretion (GO:1902713),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RASGRP1
potassium ion export (GO:0071435),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KCNE2
regulation of mast cell activation involved in immune response (GO:0033006),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,C12ORF4
mature B cell differentiation involved in immune response (GO:0002313),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DLL1
cellular response to dopamine (GO:1903351),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DRD1
homocysteine metabolic process (GO:0050667),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BLMH
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSN
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TLR9
L-fucose catabolic process (GO:0042355),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT7
adipose tissue development (GO:0060612),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RORC
positive regulation of cholesterol esterification (GO:0010873),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOA5
Cdc42 protein signal transduction (GO:0032488),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NTN1
positive regulation of immunoglobulin secretion (GO:0051024),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HLA-E
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDGFA
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EXOSC6
regulation of integrin activation (GO:0033623),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FBLIM1
regulation of endoplasmic reticulum unfolded protein response (GO:1900101),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PIK3R1
response to dopamine (GO:1903350),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DRD1
negative regulation of protein exit from endoplasmic reticulum (GO:0070862),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,UBAC2
endosome to pigment granule transport (GO:0043485),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAB38
response to leucine (GO:0043201),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,UBR1
virion attachment to host cell (GO:0019062),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LRRC15
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NLRC3
sympathetic ganglion development (GO:0061549),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRP1
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCNL2
positive regulation of autophagosome assembly (GO:2000786),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAB3GAP2
negative regulation of histone methylation (GO:0031061),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BRCA1
regulation of cytokine secretion involved in immune response (GO:0002739),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TRIM6
receptor recycling (GO:0001881),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EHD3
"nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EXOSC6
pinocytosis (GO:0006907),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DOCK2
regulation of sequestering of calcium ion (GO:0051282),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CASQ1
regulation of natural killer cell activation (GO:0032814),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MICA
endothelial cell chemotaxis (GO:0035767),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NRP1
regulation of cell-cell adhesion mediated by cadherin (GO:2000047),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MAD2L2
regulation of leukocyte activation (GO:0002694),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GPER1
negative regulation of interferon-beta production (GO:0032688),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NLRC3
fucose catabolic process (GO:0019317),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT7
regulation of leukocyte degranulation (GO:0043300),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,C12ORF4
cholesterol catabolic process (GO:0006707),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TRERF1
ether lipid metabolic process (GO:0046485),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AGMO
cellular response to leucine (GO:0071233),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,UBR1
endosome to melanosome transport (GO:0035646),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAB38
negative regulation of transcription by competitive promoter binding (GO:0010944),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MAD2L2
positive regulation of vascular endothelial cell proliferation (GO:1905564),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDPK1
negative regulation of potassium ion transmembrane transport (GO:1901380),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CAV3
axonal transport of mitochondrion (GO:0019896),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MGARP
cellular response to acidic pH (GO:0071468),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAB11FIP5
mesodermal cell differentiation (GO:0048333),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KDM6B
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HLA-E
neuron projection organization (GO:0106027),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PSEN1
regulation of oxidative stress-induced cell death (GO:1903201),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDILT
tRNA wobble uridine modification (GO:0002098),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TRMU
nuclear RNA surveillance (GO:0071027),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,EXOSC6
cytoskeletal anchoring at plasma membrane (GO:0007016),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TLN1
"negative regulation of synaptic transmission, glutamatergic (GO:0051967)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ATAD1
regulation of nephron tubule epithelial cell differentiation (GO:0072182),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PROM1
positive regulation of triglyceride lipase activity (GO:0061365),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APOA5
Golgi inheritance (GO:0048313),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CDK1
negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BRCA1
vitamin transmembrane transport (GO:0035461),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC25A32
cyclic nucleotide catabolic process (GO:0009214),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PDE4A
spindle assembly (GO:0051225),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,GOLGA8S;GOLGA8DP;HDAC3;HAUS3;TUBGCP3
positive regulation of stress-activated MAPK cascade (GO:0032874),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,GADD45A;CARD9;TLR9;RASGRP1;MAP3K4
negative regulation of defense response (GO:0031348),5/80,0.37109875658286956,1,0,0,1.25,1.239108826933398,NLRP7;GPER1;RORC;NLRC3;PYDC2
negative regulation of Wnt signaling pathway (GO:0030178),10/174,0.3718725055193731,1,0,0,1.1494252873563218,1.1370163339675912,INVS;MAD2L2;WWTR1;PSMA6;SDHAF2;PSME3;PTPRO;PSME1;NKX2-5;CXXC4
positive regulation of type I interferon production (GO:0032481),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,IRF3;TLR9;POLR2F;LRRFIP1
positive regulation of catabolic process (GO:0009896),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,WWP1;APOA5;ATG7;TRIM32
cellular amide metabolic process (GO:0043603),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,FUT7;MCCC1;ACACB;ENPP7
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,MAPRE3;CCNL2
positive regulation of synapse assembly (GO:0051965),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SRPX2;SLITRK2
positive regulation of interferon-beta production (GO:0032728),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,IRF3;TLR9
regulation of p38MAPK cascade (GO:1900744),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,GADD45A;MAP3K4
regulation of NF-kappaB import into nucleus (GO:0042345),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TLR9;PYDC2
tRNA methylation (GO:0030488),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TRMT13;FTSJ1
negative regulation of catalytic activity (GO:0043086),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PARP9;TIMP4
regulation of histone acetylation (GO:0035065),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,MYOCD;BRCA1
fat-soluble vitamin metabolic process (GO:0006775),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,VKORC1;CBR1
strand displacement (GO:0000732),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,RMI2;BRCA1
endocrine system development (GO:0035270),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SIX1;NKX2-5
cation transmembrane transport (GO:0098655),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SLC7A2;RHD
RNA biosynthetic process (GO:0032774),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TAF10;ELL3
translation (GO:0006412),13/232,0.3768754140664147,1,0,0,1.1206896551724137,1.0936144798817966,MRPS17;MRPS33;MTERF4;RPS6;GATC;RPS3A;HSPA14;GSPT2;MRPS6;YARS2;FTSJ1;WARS2;RPS15A
cellular response to tumor necrosis factor (GO:0071356),11/194,0.37826488217333426,1,0,0,1.134020618556701,1.1024501448540955,TNFSF18;CCL14;PSMA6;PSME3;TRADD;GPER1;PSME1;TNFRSF8;ILK;BRCA1;TNFRSF13C
cholesterol transport (GO:0030301),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,STARD5;LDLRAP1;APOA5
adherens junction organization (GO:0034332),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,AFDN;CDH10;CDH15
amide biosynthetic process (GO:0043604),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,ARG2;SAMD8;ALOX12B
regulation of steroid biosynthetic process (GO:0050810),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,SREBF1;SQLE;ACACB
positive regulation of protein targeting to mitochondrion (GO:1903955),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,LRRC46;RUVBL1;ACSM6;ATG13;OR13C4
negative regulation of cell cycle process (GO:0010948),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,UXT;GPER1;BRCA1;DUX4;E2F6
negative regulation of dephosphorylation (GO:0035305),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,FARP1;CSRNP3;SH2D4A;SYTL2
negative regulation of neuron apoptotic process (GO:0043524),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,FOXB1;SIX1;RETREG1;CRLF1
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),12/215,0.38991643248973035,1,0,0,1.1162790697674418,1.0513371220310108,TNFSF18;PSMA6;MYOCD;GTF2A2;FZD4;CRTC1;TRADD;BTK;TLR9;BCL10;TRIM32;TRIM34
positive regulation of cell cycle (GO:0045787),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,RPS15A;GPER1;MAPRE3;CCNL2;TRIM32
positive regulation of ubiquitin protein ligase activity (GO:1904668),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,PSMA6;UBE2S;PSME3;PSME1;CDK1
protein complex subunit organization (GO:0071822),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,ADAMTS3;COL2A1;CYP1B1
metal ion transport (GO:0030001),6/101,0.39300017337866283,1,0,0,1.188118811881188,1.109637892212941,KCNA2;SCN7A;KCNJ16;SLC5A2;KCNK1;SCN4B
regulation of calcium ion transmembrane transporter activity (GO:1901019),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CACNB1;CAV3
phosphatidylcholine acyl-chain remodeling (GO:0036151),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,LPCAT1;PLBD1
negative regulation of smooth muscle cell proliferation (GO:0048662),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,GPER1;TRIB1
negative regulation of synaptic transmission (GO:0050805),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,ATAD1;SLC30A1
endocytic recycling (GO:0032456),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,EHD3;STX6
regulation of protein localization to nucleus (GO:1900180),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CDK1;PARP9
transition metal ion transport (GO:0000041),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,HEPH;SLC30A1
microtubule polymerization (GO:0046785),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,TUBGCP3;CLASP2
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,NRP1;DOCK5
regulation of vascular endothelial growth factor production (GO:0010574),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CYP1B1;BRCA1
cargo loading into vesicle (GO:0035459),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,MIA;CTAGE9
regulation of autophagy of mitochondrion (GO:1903146),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,SREBF1;RUVBL1
regulation of protein localization to cell surface (GO:2000008),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CAV3;RAB11FIP5
cellular response to glucose stimulus (GO:0071333),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,GPER1;RAB11FIP5
inorganic anion transmembrane transport (GO:0098661),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,GABRA2;GABRA1;SLC1A1;SLC12A6
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,PTPRT;CDH10;CDH15;MPZL2
positive regulation of cell adhesion (GO:0045785),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,TNFSF18;TMEM102;AGR2;SIRPB1
positive regulation of peptidyl-serine phosphorylation (GO:0033138),5/83,0.40119924980674115,1,0,0,1.2048192771084336,1.1003579430959414,MAD2L2;TRIM6;IFNA1;IFNA8;CNOT9
inorganic cation transmembrane transport (GO:0098662),8/140,0.4012246378411757,1,0,0,1.1428571428571428,1.04369578789494,CACNA1A;SCN7A;SLC30A1;ATP2C1;SLC17A1;KCNK1;SCN4B;ATP6V1C1
regulation of response to stress (GO:0080134),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OPRM1
regulation of B cell apoptotic process (GO:0002902),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BTK
peptidyl-serine dephosphorylation (GO:0070262),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PPP2R2C
regulation of chromatin organization (GO:1902275),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HIRA
membrane raft organization (GO:0031579),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CAV3
ganglion development (GO:0061548),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NRP1
negative regulation of cellular protein catabolic process (GO:1903363),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EPHA4
male meiosis I (GO:0007141),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ING2
endothelium development (GO:0003158),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,KDM6B
dorsal/ventral axis specification (GO:0009950),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CXXC4
glucosamine-containing compound catabolic process (GO:1901072),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CHIA
regulation of sequestering of zinc ion (GO:0061088),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC30A1
neuron projection regeneration (GO:0031102),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APOA5
regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DEAF1
chloride ion homeostasis (GO:0055064),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC12A6
positive regulation of amyloid-beta formation (GO:1902004),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EPHA4
response to acidic pH (GO:0010447),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RAB11FIP5
contractile actin filament bundle assembly (GO:0030038),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TNFAIP1
glycine metabolic process (GO:0006544),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC25A32
I-kappaB phosphorylation (GO:0007252),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TLR9
detection of light stimulus involved in sensory perception (GO:0050962),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CNGB1
regulation of triglyceride catabolic process (GO:0010896),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,APOA5
L-glutamate transport (GO:0015813),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC1A1
muscle cell migration (GO:0014812),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SIX1
hair cell differentiation (GO:0035315),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ERCC3
positive regulation of glucose import in response to insulin stimulus (GO:2001275),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PIK3R1
positive regulation of glial cell differentiation (GO:0045687),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ZNF365
cellular copper ion homeostasis (GO:0006878),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCDC22
regulation of amyloid-beta clearance (GO:1900221),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MYOCD
positive regulation of cardiac muscle cell differentiation (GO:2000727),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MYOCD
peptidyl-lysine dimethylation (GO:0018027),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SETD3
positive regulation of lipase activity (GO:0060193),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDPK1
androgen biosynthetic process (GO:0006702),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SRD5A1
nuclear pore complex assembly (GO:0051292),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TMEM170A
actin filament depolymerization (GO:0030042),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DSTN
negative regulation of reproductive process (GO:2000242),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ARHGDIB
primary alcohol catabolic process (GO:0034310),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,AKR1B10
regulation of histone phosphorylation (GO:0033127),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,AKAP8L
central nervous system projection neuron axonogenesis (GO:0021952),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EPHA4
motor neuron axon guidance (GO:0008045),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EPHA4
nuclear mRNA surveillance (GO:0071028),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EXOSC6
insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PIK3R1
DNA replication-dependent nucleosome assembly (GO:0006335),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ASF1A
positive regulation of circadian rhythm (GO:0042753),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RORC
actin filament capping (GO:0051693),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GSN
protein-cofactor linkage (GO:0018065),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SDHAF2
negative regulation of protein maturation (GO:1903318),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NLRP7
negative regulation of centrosome duplication (GO:0010826),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BRCA1
regulation of podosome assembly (GO:0071801),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GSN
telomere maintenance via recombination (GO:0000722),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ERCC4
neuron projection fasciculation (GO:0106030),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EPHA4
ceramide catabolic process (GO:0046514),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NAGA
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DNAJB1
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,C2CD2L
regulation of phospholipase activity (GO:0010517),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDPK1
coenzyme A metabolic process (GO:0015936),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PPCDC
ganglioside biosynthetic process (GO:0001574),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ST8SIA6
detection of light stimulus involved in visual perception (GO:0050908),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CNGB1
stress fiber assembly (GO:0043149),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TNFAIP1
regulation of astrocyte differentiation (GO:0048710),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EPHA4
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PBLD
positive regulation of interleukin-13 production (GO:0032736),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HLA-E
DNA replication-dependent nucleosome organization (GO:0034723),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ASF1A
poly-N-acetyllactosamine metabolic process (GO:0030309),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GAL3ST3
regulation of immunoglobulin production (GO:0002637),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TLR9
positive regulation of execution phase of apoptosis (GO:1900119),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FAP
urate transport (GO:0015747),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC17A1
endothelial tube morphogenesis (GO:0061154),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CSNK2B
positive regulation of vacuole organization (GO:0044090),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RAB3GAP2
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRDX6
sequestering of actin monomers (GO:0042989),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GSN
regulation of phospholipid metabolic process (GO:1903725),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PIK3R1
positive regulation of nuclease activity (GO:0032075),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PCNA
smooth muscle cell differentiation (GO:0051145),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MYOCD
protein prenylation (GO:0018342),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PTAR1
intracellular cholesterol transport (GO:0032367),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LDLRAP1
regulation of axon regeneration (GO:0048679),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,EPHA4
stimulatory C-type lectin receptor signaling pathway (GO:0002223),7/121,0.40189970418865884,1,0,0,1.1570247933884297,1.054689090068788,PSMA6;PDPK1;PSME3;CLEC6A;CARD9;PSME1;BCL10
regulation of cell differentiation (GO:0045595),7/121,0.40189970418865884,1,0,0,1.1570247933884297,1.054689090068788,TRPS1;RORC;NANOG;DLL1;KLHL41;ELL3;CLASP2
nucleocytoplasmic transport (GO:0006913),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,RITA1;PHAX;BACH2
cellular response to ionizing radiation (GO:0071479),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,GADD45A;ERCC4;ATR
regulation of generation of precursor metabolites and energy (GO:0043467),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,NUP210;NUP50;NUP62
negative regulation of autophagy (GO:0010507),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,CPTP;ATG7;EIF4G2
negative regulation of cell adhesion (GO:0007162),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,FZD4;PTPRO;ARHGDIB;CYP1B1
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,BRCA1;CNOT9
cellular response to alcohol (GO:0097306),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GNG2;BRCA1
negative regulation of homeostatic process (GO:0032845),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,ERCC4;BCL10
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GPER1;BCL10
organelle fission (GO:0048285),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,MTFP1;MTFR1
protein K11-linked ubiquitination (GO:0070979),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,UBE2W;UBE2S
positive regulation of cell communication (GO:0010647),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,LGI1;ILK
regulation of lipid biosynthetic process (GO:0046890),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GPER1;APOA5
dopamine receptor signaling pathway (GO:0007212),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GNG2;DRD1
regulation of fatty acid biosynthetic process (GO:0042304),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,BRCA1;APOA5
positive regulation of lipid biosynthetic process (GO:0046889),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,SREBF1;APOA5
regulation of adenylate cyclase activity (GO:0045761),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CAP1;OPRM1
primary neural tube formation (GO:0014020),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,DEAF1;BCL10
positive regulation of fibroblast proliferation (GO:0048146),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,FN1;PDGFA
bicellular tight junction assembly (GO:0070830),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,MARVELD2;POF1B
negative regulation of intracellular signal transduction (GO:1902532),9/161,0.41458031243382526,1,0,0,1.1180124223602483,0.9843971543058295,PKHD1;ADGRG3;CAV3;USP10;GPER1;NLRC3;UBR1;CCDC22;PHLDA3
myofibril assembly (GO:0030239),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,TNNT3;CASQ1;KLHL41
regulation of organelle assembly (GO:1902115),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,SENP6;GSN;TBC1D12
negative regulation of JAK-STAT cascade (GO:0046426),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,LRRC15;LRRC66;SOCS4
"positive regulation of gene expression, epigenetic (GO:0045815)",3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,POLR2F;SF3B1;ASF1A
cellular response to heat (GO:0034605),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,HSF4;STUB1;HSPA14
monovalent inorganic cation transport (GO:0015672),6/104,0.4200266801120024,1,0,0,1.1538461538461537,1.0008888988224178,KCNA2;SCN7A;KCNJ16;SLC5A2;KCNK1;SCN4B
organelle assembly (GO:0070925),20/376,0.4204542726130784,1,0,0,1.0638297872340425,0.921722926334509,GOLGA8S;GRB7;GSN;HDAC3;WDR45B;MTERF4;HAUS3;ATG13;KLHL41;PKHD1;GOLGA8DP;EHD3;TRAPPC6A;RILPL1;NUP62;UNC119;POC1B;RAB38;ATG7;ATP6V1D
regulation of type I interferon production (GO:0032479),5/85,0.42118396120911705,1,0,0,1.176470588235294,1.0172771508801166,IRF3;TREX1;POLR2F;LRRFIP1;TRIM32
innate immune response activating cell surface receptor signaling pathway (GO:0002220),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,PSMA6;PDPK1;PSME3;CLEC6A;CARD9;PSME1;BCL10
dephosphorylation (GO:0016311),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,PTPRT;PPP3CC;SDHAF2;PLPPR3;PTPRO;DUSP16;PTPN3
organic anion transport (GO:0015711),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,SLCO1B1;SLCO1B3;SLC4A10;SLCO5A1;CYB5RL;SLC17A1;MFSD10
T cell receptor signaling pathway (GO:0050852),9/163,0.4289504847985568,1,0,0,1.1042944785276072,0.9346900712747971,PSMA6;PDPK1;GRAP2;PSME3;BTK;PSME1;PIK3R1;BCL10;HLA-DQB2
translational elongation (GO:0006414),6/105,0.4290058391536542,1,0,0,1.1428571428571428,0.9671825703611097,MRPS17;MRPS33;MRPS23;MRPS30;MRPS6;MRPL46
dicarboxylic acid transport (GO:0006835),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SLC1A1;SLC25A32
cellular response to cadmium ion (GO:0071276),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,MT1A;MT1M
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,ERCC3;GTF2H3
very long-chain fatty acid metabolic process (GO:0000038),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,TECR;SLC27A5
tube closure (GO:0060606),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,DEAF1;BCL10
determination of bilateral symmetry (GO:0009855),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,DLL1;DNAI1
cardiac muscle cell action potential (GO:0086001),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,KCNE2;SCN4B
protein alkylation (GO:0008213),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,VCPKMT;ETFB
negative regulation of Notch signaling pathway (GO:0045746),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,NOTCH3;RITA1
lysosome localization (GO:0032418),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,PLEKHM2;BORCS6
regulation of chromosome segregation (GO:0051983),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,RMI2;BUB1
B cell proliferation (GO:0042100),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,IFNA1;IFNA8
amino acid transmembrane transport (GO:0003333),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SLC38A5;SLC38A4
regulation of cellular biosynthetic process (GO:0031326),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,SIRT5;TRERF1
carbohydrate derivative biosynthetic process (GO:1901137),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,GCNT1;ST8SIA6
regulation of myoblast differentiation (GO:0045661),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,DLL1;KLHL41
isotype switching (GO:0045190),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EXOSC6
positive regulation of endothelial cell apoptotic process (GO:2000353),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GPER1
negative regulation of morphogenesis of an epithelium (GO:1905331),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CLASP2
atrial septum morphogenesis (GO:0060413),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NKX2-5
regulation of histone H3-K9 methylation (GO:0051570),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BRCA1
interleukin-27-mediated signaling pathway (GO:0070106),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CRLF1
replicative senescence (GO:0090399),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ATR
negative regulation of leukocyte activation (GO:0002695),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GPER1
regulation of myeloid leukocyte mediated immunity (GO:0002886),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,C12ORF4
regulation of tumor necrosis factor biosynthetic process (GO:0042534),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TNFRSF8
cellular response to prostaglandin stimulus (GO:0071379),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GNG2
regulation of lipid kinase activity (GO:0043550),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PIK3R1
regulation of trophoblast cell migration (GO:1901163),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ARHGDIB
regulation of leukocyte cell-cell adhesion (GO:1903037),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IFNL2
regulation of hydrogen peroxide-induced cell death (GO:1903205),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PDE8A
UV-damage excision repair (GO:0070914),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACTR5
T-helper cell differentiation (GO:0042093),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RORC
carnitine shuttle (GO:0006853),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
Golgi ribbon formation (GO:0090161),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,STX6
negative regulation of fatty acid biosynthetic process (GO:0045717),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BRCA1
regulation of long-term neuronal synaptic plasticity (GO:0048169),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NETO1
cellular response to sterol (GO:0036315),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RORC
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CYP1B1
urea cycle (GO:0000050),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ARG2
regulation of non-canonical Wnt signaling pathway (GO:2000050),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RSPO3
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TRADD
myeloid cell activation involved in immune response (GO:0002275),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DOCK2
purine nucleobase metabolic process (GO:0006144),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PRTFDC1
rRNA base methylation (GO:0070475),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EMG1
negative regulation of myotube differentiation (GO:0010832),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NKX2-5
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCNL2
stress granule assembly (GO:0034063),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GRB7
T cell proliferation (GO:0042098),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TNFSF18
positive regulation of mesenchymal cell proliferation (GO:0002053),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PDGFA
positive regulation of actin filament depolymerization (GO:0030836),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CARMIL2
regulation of ceramide biosynthetic process (GO:2000303),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SAMD8
cytidine to uridine editing (GO:0016554),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APOBEC3C
negative regulation of histone acetylation (GO:0035067),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BRCA1
regulation of chromatin binding (GO:0035561),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PARP9
negative regulation of protein localization to cell surface (GO:2000009),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CAV3
response to sterol (GO:0036314),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RORC
negative regulation of receptor binding (GO:1900121),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PTPRF
regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ATF7IP
progesterone metabolic process (GO:0042448),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SRD5A1
cellular response to interferon-beta (GO:0035458),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TRIM6
positive regulation of fatty acid biosynthetic process (GO:0045723),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APOA5
regulation of cholesterol esterification (GO:0010872),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,APOA5
negative regulation of potassium ion transport (GO:0043267),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CAV3
fatty acid transmembrane transport (GO:1902001),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ING2
metanephric mesenchyme development (GO:0072075),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SIX1
negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CAV3
regulation of synaptic vesicle cycle (GO:0098693),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PREPL
cellular response to increased oxygen levels (GO:0036295),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ATG7
retinal metabolic process (GO:0042574),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CYP1B1
cyclooxygenase pathway (GO:0019371),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CBR1
magnesium ion transport (GO:0015693),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NIPAL3
carbohydrate derivative catabolic process (GO:1901136),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NAGA
protein carboxylation (GO:0018214),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,VKORC1
peptidyl-glutamic acid carboxylation (GO:0017187),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,VKORC1
alcohol catabolic process (GO:0046164),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TRERF1
positive regulation of interferon-gamma biosynthetic process (GO:0045078),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TLR9
membrane repolarization during action potential (GO:0086011),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,KCNE2
spinal cord development (GO:0021510),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DLL1
RNA polymerase II transcriptional preinitiation complex assembly (GO:0051123),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GTF2A2
hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NRP1
regulation of gene silencing by miRNA (GO:0060964),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,NUP210;NUP50;NUP62;POLR2F
negative regulation of protein serine/threonine kinase activity (GO:0071901),4/67,0.4327475179328833,1,0,0,1.1940298507462686,1.0001203826990046,HEXIM2;MYOCD;PRKAR1B;CAV3
negative regulation of mitotic cell cycle (GO:0045930),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,FAP;GADD45A;PTPN3
cytoplasmic microtubule organization (GO:0031122),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,ATAD1;CCDC13;TUBGCP3
regulation of cell cycle arrest (GO:0071156),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,FAP;GPER1;BRCA1
regulation of epithelial cell migration (GO:0010632),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,DOCK5;PBLD;CLASP2
negative regulation of multicellular organismal process (GO:0051241),7/125,0.4348899664469206,1,0,0,1.1199999999999999,0.9325816982581239,MAD2L2;MYOCD;SDHAF2;ARHGDIB;PTPRO;RAB11FIP5;PBLD
glycerophospholipid biosynthetic process (GO:0046474),9/164,0.4361267814583617,1,0,0,1.097560975609756,0.910780567398606,RUFY1;MTMR14;ACP6;CSNK2B;LPCAT1;PIK3R1;CEPT1;AGPAT2;AGPAT3
fatty acid metabolic process (GO:0006631),6/106,0.43796290568349927,1,0,0,1.1320754716981132,0.9346653536744506,ACSM6;ALOX12B;ALKBH7;HSD17B8;SLC27A5;CBR4
calcium ion homeostasis (GO:0055074),5/87,0.44104723204673524,1,0,0,1.1494252873563218,0.9409233415212925,CCL14;PKHD1;RMDN3;SLC30A1;ATP2C1
organic substance transport (GO:0071702),5/87,0.44104723204673524,1,0,0,1.1494252873563218,0.9409233415212925,SLCO1B1;CAV3;SLCO1B3;APOA5;RHD
negative regulation of phosphatase activity (GO:0010923),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,FARP1;CSRNP3;SH2D4A;SYTL2
regulation of endopeptidase activity (GO:0052548),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,SERPINB10;PSME3;PSME1;TIMP4
non-recombinational repair (GO:0000726),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,ERCC4;BRCA1;NHEJ1
protein autoubiquitination (GO:0051865),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,RNF208;STUB1;BRCA1
regulation of defense response to virus by host (GO:0050691),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,TRIM6;PARP9
replication fork processing (GO:0031297),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,ZRANB3;PCNA
connective tissue development (GO:0061448),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,COL2A1;RORC
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,MAPRE3;CCNL2
negative regulation of secretion by cell (GO:1903531),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,SYT4;SLC30A1
regulation of cation transmembrane transport (GO:1904062),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,DPP10;KCNE2
'de novo' posttranslational protein folding (GO:0051084),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,DNAJB1;HSPA14
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,BRCA1;CNOT9
aminoglycan metabolic process (GO:0006022),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CHIA;GAL3ST3
response to estradiol (GO:0032355),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,GPER1;CCDC62
nuclear envelope organization (GO:0006998),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,AKAP8L;TMEM170A
skeletal system development (GO:0001501),8/146,0.44715332178021977,1,0,0,1.095890410958904,0.8820314974627516,VKORC1;GDF10;COL2A1;DEAF1;TRPS1;PRELP;HAPLN3;DSPP
non-canonical Wnt signaling pathway (GO:0035567),7/127,0.45129692526290477,1,0,0,1.1023622047244093,0.8770722042008007,PSMA6;GNG2;FZD4;PSME3;PSME1;FZD10;PDE6A
negative regulation of cell cycle G2/M phase transition (GO:1902750),4/69,0.45518892642326336,1,0,0,1.1594202898550725,0.9125133023815558,PSMA6;PSME3;PSME1;BRCA1
positive regulation of nucleic acid-templated transcription (GO:1903508),26/502,0.4552655671825553,1,0,0,1.0358565737051793,0.815088984866276,CASZ1;SETD3;RORC;ILK;SIX1;BCL10;BRCA1;PSEN1;PHF8;ING2;MED30;DEAF1;NUP62;NKX2-5;ZNF423;ATF7IP;MYOCD;POU1F1;FZD4;PARP9;TRERF1;MAD2L2;LHX3;LHX2;KAT6A;MAPRE3
positive regulation of mitochondrion organization (GO:0010822),7/128,0.45946687100202477,1,0,0,1.09375,0.8505967287493645,LRRC46;GPER1;RUVBL1;ACSM6;MGARP;ATG13;OR13C4
positive regulation of NF-kappaB transcription factor activity (GO:0051092),7/128,0.45946687100202477,1,0,0,1.09375,0.8505967287493645,TNFSF18;PSMA6;TRADD;BTK;TLR9;BCL10;TRIM32
positive regulation of JUN kinase activity (GO:0043507),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,TLR9;FZD10;MAP3K4
regulation of blood vessel endothelial cell migration (GO:0043535),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,PDPK1;CSNK2B;PRCP
fatty acid beta-oxidation (GO:0006635),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,GCDH;ACOX2;ETFB
double-strand break repair via nonhomologous end joining (GO:0006303),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,ERCC4;BRCA1;NHEJ1
"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBAC2
rRNA 3'-end processing (GO:0031125),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EXOSC6
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PARP9
regulation of mesenchymal cell proliferation (GO:0010464),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PDGFA
cardiac right ventricle morphogenesis (GO:0003215),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NKX2-5
axonal fasciculation (GO:0007413),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EPHA4
regulation of nitric-oxide synthase biosynthetic process (GO:0051769),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TLR9
signal transduction involved in G2 DNA damage checkpoint (GO:0072425),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BRCA1
histone H3-K9 demethylation (GO:0033169),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PHF8
regulation of DNA-dependent DNA replication (GO:0090329),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ZNF365
protein localization to kinetochore (GO:0034501),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CDK1
fatty acid elongation (GO:0030497),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TECR
regulation of IRE1-mediated unfolded protein response (GO:1903894),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AGR2
retinol metabolic process (GO:0042572),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CYP1B1
negative regulation of ERAD pathway (GO:1904293),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBAC2
iron ion transport (GO:0006826),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HEPH
negative regulation of oxidoreductase activity (GO:0051354),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DAOA
pyrimidine nucleoside salvage (GO:0043097),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PUDP
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ING2
viral RNA genome replication (GO:0039694),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PCBP1
oligodendrocyte development (GO:0014003),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PLP1
positive regulation of skeletal muscle tissue development (GO:0048643),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DLL1
histone arginine methylation (GO:0034969),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,COPRS
phospholipid efflux (GO:0033700),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,APOA5
skeletal muscle fiber development (GO:0048741),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,KLHL41
regulation of rRNA processing (GO:2000232),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SHQ1
lysine catabolic process (GO:0006554),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GCDH
protein import into peroxisome matrix (GO:0016558),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PEX5
positive regulation of amyloid precursor protein catabolic process (GO:1902993),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EPHA4
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SIX1
response to prostaglandin E (GO:0034695),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GNG2
positive regulation of ruffle assembly (GO:1900029),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CARMIL2
regulation of interleukin-8 biosynthetic process (GO:0045414),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BCL10
regulation of protein localization to cell periphery (GO:1904375),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,LDLRAP1
negative regulation by host of viral transcription (GO:0043922),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,POU2F3
cellular response to fluid shear stress (GO:0071498),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HDAC3
lysine metabolic process (GO:0006553),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GCDH
negative regulation of histone modification (GO:0031057),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BRCA1
negative regulation of vascular smooth muscle cell proliferation (GO:1904706),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GPER1
"regulation of protein import into nucleus, translocation (GO:0033158)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PSEN1
collagen metabolic process (GO:0032963),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ADAMTS3
negative regulation of epithelial cell differentiation (GO:0030857),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DLL1
skeletal muscle cell differentiation (GO:0035914),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,KLHL41
regulation of vascular endothelial cell proliferation (GO:1905562),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PDPK1
pyrimidine-containing compound salvage (GO:0008655),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PUDP
positive regulation of stem cell differentiation (GO:2000738),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NKX2-5
dermatan sulfate biosynthetic process (GO:0030208),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CHST14
negative regulation of myoblast differentiation (GO:0045662),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DLL1
keratan sulfate catabolic process (GO:0042340),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRELP
regulation of sister chromatid cohesion (GO:0007063),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BUB1
negative regulation of fatty acid metabolic process (GO:0045922),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BRCA1
regulation of catabolic process (GO:0009894),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FAP
microtubule anchoring (GO:0034453),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CLASP2
eye photoreceptor cell differentiation (GO:0001754),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PROM1
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),5/89,0.460744839318766,1,0,0,1.1235955056179774,0.8706863855115896,RPS15A;RPS6;RPS3A;SRP68;SEC63
negative regulation of toll-like receptor signaling pathway (GO:0034122),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,NFKBIL1;TLR9
regulation of dendritic spine development (GO:0060998),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,EPHA4;PSEN1
regulation of protein tyrosine kinase activity (GO:0061097),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,EPHA4;UNC119
secondary alcohol metabolic process (GO:1902652),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,SQLE;LDLRAP1
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,TRADD;BRCA1
positive regulation of insulin secretion (GO:0032024),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,GPER1;C2CD2L
response to cadmium ion (GO:0046686),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,MT1A;MT1M
regulation of Notch signaling pathway (GO:0008593),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,NOTCH3;POGLUT1;RITA1;DLL1
interferon-gamma-mediated signaling pathway (GO:0060333),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,IRF3;HLA-DQB2;HLA-E;TRIM34
regulation of JNK cascade (GO:0046328),5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,HDAC3;GADD45A;CARD9;TLR9;RASGRP1
protein ubiquitination (GO:0016567),26/506,0.47177903125247966,1,0,0,1.0276679841897234,0.7720299796706346,PCNA;FBXO25;BCL10;UBR1;BRCA1;TNFAIP1;ASB12;BACH2;PCNP;MAEA;RMND5A;WWP1;RNF208;FBXL16;KLHL41;PSMA6;UBE2W;UBOX5;UBE2S;PSME3;PEX5;PSME1;STUB1;BLMH;CCDC22;TRIM32
positive regulation of actin filament polymerization (GO:0030838),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,CARMIL2;GSN;CTTN
regulation of cellular amine metabolic process (GO:0033238),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,PSMA6;PSME3;PSME1
telomere maintenance (GO:0000723),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,PCNA;ERCC4;ZNF365
regulation of cellular amino acid metabolic process (GO:0006521),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,PSMA6;PSME3;PSME1
viral gene expression (GO:0019080),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,RPS15A;NUP210;NUP50;RPS6;NUP62;RPS3A
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,PPP3CC;LRRC46;RUVBL1;ACSM6;ATG13;OR13C4
cellular response to peptide hormone stimulus (GO:0071375),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,GNG2;PRKAR1B;PDPK1;GPER1;MGARP;PIK3R1
generation of neurons (GO:0048699),7/130,0.47572414988888423,1,0,0,1.0769230769230769,0.8000645797585316,NRP1;FZD4;UNC119;SIX1;FZD10;LMX1B;DLL1
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,PSMA6;PSME3;PSME1;CDK1
regulation of cation channel activity (GO:2001257),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,CACNB1;KCNE2;NETO1;OPRM1
dendrite morphogenesis (GO:0048813),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,FARP1;ZNF365
protein deacetylation (GO:0006476),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,HDAC3;SIRT5
regulation of glutamate receptor signaling pathway (GO:1900449),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,NETO1;OPRM1
cellular response to glucagon stimulus (GO:0071377),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,GNG2;PRKAR1B
sister chromatid segregation (GO:0000819),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,TOP2A;HIRA
protein trimerization (GO:0070206),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,TRIM6;TRIM34
activation of adenylate cyclase activity (GO:0007190),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CAP1;DRD1
negative regulation of fat cell differentiation (GO:0045599),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CCDC85B;GPER1
mismatch repair (GO:0006298),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PCNA;TREX1
regulation of protein catabolic process (GO:0042176),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,MAD2L2;WWP1;MDM4;ATG7;TRIM32
triglyceride metabolic process (GO:0006641),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,CAV3;AGMO;APOA5
DNA-templated transcriptional preinitiation complex assembly (GO:0070897),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GTF2A2
dermatan sulfate metabolic process (GO:0030205),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CHST14
positive regulation of histone H3-K4 methylation (GO:0051571),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BRCA1
signal transduction involved in DNA damage checkpoint (GO:0072422),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BRCA1
nucleotide-sugar metabolic process (GO:0009225),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GMDS
regulation of lymphocyte activation (GO:0051249),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IFNL2
intestinal absorption (GO:0050892),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC2A5
glucosamine-containing compound metabolic process (GO:1901071),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CHIA
cellular response to nitrogen starvation (GO:0006995),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ATG7
glycerolipid catabolic process (GO:0046503),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PRDX6
regulation of NMDA receptor activity (GO:2000310),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,OPRM1
regulation of cell aging (GO:0090342),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ING2
water transport (GO:0006833),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,AQP6
renal absorption (GO:0070293),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GSN
very long-chain fatty acid biosynthetic process (GO:0042761),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TECR
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PTBP1
muscle cell development (GO:0055001),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CAV3
chromatin assembly or disassembly (GO:0006333),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GATAD1
regulation of glucose import in response to insulin stimulus (GO:2001273),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PIK3R1
synaptic vesicle cycle (GO:0099504),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC17A6
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SOCS4
regulation of DNA-templated transcription in response to stress (GO:0043620),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HSF4
endoplasmic reticulum tubular network organization (GO:0071786),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TMEM170A
positive regulation of T cell mediated cytotoxicity (GO:0001916),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HLA-E
regulation of triglyceride biosynthetic process (GO:0010866),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SREBF1
tricarboxylic acid metabolic process (GO:0072350),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IDH3B
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BRCA1
atrial septum development (GO:0003283),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NKX2-5
positive regulation of actin nucleation (GO:0051127),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GSN
regulation of axon guidance (GO:1902667),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NRP1
poly(A)+ mRNA export from nucleus (GO:0016973),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NXF2
copper ion homeostasis (GO:0055070),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CCDC22
phosphate ion transport (GO:0006817),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLC17A1
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DRD1
B cell activation involved in immune response (GO:0002312),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,EXOSC6
negative regulation of viral release from host cell (GO:1902187),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TRIM32
leukocyte differentiation (GO:0002521),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RRAS
toll-like receptor 9 signaling pathway (GO:0034162),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TLR9
regulation of execution phase of apoptosis (GO:1900117),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FAP
neuron fate commitment (GO:0048663),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DLL1
sensory perception of taste (GO:0050909),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TAS1R2
membrane repolarization (GO:0086009),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KCNE2
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MPV17L
protein localization to endoplasmic reticulum (GO:0070972),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,UBAC2
regulation of necrotic cell death (GO:0010939),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TRADD
motile cilium assembly (GO:0044458),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BBOF1
negative regulation of hormone secretion (GO:0046888),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RAB11FIP5
regulation of neurotransmitter transport (GO:0051588),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CPLX3
triglyceride-rich lipoprotein particle remodeling (GO:0034370),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,APOA5
regulation of fibrinolysis (GO:0051917),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FAP
regulation of cAMP-dependent protein kinase activity (GO:2000479),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PRKAR1B
nucleotide metabolic process (GO:0009117),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PDE8A
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NRP1
negative regulation of blood pressure (GO:0045776),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PRCP
positive regulation of alpha-beta T cell proliferation (GO:0046641),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,HLA-E
negative regulation of ubiquitin-protein transferase activity (GO:0051444),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MAD2L2
regulation of leukocyte migration (GO:0002685),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TNFSF18
high-density lipoprotein particle assembly (GO:0034380),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,APOA5
endothelial cell differentiation (GO:0045446),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KDM6B
response to fatty acid (GO:0070542),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,FFAR1
negative regulation of interleukin-10 production (GO:0032693),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DLL1
mitotic DNA integrity checkpoint (GO:0044774),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TOP2A
regulation of synaptic vesicle transport (GO:1902803),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PREPL
ribonucleoprotein complex disassembly (GO:0032988),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MTIF2
cellular response to nitrogen levels (GO:0043562),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ATG7
regulation of cellular carbohydrate metabolic process (GO:0010675),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RORC
regulation of phosphatase activity (GO:0010921),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,FARP1;CSRNP3;SH2D4A;SYTL2
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,PSMA6;PSME3;PSME1;CDK1
regulation of epithelial cell proliferation (GO:0050678),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,DEAF1;NLRC3;LACRT;PBLD
nuclear export (GO:0051168),5/92,0.48989166823392183,1,0,0,1.0869565217391304,0.7756206495188073,NXF2;XPO6;NUP62;RITA1;PHAX
positive regulation of gene expression (GO:0010628),39/771,0.4940195784553427,1,0,0,1.0116731517509727,0.7134118047490489,CASZ1;RHOXF1;SETD3;RORC;ILK;SIX1;ALOX12B;PIK3R1;BRCA1;PSEN1;BCL10;PHF8;ING2;MED30;DEAF1;GPER1;NUP62;AGR2;POLR2F;STAP1;DRD1;ZNF423;NKX2-5;SF3B1;ATF7IP;MYOCD;POU1F1;GSN;FZD4;FN1;UPF3A;PARP9;TRERF1;MAD2L2;LHX3;LHX2;KAT6A;TLR9;MAPRE3
positive regulation of protein phosphorylation (GO:0001934),21/412,0.4959196507196279,1,0,0,1.0194174757281553,0.7149596387295617,GDF10;EPHA4;NRP1;HDAC3;MMD;PDGFA;ILK;ALOX12B;RASGRP1;MAD2L2;GH2;TRIM6;GPER1;CSNK2B;TLR9;JTB;MAPRE3;CCNL2;LACRT;CNOT9;PDE8A
positive regulation of adenylate cyclase activity (GO:0045762),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CAP1;DRD1
activation of MAPKK activity (GO:0000186),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,FRS2;MAP3K4
oligosaccharide biosynthetic process (GO:0009312),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,GALNT12;GALNT9
neural tube closure (GO:0001843),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,DEAF1;BCL10
response to exogenous dsRNA (GO:0043330),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IFNA1;IFNA8
platelet aggregation (GO:0070527),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ILK;TLN1
regulation of autophagosome assembly (GO:2000785),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,RAB3GAP2;TBC1D12
regulation of DNA recombination (GO:0000018),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ZRANB3;ZNF365
positive regulation of Notch signaling pathway (GO:0045747),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,POGLUT1;DLL1
positive regulation of locomotion (GO:0040017),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,NTN1;TRIM32
cellular glucose homeostasis (GO:0001678),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,GPER1;PIK3R1
regulation of neurotransmitter receptor activity (GO:0099601),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,NETO1;OPRM1
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,PDPK1;STUB1;PBLD
regulation of calcium ion-dependent exocytosis (GO:0017158),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,SYT4;PREPL;SYTL2
positive regulation of protein import into nucleus (GO:0042307),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,HDAC3;PIK3R1;PSEN1
lymphocyte differentiation (GO:0030098),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,ADGRG3;IFNA1;IFNA8;NHEJ1
positive regulation of cytokine secretion (GO:0050715),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,TRIM6;CHIA;CLEC6A;RASGRP1
cellular transition metal ion homeostasis (GO:0046916),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,MT1A;HEPH;MT1M;SLC30A1;CCDC22
cotranslational protein targeting to membrane (GO:0006613),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,RPS15A;RPS6;RPS3A;SRP68;SEC63
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,PSMA6;DNAJB1;PSME3;PSME1;HSF4
proteolysis involved in cellular protein catabolic process (GO:0051603),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,PSMA6;UBE2W;FAP;STUB1;CTSC
viral transcription (GO:0019083),6/113,0.4997075653239782,1,0,0,1.0619469026548671,0.7367067833785346,RPS15A;NUP210;NUP50;RPS6;NUP62;RPS3A
regulation of translation (GO:0006417),11/213,0.5001763192159705,1,0,0,1.0328638497652582,0.7155625020839014,GRB7;NUP210;NUP50;NUP62;POLR2F;UPF3A;MTIF2;MEX3D;CNOT9;EIF4G3;EIF4G2
axon development (GO:0061564),5/94,0.509002443009079,1,0,0,1.0638297872340425,0.7184068753385349,SLITRK2;SLITRK4;TLR9;PLP1;PRELP
"regulation of gene expression, epigenetic (GO:0040029)",4/74,0.5098528753630284,1,0,0,1.0810810810810811,0.7282519724998587,CREBZF;MTA1;POLR2F;SF3B1
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),4/74,0.5098528753630284,1,0,0,1.0810810810810811,0.7282519724998587,GPER1;RHO;PDE6A;CNGB1
intracellular transport of virus (GO:0075733),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,NUP210;NUP50;NUP62
transport of virus (GO:0046794),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,NUP210;NUP50;NUP62
glycosphingolipid metabolic process (GO:0006687),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,CPTP;ARSD;ENPP7
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PDE8A
branching involved in blood vessel morphogenesis (GO:0001569),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NRP1
fluid transport (GO:0042044),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,AQP6
clathrin coat assembly (GO:0048268),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,FCHO2
acetyl-CoA metabolic process (GO:0006084),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ACACB
negative regulation of receptor-mediated endocytosis (GO:0048261),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UNC119
myeloid dendritic cell activation (GO:0001773),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,DOCK2
gliogenesis (GO:0042063),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PLP1
regulation of activin receptor signaling pathway (GO:0032925),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CSNK2B
myotube cell development (GO:0014904),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,KLHL41
"retrograde transport, endosome to plasma membrane (GO:1990126)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ANKRD27
pore complex assembly (GO:0046931),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TMEM170A
positive regulation of response to cytokine stimulus (GO:0060760),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,AGPAT2
regulation of secretion (GO:0051046),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,LACRT
negative regulation of Rho protein signal transduction (GO:0035024),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TNFAIP1
regulation of calcineurin-NFAT signaling cascade (GO:0070884),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RCAN3
glucuronate metabolic process (GO:0019585),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UGT2B15
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ING2
negative regulation of focal adhesion assembly (GO:0051895),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CLASP2
thymus development (GO:0048538),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SIX1
regulation of lymphocyte differentiation (GO:0045619),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TLR9
hydrogen peroxide catabolic process (GO:0042744),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PRDX6
cellular protein complex disassembly (GO:0043624),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GSPT2
purine-containing compound salvage (GO:0043101),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PRTFDC1
cell migration involved in sprouting angiogenesis (GO:0002042),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NRP1
amyloid-beta metabolic process (GO:0050435),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PSEN1
monosaccharide transport (GO:0015749),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC5A2
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ATR
DNA modification (GO:0006304),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EXOSC6
epiboly involved in wound healing (GO:0090505),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CARMIL2
fatty acid transport (GO:0015908),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,LCN1
regulation of synapse organization (GO:0050807),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EPHA4
negative regulation of smooth muscle cell migration (GO:0014912),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TRIB1
positive regulation of calcium ion-dependent exocytosis (GO:0045956),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SYT4
regulation of interferon-gamma biosynthetic process (GO:0045072),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TLR9
regulation of response to interferon-gamma (GO:0060330),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PARP9
negative regulation of cation transmembrane transport (GO:1904063),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CAV3
positive regulation of blood vessel diameter (GO:0097755),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GPER1
negative regulation of DNA binding (GO:0043392),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,MAD2L2;MSX2
negative regulation of cellular metabolic process (GO:0031324),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,SIRT5;BRCA1
positive regulation of muscle cell differentiation (GO:0051149),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,MYOCD;CDH15
positive regulation of cytokinesis (GO:0032467),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,CXCR5;TAS1R2
endoplasmic reticulum organization (GO:0007029),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,TMCC1;TMEM170A
positive regulation of chemokine production (GO:0032722),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,CHIA;TLR9
response to glucagon (GO:0033762),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,GNG2;PRKAR1B
protein O-linked glycosylation (GO:0006493),6/115,0.5169320021309768,1,0,0,1.0434782608695652,0.6885328038765365,GALNT12;ADAMTS5;POGLUT1;GCNT1;ST8SIA6;GALNT9
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",4/75,0.520490485053102,1,0,0,1.0666666666666667,0.6965159162578138,PSMA6;PSME3;PSME1;HLA-E
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,PDPK1;STUB1;PBLD
DNA recombination (GO:0006310),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,RMI2;TREX1;BRCA1
proteasomal protein catabolic process (GO:0010498),12/237,0.5242381291495107,1,0,0,1.0126582278481011,0.6539840536183389,PCNP;PSMA6;UBE2W;MAEA;MTA1;RMND5A;PSME3;PSME1;CDK1;WWP1;STUB1;TNFAIP1
sphingolipid metabolic process (GO:0006665),6/116,0.5254581276778527,1,0,0,1.0344827586206895,0.6656739028524064,FUT7;SAMD8;CPTP;ALOX12B;ARSD;ENPP7
neutrophil degranulation (GO:0043312),24/479,0.5259864526432697,1,0,0,1.0020876826722338,0.6438211159988143,SERPINB10;CAP1;SIGLEC9;GSN;LPCAT1;PDAP1;PRCP;TMC6;PSEN1;RETN;SLC2A5;PRDX6;AGPAT2;DDOST;SIRPB1;ADGRG3;ADGRE5;CSNK2B;CCT8;DOCK2;ATG7;SPTAN1;ATP6V1D;CTSC
epithelial cell differentiation (GO:0030855),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,KDM6B;CBR1;PCNA;CDK1;SIX1
regulation of cell death (GO:0010941),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,ACOX2;RILPL1;AGR2;DHCR24;PDE8A
regulation of heart rate by cardiac conduction (GO:0086091),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,KCNE2;SCN4B
negative regulation of cell-substrate adhesion (GO:0010812),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,FZD4;PTPRO
regulation of endothelial cell apoptotic process (GO:2000351),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PDPK1;GPER1
positive regulation of DNA replication (GO:0045740),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PCNA;PDGFA
apical junction assembly (GO:0043297),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,MARVELD2;POF1B
regulation of mitotic spindle organization (GO:0060236),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,NUP62;CEP97
"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,EMG1;NGDN
regulation of synapse assembly (GO:0051963),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,SRPX2;SLITRK2
regulation of ion transmembrane transport (GO:0034765),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,KCNE2;KCNJ16
positive regulation of telomerase activity (GO:0051973),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,TCP1;MAP3K4
regulation of cardiac muscle contraction (GO:0055117),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,CAV3;NKX2-5
flagellated sperm motility (GO:0030317),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ING2;DNAI1
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ZRANB3;PCNA
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,PSMA6;PSME3;PSME1;CDK1
hemopoiesis (GO:0030097),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,RRAS;KAT6A;NKX2-5;DLL1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,EYA2;TRADD;PSME3;BRCA1
cellular response to lipid (GO:0071396),9/178,0.5347004634884791,1,0,0,1.0112359550561796,0.6330828238059982,NLRP7;FZD4;NFKBIL1;GPER1;RORC;STAP1;FZD10;MGARP;CCDC62
DNA-dependent DNA replication (GO:0006261),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,POLA2;RFC2;MCM2
autophagosome organization (GO:1905037),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,WDR45B;ATG13;ATG7
positive regulation of peptidyl-lysine acetylation (GO:2000758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BRCA1
membrane repolarization during cardiac muscle cell action potential (GO:0086013),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KCNE2
regulation of mast cell degranulation (GO:0043304),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,C12ORF4
regulation of branching involved in ureteric bud morphogenesis (GO:0090189),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SIX1
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACOX2
catecholamine metabolic process (GO:0006584),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DRD1
apoptotic DNA fragmentation (GO:0006309),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DNASE2
nuclear pore organization (GO:0006999),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TMEM170A
selective autophagy (GO:0061912),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RETREG1
digestive tract morphogenesis (GO:0048546),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AGR2
histone H4-K8 acetylation (GO:0043982),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,JADE2
phosphatidylethanolamine biosynthetic process (GO:0006646),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CEPT1
negative regulation of adherens junction organization (GO:1903392),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CLASP2
autonomic nervous system development (GO:0048483),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NRP1
positive regulation of mesonephros development (GO:0061213),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SIX1
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDGFA
mitotic sister chromatid cohesion (GO:0007064),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NAA50
pyrimidine nucleoside biosynthetic process (GO:0046134),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PUDP
"protein localization to chromosome, telomeric region (GO:0070198)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ATR
positive regulation of small GTPase mediated signal transduction (GO:0051057),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RASGRP1
positive regulation of CREB transcription factor activity (GO:0032793),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CRTC1
G-protein coupled glutamate receptor signaling pathway (GO:0007216),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HOMER3
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CARD9
"protein localization to chromosome, centromeric region (GO:0071459)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CDK1
lipoxygenase pathway (GO:0019372),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ALOX12B
negative regulation of insulin secretion (GO:0046676),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FAM3D
positive regulation of cytokine production involved in immune response (GO:0002720),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TRIM6
regulation of interleukin-4 production (GO:0032673),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HLA-E
regulation of establishment of cell polarity (GO:2000114),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GSN
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GTF2F2
unsaturated fatty acid biosynthetic process (GO:0006636),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ALOX12B
intracellular lipid transport (GO:0032365),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ACACB
glycerophospholipid catabolic process (GO:0046475),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PRDX6
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CHST14
regulation of clathrin-dependent endocytosis (GO:2000369),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,UNC119
mitotic chromosome condensation (GO:0007076),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AKAP8L
negative regulation of cellular component movement (GO:0051271),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PKHD1
N-terminal protein amino acid acetylation (GO:0006474),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NAA50
ganglioside metabolic process (GO:0001573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ST8SIA6
regulation of delayed rectifier potassium channel activity (GO:1902259),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KCNE2
regulation of macrophage chemotaxis (GO:0010758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STAP1
negative regulation of viral entry into host cell (GO:0046597),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GSN
positive regulation of cellular response to insulin stimulus (GO:1900078),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PIK3R1
amide transport (GO:0042886),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC25A32
cofactor transport (GO:0051181),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC25A32
body fluid secretion (GO:0007589),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FOXB1
negative regulation of platelet activation (GO:0010544),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDGFA
positive regulation of interleukin-4 production (GO:0032753),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HLA-E
negative regulation of DNA-dependent DNA replication (GO:2000104),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ZRANB3
positive regulation of NF-kappaB import into nucleus (GO:0042346),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TLR9
filopodium assembly (GO:0046847),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FGD6
monovalent inorganic anion homeostasis (GO:0055083),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC12A6
positive regulation of double-strand break repair (GO:2000781),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PARP9
protein O-linked fucosylation (GO:0036066),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ADAMTS5
negative regulation of mRNA processing (GO:0050686),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PTBP1
negative regulation of protein processing (GO:0010955),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NLRP7
regulation of RNA export from nucleus (GO:0046831),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AKAP8L
regulation of lymphocyte proliferation (GO:0050670),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TNFSF18
regulation of T cell mediated cytotoxicity (GO:0001914),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HLA-E
positive regulation of potassium ion transport (GO:0043268),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DRD1
protein targeting to peroxisome (GO:0006625),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PEX5
embryonic cranial skeleton morphogenesis (GO:0048701),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SIX1
cytoplasmic sequestering of protein (GO:0051220),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NFKBIL1
regulation of peptide secretion (GO:0002791),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DNAJC1
base conversion or substitution editing (GO:0016553),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,APOBEC3C
histone H4-K5 acetylation (GO:0043981),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,JADE2
regulation of cartilage development (GO:0061035),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TRPS1
cellular response to corticosteroid stimulus (GO:0071384),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GPER1
cell morphogenesis involved in neuron differentiation (GO:0048667),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,FARP1;SLITRK2;SLITRK4;TLR9;PRELP
water-soluble vitamin metabolic process (GO:0006767),4/77,0.541429111359833,1,0,0,1.0389610389610389,0.6374474106254083,FLAD1;MCCC1;SLC25A32;ACACB
positive regulation of cell motility (GO:2000147),9/179,0.5415277319341373,1,0,0,1.005586592178771,0.6167875984468218,GRB7;LRRC15;CARMIL2;FAM110C;GPER1;PDGFA;DRD1;NTN1;TRIM32
neutrophil activation involved in immune response (GO:0002283),24/483,0.5427846009403516,1,0,0,0.9937888198757763,0.6072474246946159,SERPINB10;CAP1;SIGLEC9;GSN;LPCAT1;PDAP1;PRCP;TMC6;PSEN1;RETN;SLC2A5;PRDX6;AGPAT2;DDOST;SIRPB1;ADGRG3;ADGRE5;CSNK2B;CCT8;DOCK2;ATG7;SPTAN1;ATP6V1D;CTSC
regulation of receptor-mediated endocytosis (GO:0048259),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,LDLRAP1;APOA5
regulation of nitric-oxide synthase activity (GO:0050999),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,CAV3;NOSTRIN
transferrin transport (GO:0033572),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ATP6V1D;ATP6V1C1
lymphocyte proliferation (GO:0046651),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,IFNA1;IFNA8
positive regulation of signaling (GO:0023056),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,LGI1;ILK
organophosphate biosynthetic process (GO:0090407),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,LPCAT1;AGPAT3
heart looping (GO:0001947),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,NKX2-5;DLL1
ferric iron transport (GO:0015682),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ATP6V1D;ATP6V1C1
acylglycerol metabolic process (GO:0006639),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,CAV3;APOA5
cardiac muscle contraction (GO:0060048),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TNNT3;SCN4B
histone modification (GO:0016570),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,NAA50;EYA2;KAT6A;TAF10;RUVBL1
positive regulation of cell growth (GO:0030307),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,LGI1;SYT4;NTN1;TRIM32;EIF4G2
response to molecule of bacterial origin (GO:0002237),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,TRIM6;TLR9;TNFRSF8;BCL10;TRIB1
regulation of primary metabolic process (GO:0080090),7/139,0.546960679882136,1,0,0,1.0071942446043165,0.6077192138852752,PSMA6;HDAC3;PSME3;OPA3;PSME1;RGL1;APOA5
regulation of glycolytic process (GO:0006110),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,NUP210;NUP50;NUP62
regulation of Rho protein signal transduction (GO:0035023),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,NRP1;ARHGDIB;TNFAIP1
epidermal growth factor receptor signaling pathway (GO:0007173),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,GRB7;PDPK1;PIK3R1
negative regulation of cell proliferation (GO:0008285),18/363,0.5490379252117642,1,0,0,0.9917355371900827,0.5946324885888693,MYOCD;POU1F1;TES;NLRC3;OPRM1;DUX4;DLL1;PBLD;RPS6KA2;GPER1;CSNK2B;NUP62;CYP1B1;TNFRSF8;MDM4;TRIB1;TRIM32;ENPP7
protein localization to membrane (GO:0072657),8/160,0.5511758519618988,1,0,0,1,0.5957013701808717,GOLGA7B;DPP10;EHD3;CAV3;FCHO2;RAB38;TSPAN33;CLASP2
extracellular matrix disassembly (GO:0022617),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,ADAMTS5;ELN;FN1;KLK2
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,PSMA6;PSME3;PSME1;HLA-E
fibroblast growth factor receptor signaling pathway (GO:0008543),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,PTBP1;POLR2F;FRS2;GTF2F2
regulation of regulated secretory pathway (GO:1903305),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,SYT4;SYTL2
protein K63-linked ubiquitination (GO:0070534),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,UBE2S;STUB1
response to steroid hormone (GO:0048545),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,CATSPER4;MGARP
organic cyclic compound biosynthetic process (GO:1901362),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,SRD5A1;TRERF1
enzyme linked receptor protein signaling pathway (GO:0007167),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,PTPRT;GRAP2;BTK;STAP1;FRS2;PTPRF
actin filament organization (GO:0007015),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,CAP1;MAD2L2;CARMIL2;GSN;POF1B;DSTN
neutrophil mediated immunity (GO:0002446),24/487,0.5594149167429713,1,0,0,0.9856262833675564,0.5725146608215005,SERPINB10;CAP1;SIGLEC9;GSN;LPCAT1;PDAP1;PRCP;TMC6;PSEN1;RETN;SLC2A5;PRDX6;AGPAT2;DDOST;SIRPB1;ADGRG3;ADGRE5;CSNK2B;CCT8;DOCK2;ATG7;SPTAN1;ATP6V1D;CTSC
cholesterol homeostasis (GO:0042632),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,CAV3;LDLRAP1;APOA5
autophagosome assembly (GO:0000045),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,WDR45B;ATG13;ATG7
sterol homeostasis (GO:0055092),3/58,0.559676962497205,1,0,0,1.0344827586206895,0.6004091528069233,CAV3;LDLRAP1;APOA5
regulation of actin nucleation (GO:0051125),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GSN
C21-steroid hormone biosynthetic process (GO:0006700),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TSPOAP1
DNA strand elongation involved in DNA replication (GO:0006271),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PCNA
glucose transmembrane transport (GO:1904659),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SLC2A5
DNA alkylation (GO:0006305),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ATF7IP
establishment of skin barrier (GO:0061436),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ALOX12B
positive regulation of regulated secretory pathway (GO:1903307),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SYT4
negative regulation of response to wounding (GO:1903035),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EPHA4
phosphatidylinositol acyl-chain remodeling (GO:0036149),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PLBD1
histone H2A acetylation (GO:0043968),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RUVBL1
regulation of cell cycle phase transition (GO:1901987),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ERCC3
regulation of water loss via skin (GO:0033561),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ALOX12B
stabilization of membrane potential (GO:0030322),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,KCNK1
sympathetic nervous system development (GO:0048485),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NRP1
regulation of histone H3-K4 methylation (GO:0051569),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BRCA1
positive regulation of mRNA processing (GO:0050685),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PRDX6
positive regulation of lymphocyte differentiation (GO:0045621),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BTK
guanosine-containing compound metabolic process (GO:1901068),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PDE6A
regulation of bicellular tight junction assembly (GO:2000810),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NPHP1
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,STAP1
regulation of energy homeostasis (GO:2000505),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DLL1
DNA methylation or demethylation (GO:0044728),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ATF7IP
negative regulation of translational initiation (GO:0045947),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EIF2AK1
positive regulation of immune system process (GO:0002684),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TNFSF18
cellular response to pH (GO:0071467),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RAB11FIP5
dendritic spine morphogenesis (GO:0060997),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ZNF365
negative regulation of DNA recombination (GO:0045910),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ZRANB3
negative regulation of peptide hormone secretion (GO:0090278),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FAM3D
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CDK1
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SRPX2
artery development (GO:0060840),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NRP1
regulation of necroptotic process (GO:0060544),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TRADD
activation of protein kinase A activity (GO:0034199),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PRKAR1B
embryonic heart tube development (GO:0035050),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NKX2-5
regulation of membrane repolarization (GO:0060306),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,KCNE2
linoleic acid metabolic process (GO:0043651),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ALOX12B
positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PIK3R1
programmed necrotic cell death (GO:0097300),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ALKBH7
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TRIM32
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,ING2;PDPK1;STUB1;PBLD
double-strand break repair (GO:0006302),7/141,0.562244066689369,1,0,0,0.9929078014184397,0.5717354165920848,MAD2L2;MTA1;ERCC4;ACTR5;BRCA1;PARP9;NHEJ1
regulation of lipid metabolic process (GO:0019216),5/100,0.5644459548061124,1,0,0,1,0.5719106399118082,HDAC3;OPA3;RORC;RGL1;APOA5
phosphate-containing compound metabolic process (GO:0006796),9/183,0.5684423222988123,1,0,0,0.9836065573770492,0.5555955018465372,MINPP1;PLCZ1;IMPA2;PLPPR3;ACP6;PLBD1;PLCH2;DUSP16;AGPAT2
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,GDF10;CSNK2B;PBLD
ERBB signaling pathway (GO:0038127),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,GRB7;PDPK1;STUB1;PIK3R1
regulation of hydrolase activity (GO:0051336),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,EPHA4;FGD6;TNNT3;RAB3GAP2
neuron projection morphogenesis (GO:0048812),8/163,0.5724547815603112,1,0,0,0.9815950920245399,0.5475548769053109,FARP1;ANKRD27;CTTN;SLITRK2;SLITRK4;TLR9;PRELP;ZNF365
regulation of protein kinase B signaling (GO:0051896),8/163,0.5724547815603112,1,0,0,0.9815950920245399,0.5475548769053109,PKHD1;RRAS;FAM110C;GPER1;PDGFA;FRS2;PIK3R1;PHLDA3
DNA damage checkpoint (GO:0000077),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,ERCC4;ATR
homotypic cell-cell adhesion (GO:0034109),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,ILK;TLN1
protein processing (GO:0016485),5/101,0.5733754172932677,1,0,0,0.9900990099009901,0.5507075230503586,ADAMTS3;CASP2;PSEN1;KLK2;ASPRV1
intrinsic apoptotic signaling pathway (GO:0097193),5/101,0.5733754172932677,1,0,0,0.9900990099009901,0.5507075230503586,ZNF385C;CYP1B1;CASP2;BRCA1;CRIP1
"positive regulation of transcription, DNA-templated (GO:0045893)",55/1120,0.5767410340000697,1,0,0,0.9821428571428571,0.5405340362118862,CSRNP3;SETD3;CRTC1;AKAP8L;RORC;ILK;SIX1;BRCA1;DUX4;DCAF6;PHF8;ING2;GPER1;NUP62;CCNL2;KDM6B;SREBF1;MYOCD;POU1F1;EBF1;PARP9;IRF3;KAT6A;TLR9;MAPRE3;LMX1B;ASF1A;GTF2A2;CASZ1;ZNF350;HDAC3;GLIS3;PIK3R1;PSEN1;BCL10;DLL1;MED30;DEAF1;ZNF423;NKX2-5;ATF7IP;WWTR1;FZD4;ZNF76;TRERF1;POU2F3;ELL3;RAX2;MAD2L2;ERCC3;LHX3;LHX2;NANOG;PAXBP1;CCDC62
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),25/512,0.5784163324196347,1,0,0,0.9765625,0.5346302454064581,CREBZF;GRB7;ZNF350;HDAC3;UBP1;BRCA1;DMBX1;CCDC85B;DEAF1;LRRFIP1;NKX2-5;ZNF423;ENPP7;ATF7IP;HEXIM2;ZHX3;MSX2;EIF2AK1;WWP1;MEX3D;RIPPLY1;ERN2;KAT6A;CNOT9;ATR
positive regulation of protein processing (GO:0010954),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GSN
positive regulation of cell cycle G2/M phase transition (GO:1902751),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CDK1
reverse cholesterol transport (GO:0043691),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,APOA5
cellular glucuronidation (GO:0052695),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UGT2B15
positive regulation of focal adhesion assembly (GO:0051894),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NRP1
negative regulation of axon guidance (GO:1902668),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PTPRO
DNA catabolic process (GO:0006308),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TATDN2
positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GPER1
regulation of telomere maintenance via telomere lengthening (GO:1904356),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ERCC4
positive regulation of lymphocyte migration (GO:2000403),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TMEM102
cellular response to gamma radiation (GO:0071480),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ATR
ureteric bud development (GO:0001657),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SIX1
glycosphingolipid biosynthetic process (GO:0006688),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ST8SIA6
regulation of lipid catabolic process (GO:0050994),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,APOA5
positive regulation of fatty acid metabolic process (GO:0045923),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,APOA5
N-terminal protein amino acid modification (GO:0031365),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NAA50
regulation of transposition (GO:0010528),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,APOBEC3C
negative regulation of telomere maintenance (GO:0032205),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ERCC4
positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MYOCD
positive regulation of dendrite extension (GO:1903861),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SYT4
negative regulation of cell development (GO:0010721),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CAV3
negative regulation of interleukin-8 production (GO:0032717),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TLR9
cardiac atrium morphogenesis (GO:0003209),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NKX2-5
regulation of myelination (GO:0031641),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TNFRSF8
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PYDC2
maturation of 5.8S rRNA (GO:0000460),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RRP15
negative regulation of intracellular transport (GO:0032387),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MPV17L
positive regulation of cellular protein catabolic process (GO:1903364),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CTSC
pharyngeal system development (GO:0060037),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NKX2-5
embryo development ending in birth or egg hatching (GO:0009792),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BRCA1
phospholipid catabolic process (GO:0009395),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PRDX6
positive regulation of calcium ion transmembrane transporter activity (GO:1901021),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CASQ1
positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,ATR
positive regulation of macrophage activation (GO:0043032),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,STAP1
regulation of transcription from RNA polymerase I promoter (GO:0006356),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PHF8
regulation of synaptic vesicle exocytosis (GO:2000300),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PREPL
defense response to fungus (GO:0050832),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CLEC6A
regulation of T cell migration (GO:2000404),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TMEM102
regulation of lamellipodium organization (GO:1902743),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CARMIL2
positive chemotaxis (GO:0050918),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NRP1
regulation of B cell receptor signaling pathway (GO:0050855),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,STAP1
positive regulation of telomere capping (GO:1904355),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MAP3K4
detection of mechanical stimulus (GO:0050982),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DENND5B
mesonephric tubule development (GO:0072164),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SIX1
positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NOTCH3
viral entry into host cell (GO:0046718),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,WWP1
membrane depolarization during cardiac muscle cell action potential (GO:0086012),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SCN4B
"regulation of mRNA splicing, via spliceosome (GO:0048024)",3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,PTBP1;PRDX6;JMJD6
regulation of stress fiber assembly (GO:0051492),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,NRP1;WASF2;CLASP2
muscle organ development (GO:0007517),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,SGCE;COPRS;CAV3
skeletal muscle tissue development (GO:0007519),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,SIX1;KLHL41
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,TRADD;BRCA1
clathrin-dependent endocytosis (GO:0072583),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,FCHO2;DLL1
regulation of RNA metabolic process (GO:0051252),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,RBM38;CLK4
alpha-amino acid catabolic process (GO:1901606),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,MCCC1;BLMH
acyl-CoA metabolic process (GO:0006637),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,ACSM6;ACACB
DNA biosynthetic process (GO:0071897),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,RMI2;BRCA1
positive regulation of angiogenesis (GO:0045766),5/103,0.5909417872320486,1,0,0,0.9708737864077669,0.5107162768822324,RRAS;PDPK1;CYP1B1;BRCA1;DLL1
mitotic sister chromatid segregation (GO:0000070),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,NAA50;HIRA;AKAP8L;NUP62
positive regulation of DNA metabolic process (GO:0051054),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,PCNA;EYA2;PDGFA;BRCA1
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,GDF10;ING2;CSNK2B;ZNF423
ephrin receptor signaling pathway (GO:0048013),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,EPHA4;ARPC3;PSEN1;ANKS1A
potassium ion transport (GO:0006813),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,KCNA2;KCNJ16;KCNK1
striated muscle contraction (GO:0006941),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,TNNT3;SCN4B;KLHL41
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),14/291,0.5977003096216139,1,0,0,0.9621993127147767,0.4952110839741616,WWP1;UBR1;TNFAIP1;PCNP;PSMA6;UBE2W;MAEA;MTA1;RMND5A;UBE2S;PSME3;PSME1;CDK1;STUB1
proteolysis (GO:0006508),14/291,0.5977003096216139,1,0,0,0.9621993127147767,0.4952110839741616,PRSS16;PRCP;PSEN1;ASPRV1;PRSS56;SENP6;PSMA6;CAPN14;ADAMTS3;FAP;LCN1;CASP2;CPA6;CTSC
extracellular matrix organization (GO:0030198),11/229,0.597790330332266,1,0,0,0.9606986899563319,0.49429408310435485,ADAMTS5;COL2A1;ADAMTS3;ITGAD;ELN;FN1;CYP1B1;PDGFA;TNR;KLK2;DSPP
regulation of GTPase activity (GO:0043087),9/188,0.6010901477918724,1,0,0,0.9574468085106382,0.4873503440770302,CCL14;EPHA4;AFDN;KLRK1;FGD6;RAB3GAP2;FZD10;ARHGAP27;RASGRP1
embryonic heart tube morphogenesis (GO:0003143),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,NKX2-5;DLL1
regulation of cellular localization (GO:0060341),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,GSN;CPLX3
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,SOCS4;PTPN3
cognition (GO:0050890),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,CHRNA4;SLC1A4
androgen receptor signaling pathway (GO:0030521),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,MED30;BRCA1
negative regulation of catabolic process (GO:0009895),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,MAD2L2;MDM4
negative regulation of cytokine-mediated signaling pathway (GO:0001960),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,STAP1;PYDC2
regulation of intracellular transport (GO:0032386),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,C12ORF4;TMEM102
determination of heart left/right asymmetry (GO:0061371),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,NKX2-5;DLL1
JAK-STAT cascade (GO:0007259),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,GH2;CSH1
negative regulation of neuron death (GO:1901215),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,FOXB1;SIX1;RETREG1;CRLF1
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TECR
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DRD1
membrane protein ectodomain proteolysis (GO:0006509),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PSEN1
homologous chromosome segregation (GO:0045143),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TERB2
regulation of amyloid-beta formation (GO:1902003),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,EPHA4
response to nutrient levels (GO:0031667),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GH2
glucan biosynthetic process (GO:0009250),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GYS1
positive regulation of lipid catabolic process (GO:0050996),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,APOA5
endoplasmic reticulum calcium ion homeostasis (GO:0032469),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PSEN1
anterior/posterior axis specification (GO:0009948),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RIPPLY1
positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GPER1
regulation of chemokine production (GO:0032642),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TLR9
negative regulation of RNA splicing (GO:0033119),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PTBP1
regulation of dephosphorylation (GO:0035303),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PPP1R14D
positive regulation of metabolic process (GO:0009893),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ACACB
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,UBAP1L
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PDILT
prostaglandin biosynthetic process (GO:0001516),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CBR1
outer dynein arm assembly (GO:0036158),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DNAI1
negative regulation of microtubule depolymerization (GO:0007026),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CLASP2
insulin secretion (GO:0030073),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RAB11FIP5
skeletal muscle contraction (GO:0003009),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TNNT3
tRNA metabolic process (GO:0006399),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,YARS2
phosphatidylglycerol acyl-chain remodeling (GO:0036148),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,LPCAT1
glycogen biosynthetic process (GO:0005978),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GYS1
blood vessel endothelial cell migration (GO:0043534),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NRP1
regulation of cellular response to growth factor stimulus (GO:0090287),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CAV3
DNA methylation (GO:0006306),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ATF7IP
regulation of microtubule polymerization or depolymerization (GO:0031110),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CLASP2
cell-substrate adherens junction assembly (GO:0007045),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CTTN
regulation of dendrite extension (GO:1903859),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SYT4
snRNA metabolic process (GO:0016073),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MEPCE
mRNA destabilization (GO:0061157),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,MEX3D
positive regulation of morphogenesis of an epithelium (GO:1905332),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SIX1
focal adhesion assembly (GO:0048041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CTTN
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,PSMA6;PSME3;PSME1
cellular protein catabolic process (GO:0044257),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,PSMA6;FAP;CTSC
negative regulation of peptidase activity (GO:0010466),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,SERPINB10;NLRP7;TIMP4
second-messenger-mediated signaling (GO:0019932),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,PDPK1;BTK;LACRT
regulation of translational initiation (GO:0006446),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,MTIF2;EIF4G3;EIF4G2
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),19/396,0.6070724877040653,1,0,0,0.9595959595959594,0.47894113299921065,PTPRT;EPHA4;NRP1;PDGFA;FRS2;PIK3R1;PSEN1;GTF2F2;GH2;PTBP1;ARPC3;GRAP2;BTK;POLR2F;STAP1;ANKS1A;WASF2;ATP6V1D;ATP6V1C1
G1/S transition of mitotic cell cycle (GO:0000082),5/105,0.6081022529852088,1,0,0,0.9523809523809523,0.47372593514716843,POLA2;PCNA;CDK3;PHF8;MCM2
odontogenesis (GO:0042476),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,AQP6;ACP4
bicarbonate transport (GO:0015701),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,SLC4A10;CYB5RL
regulation of phagocytosis (GO:0050764),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,DOCK2;SIRPB1
regulation of calcium-mediated signaling (GO:0050848),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,RCAN3;LACRT
peptide transport (GO:0015833),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,RUFY1;RAB38
DNA duplex unwinding (GO:0032508),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,ERCC3;GTF2H3
positive regulation of cell division (GO:0051781),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,CXCR5;TAS1R2
regulation of substrate adhesion-dependent cell spreading (GO:1900024),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,NRP1;DOCK5
positive regulation of viral transcription (GO:0050434),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,POLR2F;GTF2F2
monocyte chemotaxis (GO:0002548),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,CCL14;PTPRO
regulation of viral genome replication (GO:0045069),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,TOP2A;APOBEC3C;TRIM6
RNA splicing (GO:0008380),5/106,0.6165249871762161,1,0,0,0.9433962264150944,0.4562796476411569,PTBP1;NWD1;ZMAT5;MTERF4;SF3B1
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),4/85,0.6201271748700885,1,0,0,0.9411764705882353,0.4497230129121684,GH2;NRP1;PDGFA;LACRT
peptidyl-serine modification (GO:0018209),8/170,0.6202201527232523,1,0,0,0.9411764705882353,0.4495819095842526,GALNT12;POGLUT1;PDPK1;DAPK2;CDK1;GALNT9;PSKH1;ATR
regulation of mitotic spindle assembly (GO:1901673),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CEP97
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ING2
negative regulation of smoothened signaling pathway (GO:0045879),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PTCH2
primary alcohol metabolic process (GO:0034308),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CYP1B1
negative regulation of lymphocyte activation (GO:0051250),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MICA
protein ADP-ribosylation (GO:0006471),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PARP9
negative regulation of phosphate metabolic process (GO:0045936),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,STAP1
negative regulation of cell junction assembly (GO:1901889),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CLASP2
negative regulation of protein localization to plasma membrane (GO:1903077),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,LRRC15
positive regulation of heart contraction (GO:0045823),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NKX2-5
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,EPHA4
negative regulation of transposition (GO:0010529),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,APOBEC3C
endothelial cell development (GO:0001885),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MARVELD2
acylglycerol biosynthetic process (GO:0046463),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,AGMO
regulation of myotube differentiation (GO:0010830),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NKX2-5
muscle tissue morphogenesis (GO:0060415),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NKX2-5
morphogenesis of an epithelium (GO:0002009),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,KRT6A
cyclic nucleotide biosynthetic process (GO:0009190),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GUCY1B2
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TLR9
negative regulation of lipid metabolic process (GO:0045833),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GPER1
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,CASP2
purine ribonucleotide catabolic process (GO:0009154),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PDE4A
folic acid metabolic process (GO:0046655),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLC25A32
histone deubiquitination (GO:0016578),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TAF10
negative regulation of protein localization to cell periphery (GO:1904376),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,LRRC15
nucleotide-sugar biosynthetic process (GO:0009226),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GMPPB
regulation of platelet activation (GO:0010543),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PDGFA
positive regulation of phospholipase activity (GO:0010518),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PDPK1
DNA double-strand break processing (GO:0000729),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,BRCA1
aspartate family amino acid catabolic process (GO:0009068),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GCDH
positive regulation of adherens junction organization (GO:1903393),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,NRP1
hexose transmembrane transport (GO:0035428),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLC2A5
positive regulation of transcription regulatory region DNA binding (GO:2000679),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TRIM6
triglyceride biosynthetic process (GO:0019432),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,AGMO
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ING2
regulation of catenin import into nucleus (GO:0035412),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,WWTR1
viral life cycle (GO:0019058),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,NUP210;NUP50;NUP62;UBP1;WWP1
regulation of response to external stimulus (GO:0032101),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,PSMA6;NLRP7;RHO;PDE6A;CNGB1
positive regulation of cell cycle process (GO:0090068),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,FAP;NUP62;CXCR5;TAS1R2;BRCA1
glycerophospholipid metabolic process (GO:0006650),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,ACP6;APOA5;PRDX6
cellular response to decreased oxygen levels (GO:0036294),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,MDM4;STUB1;MGARP
regulation of interleukin-6 production (GO:0032675),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,TLR9;NLRC3
determination of left/right symmetry (GO:0007368),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,DLL1;DNAI1
regulation of telomerase activity (GO:0051972),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,TCP1;MAP3K4
cellular response to retinoic acid (GO:0071300),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,FZD4;FZD10
regulation of macromolecule metabolic process (GO:0060255),6/129,0.6298141258718173,1,0,0,0.9302325581395349,0.4300749222582539,NLRP7;DPPA3;CDK3;CDK1;NANOG;CRIP1
regulation of cytokine production (GO:0001817),5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,IRF3;NLRP7;TREX1;AGPAT2;TRIM32
positive regulation of protein kinase activity (GO:0045860),8/172,0.6333337048835047,1,0,0,0.9302325581395349,0.4248909914769504,SBK2;EPHA4;MMD;JTB;UNC119;MAPRE3;ATG13;MAP3K4
O-glycan processing (GO:0016266),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,GALNT12;GCNT1;GALNT9
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,STUB1;BRCA1;BCL10
regulation of MAP kinase activity (GO:0043405),4/87,0.6384210161989183,1,0,0,0.9195402298850575,0.41265040301361416,CAV3;PDGFA;TRIB1;RASGRP1
positive regulation of interferon-gamma production (GO:0032729),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,TLR9;RASGRP1
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,ZNF385C;PHLDA3
response to unfolded protein (GO:0006986),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,DNAJB1;HSPA14
substantia nigra development (GO:0021762),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,ERCC4;PLP1
branching morphogenesis of an epithelial tube (GO:0048754),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,NRP1;SIX1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),5/109,0.6411418318346604,1,0,0,0.9174311926605505,0.4078023669950098,GSN;TRADD;GPER1;CASP2;BLID
negative regulation of innate immune response (GO:0045824),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NLRC3
regulation of vacuole organization (GO:0044088),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TBC1D12
cell projection assembly (GO:0030031),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PDGFA
mesoderm formation (GO:0001707),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,KDM6B
hydrogen peroxide metabolic process (GO:0042743),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PRDX6
regulation of epidermal cell differentiation (GO:0045604),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DLL1
ureteric bud morphogenesis (GO:0060675),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SIX1
positive regulation of dendritic spine development (GO:0060999),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PSEN1
"wound healing, spreading of cells (GO:0044319)",1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CARMIL2
synapsis (GO:0007129),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TERB2
negative regulation of ion transport (GO:0043271),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CAV3
regulation of lipoprotein lipase activity (GO:0051004),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,APOA5
response to progesterone (GO:0032570),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CATSPER4
negative regulation of cyclase activity (GO:0031280),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,OPRM1
regulation of cholesterol transport (GO:0032374),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,APOA5
phosphatidylethanolamine metabolic process (GO:0046337),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CEPT1
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CLDN16
"regulation of DNA-templated transcription, elongation (GO:0032784)",1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ELL3
axon extension (GO:0048675),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NRP1
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PHLDA3
dopamine metabolic process (GO:0042417),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DRD1
androgen metabolic process (GO:0008209),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SRD5A1
Arp2/3 complex-mediated actin nucleation (GO:0034314),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ARPC3
regulation of cell development (GO:0060284),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DLL1
negative regulation of protein depolymerization (GO:1901880),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,CLASP2
glial cell development (GO:0021782),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DLL1
striated muscle cell development (GO:0055002),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,KLHL41
regulation of response to cytokine stimulus (GO:0060759),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PARP9
branching involved in ureteric bud morphogenesis (GO:0001658),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SIX1
positive regulation of T cell migration (GO:2000406),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TMEM102
inactivation of MAPK activity (GO:0000188),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DUSP16
dorsal/ventral pattern formation (GO:0009953),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,LMX1B
negative regulation of adenylate cyclase activity (GO:0007194),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,OPRM1
immune response-activating cell surface receptor signaling pathway (GO:0002429),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RFTN2
dopaminergic neuron differentiation (GO:0071542),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,LMX1B
regulation of transport (GO:0051049),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NRP1
positive regulation of cAMP biosynthetic process (GO:0030819),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GPER1
nuclear-transcribed mRNA catabolic process (GO:0000956),8/174,0.6461933813797057,1,0,0,0.9195402298850575,0.40152318897970674,EXOSC6;RPS15A;RPS6;UPF3A;RPS3A;GSPT2;NBDY;CNOT9
peptide biosynthetic process (GO:0043043),8/174,0.6461933813797057,1,0,0,0.9195402298850575,0.40152318897970674,MRPS17;RPS15A;MRPS33;RPS6;RPS3A;YARS2;GSPT2;MRPS6
positive regulation of protein complex assembly (GO:0031334),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,ERCC3;ERCC4;STUB1;GTF2H3
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,PSMA6;FZD4;PSME3;PSME1
purine ribonucleotide metabolic process (GO:0009150),3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,PODXL2;PDE6A;SULT4A1
positive regulation of cellular protein localization (GO:1903829),3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,NUP62;CDK1;PARP9
spermatogenesis (GO:0007283),7/153,0.6484975480312875,1,0,0,0.915032679738562,0.3962979599377591,CNBD2;ING2;NR6A1;RUVBL1;MYCBPAP;TDRD6;ELL3
negative regulation of cytokine production (GO:0001818),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,IRF3;NLRP7;TLR9;NLRC3;DLL1
protein oligomerization (GO:0051259),10/217,0.6494177009402682,1,0,0,0.9216589861751152,0.3978609790860964,EHD3;TRIM6;TRPS1;TAF10;MCCC1;HACL1;BCL10;TMCC1;RASGRP1;TRIM34
cellular response to hypoxia (GO:0071456),6/132,0.6519118466202043,1,0,0,0.9090909090909091,0.3889508461515316,PSMA6;PSME3;PSME1;MDM4;STUB1;MGARP
ribosomal small subunit biogenesis (GO:0042274),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,EMG1;RPS6
regulation of focal adhesion assembly (GO:0051893),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,NRP1;CLASP2
detection of chemical stimulus involved in sensory perception of taste (GO:0050912),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,TAS1R2;TAS2R4
unsaturated fatty acid metabolic process (GO:0033559),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,CYP1B1;ALOX12B
positive regulation of macroautophagy (GO:0016239),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,RAB3GAP2;LACRT
positive regulation of interleukin-8 production (GO:0032757),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,TLR9;BCL10
negative regulation of type I interferon production (GO:0032480),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,IRF3;NLRC3
positive regulation of transport (GO:0051050),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,DLL1;LACRT
heart contraction (GO:0060047),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,TNNT3;SCN4B
protein N-linked glycosylation via asparagine (GO:0018279),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,ALG5;DDOST
inorganic anion transport (GO:0015698),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,SLC4A10;SLC17A1
posttranscriptional regulation of gene expression (GO:0010608),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,MEX3D;PARP9
negative regulation of immune response (GO:0050777),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,NLRP7;NLRC3
positive regulation of viral process (GO:0048524),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,POLR2F;GTF2F2
male gamete generation (GO:0048232),7/154,0.6552164451795385,1,0,0,0.9090909090909091,0.3843542247980854,CNBD2;ING2;NR6A1;RUVBL1;MYCBPAP;TDRD6;ELL3
negative regulation of cellular protein metabolic process (GO:0032269),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,GRB7;DNAJC1;MEX3D;CNOT9
regulation of establishment of planar polarity (GO:0090175),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,PSMA6;FZD4;PSME3;PSME1
regulation of neuron apoptotic process (GO:0043523),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,FOXB1;SIX1;RETREG1;CRLF1
positive regulation of synaptic transmission (GO:0050806),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,LGI1;GPER1;DRD1
regulation of TOR signaling (GO:0032006),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,PKHD1;HDAC3;UBR1
extrinsic apoptotic signaling pathway (GO:0097191),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,PDPK1;TRADD;CASP2
insulin receptor signaling pathway (GO:0008286),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,PIK3R1;ATP6V1D;ATP6V1C1
regulation of protein phosphorylation (GO:0001932),12/261,0.6585582788214799,1,0,0,0.9195402298850575,0.38409403156639316,GDF10;SBK2;WWTR1;HDAC3;GPER1;AKAP8L;FN1;PDGFA;ILK;SPDYE5;PDE8A;RASGRP1
protein modification by small protein removal (GO:0070646),12/261,0.6585582788214799,1,0,0,0.9195402298850575,0.38409403156639316,SENP6;PSMA6;USP10;PSME3;ACTR5;TAF10;RUVBL1;PSME1;CDK1;MDM4;BRCA1;EIF3F
positive regulation of transcription from RNA polymerase I promoter (GO:0045943),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PHF8
establishment of protein localization to vacuole (GO:0072666),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TMEM50B
positive regulation of leukocyte cell-cell adhesion (GO:1903039),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SIRPB1
sterol transport (GO:0015918),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,LDLRAP1
mesoderm development (GO:0007498),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,BTK
negative regulation of ion transmembrane transporter activity (GO:0032413),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CAV3
positive regulation of T cell mediated immunity (GO:0002711),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,HLA-E
regulation of cardiac muscle hypertrophy (GO:0010611),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CAV3
zinc II ion transport (GO:0006829),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SLC30A1
positive regulation of histone acetylation (GO:0035066),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,BRCA1
branched-chain amino acid catabolic process (GO:0009083),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MCCC1
vesicle docking (GO:0048278),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,STX6
negative regulation of protein tyrosine kinase activity (GO:0061099),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SOCS4
non-motile cilium assembly (GO:1905515),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CCDC13
positive regulation of BMP signaling pathway (GO:0030513),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ZNF423
response to nicotine (GO:0035094),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CHRNA4
ventricular septum morphogenesis (GO:0060412),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,NKX2-5
negative regulation of viral process (GO:0048525),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TRIM32
meiosis I (GO:0007127),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ING2
negative regulation of cAMP biosynthetic process (GO:0030818),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,OPRM1
positive regulation of lipid metabolic process (GO:0045834),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,APOA5
positive regulation of receptor internalization (GO:0002092),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,ATAD1
negative regulation of cell cycle arrest (GO:0071157),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GPER1
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",5/112,0.6647517057733329,1,0,0,0.8928571428571428,0.3645907882365566,RPS15A;RPS6;UPF3A;RPS3A;GSPT2
regulation of cytokine-mediated signaling pathway (GO:0001959),4/90,0.6647641861492688,1,0,0,0.8888888888888888,0.362953696452133,IFNA1;TRADD;IFNA8;AGPAT2
plasma membrane bounded cell projection assembly (GO:0120031),11/241,0.6647649835515149,1,0,0,0.912863070539419,0.3727418090300206,PKHD1;NRP1;EHD3;FGD6;GSN;RILPL1;PTPRO;UNC119;POC1B;ATP6V1D;NTN1
sensory perception of smell (GO:0007608),11/241,0.6647649835515149,1,0,0,0.912863070539419,0.3727418090300206,OR2L8;OR5H1;OR1E1;OR2G2;OR2AG2;OR2M5;OR51B6;OR6N1;BEST2;OR10A3;OR13C4
positive regulation of MAP kinase activity (GO:0043406),8/177,0.6649907113188037,1,0,0,0.903954802259887,0.36879747468066354,GADD45A;CDK1;TLR9;PDGFA;FRS2;FZD10;RASGRP1;MAP3K4
positive regulation of blood vessel endothelial cell migration (GO:0043536),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,SRPX2;PDPK1
peptidyl-asparagine modification (GO:0018196),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,ALG5;DDOST
"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,ATAD1;DRD1
metal ion homeostasis (GO:0055065),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,CLDN16;SLC12A6
peptidyl-tyrosine autophosphorylation (GO:0038083),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,GRAP2;BTK
viral process (GO:0016032),10/220,0.6662715120641264,1,0,0,0.9090909090909091,0.36914365067906874,PTBP1;RPS15A;NUP210;NUP50;RPS6;NUP62;UBP1;RPS3A;EIF3F;DOCK2
positive regulation of cytokine production (GO:0001819),10/220,0.6662715120641264,1,0,0,0.9090909090909091,0.36914365067906874,IRF3;CLEC6A;TLR9;CYP1B1;POLR2F;BRCA1;LRRFIP1;RASGRP1;AGPAT2;HLA-E
negative regulation of protein phosphorylation (GO:0001933),8/178,0.6711220124733558,1,0,0,0.898876404494382,0.3584757948492,WWTR1;LRRC15;CAV3;PDPK1;TRIB1;LRRC66;SOCS4;PBLD
regulation of organelle organization (GO:0033043),5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,EHD3;TMED9;PDE4DIP;MGARP;TBC1D12
positive regulation of canonical Wnt signaling pathway (GO:0090263),5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,PSMA6;PSME3;RUVBL1;PSME1;ILK
regulation of calcium ion transport into cytosol (GO:0010522),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CASQ1
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PARP9
positive regulation of protein autophosphorylation (GO:0031954),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PDGFA
acylglycerol homeostasis (GO:0055090),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,APOA5
protein localization to cilium (GO:0061512),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ATP6V1D
early endosome to late endosome transport (GO:0045022),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,ANKRD27
sulfur amino acid metabolic process (GO:0000096),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CDO1
"DNA catabolic process, endonucleolytic (GO:0000737)",1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,DNASE2
negative regulation of actin filament polymerization (GO:0030837),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,GSN
positive regulation of interleukin-10 production (GO:0032733),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TLR9
histone lysine methylation (GO:0034968),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SETD3
triglyceride catabolic process (GO:0019433),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,APOA5
rRNA modification (GO:0000154),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MTERF4
phosphatidylglycerol metabolic process (GO:0046471),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,LPCAT1
branched-chain amino acid metabolic process (GO:0009081),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MCCC1
regulation of microtubule depolymerization (GO:0031114),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CLASP2
positive regulation of biosynthetic process (GO:0009891),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,APOA5
cellular response to unfolded protein (GO:0034620),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HSPA14
inner ear morphogenesis (GO:0042472),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SIX1
negative regulation of nervous system development (GO:0051961),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TNFRSF8
maturation of LSU-rRNA (GO:0000470),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RRP15
negative regulation of lyase activity (GO:0051350),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,OPRM1
NLS-bearing protein import into nucleus (GO:0006607),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TRPS1
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,C2CD2L
digestive system development (GO:0055123),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,BARX1
glucose transport (GO:0015758),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SLC2A5
regulation of G1/S transition of mitotic cell cycle (GO:2000045),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,PSME3;PSME1
protein methylation (GO:0006479),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,VCPKMT;ETFB
tRNA aminoacylation for protein translation (GO:0006418),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,YARS2;WARS2
maturation of SSU-rRNA (GO:0030490),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,EMG1;NGDN
icosanoid metabolic process (GO:0006690),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,CYP1B1;ALOX12B
regulation of endocytosis (GO:0030100),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,RUFY1;UNC119;DLL1
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,NRP1;CARMIL2;WASF2
positive regulation of cellular metabolic process (GO:0031325),4/92,0.6815826288475257,1,0,0,0.8695652173913043,0.333337208380493,ATAD1;GADD45A;APOA5;ACACB
cell cycle G1/S phase transition (GO:0044843),4/92,0.6815826288475257,1,0,0,0.8695652173913043,0.333337208380493,POLA2;CDK3;PHF8;MCM2
ER to Golgi vesicle-mediated transport (GO:0006888),8/180,0.683178744936179,1,0,0,0.8888888888888888,0.33866555380766933,TMED9;TRAPPC6A;MIA;COG5;CTAGE9;TEX261;SPTAN1;CTSC
vascular endothelial growth factor receptor signaling pathway (GO:0048010),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,NRP1;PIK3R1;WASF2
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,MAEA;RMND5A;WWP1
calcium-mediated signaling (GO:0019722),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,PDPK1;BTK;LACRT
regulation of cytosolic calcium ion concentration (GO:0051480),6/137,0.6868931771447399,1,0,0,0.8759124087591241,0.3289721085839843,SCGN;CAV3;PLCZ1;GPER1;CACNA1A;PDE6A
cilium assembly (GO:0060271),13/288,0.6870684737462829,1,0,0,0.9027777777777777,0.3388317481813433,GSN;CCDC13;HAUS3;PKHD1;EHD3;RILPL1;NPHP1;CDK1;UNC119;POC1B;BBOF1;CEP97;ATP6V1D
regulation of intrinsic apoptotic signaling pathway (GO:2001242),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,DAPK2;PDILT
negative regulation of cellular biosynthetic process (GO:0031327),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,MPV17L;BRCA1
positive regulation of organelle assembly (GO:1902117),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,NUP62;RAB3GAP2
histone H4 acetylation (GO:0043967),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,RUVBL1;JADE2
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,GDF10;CSNK2B
organonitrogen compound biosynthetic process (GO:1901566),8/181,0.6891029839377012,1,0,0,0.8839779005524862,0.32916203353182405,ARG2;SAMD8;CSNK2B;GCNT1;LPCAT1;BCL10;CEPT1;CDO1
regulation of autophagy (GO:0010506),9/203,0.6910425757023396,1,0,0,0.8866995073891626,0.32768321009203705,SREBF1;USP10;DAPK2;CPTP;RUVBL1;ATG13;ATP6V1D;ATP6V1C1;EIF4G2
exogenous drug catabolic process (GO:0042738),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CYP2C19
regulation of axon extension involved in axon guidance (GO:0048841),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NRP1
cholesterol efflux (GO:0033344),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,APOA5
ammonium transport (GO:0015696),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RHD
regulation of telomere capping (GO:1904353),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,MAP3K4
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,GTF2F2
cellular amino acid catabolic process (GO:0009063),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,MCCC1
TOR signaling (GO:0031929),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RPS6
lamellipodium assembly (GO:0030032),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PTPRO
zinc II ion transmembrane transport (GO:0071577),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC30A1
vitamin transport (GO:0051180),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC25A32
vesicle-mediated transport between endosomal compartments (GO:0098927),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,ANKRD27
metanephros development (GO:0001656),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SIX1
phospholipid dephosphorylation (GO:0046839),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PLPPR3
negative regulation of signal transduction in absence of ligand (GO:1901099),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,EYA2
positive regulation of blood circulation (GO:1903524),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NKX2-5
folic acid-containing compound metabolic process (GO:0006760),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC25A32
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,EYA2
regulation of dendritic spine morphogenesis (GO:0061001),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,EPHA4
protein localization to Golgi apparatus (GO:0034067),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,LACRT
histone H3-K4 methylation (GO:0051568),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SETD3
response to alkaloid (GO:0043279),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CHRNA4
negative regulation of axonogenesis (GO:0050771),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,EPHA4
regulation of monooxygenase activity (GO:0032768),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NOSTRIN
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CASQ1
regulation of cell size (GO:0008361),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CAV3
regulation of microtubule cytoskeleton organization (GO:0070507),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CLASP2
regulation of chondrocyte differentiation (GO:0032330),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,TRPS1
regulation of ion homeostasis (GO:2000021),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC30A1
negative regulation of axon extension (GO:0030517),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,EPHA4
regulation of macroautophagy (GO:0016241),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,TBC1D12;ATG13;ATP6V1D;LACRT;ATP6V1C1
cellular response to interferon-gamma (GO:0071346),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,CCL14;IRF3;HLA-DQB2;HLA-E;TRIM34
Fc-epsilon receptor signaling pathway (GO:0038095),8/182,0.6949570991694919,1,0,0,0.8791208791208791,0.3199166269329807,PSMA6;PDPK1;GRAP2;PSME3;BTK;PSME1;PIK3R1;BCL10
regulation of ERK1 and ERK2 cascade (GO:0070372),11/247,0.695753252942632,1,0,0,0.8906882591093116,0.3231062538084776,PKHD1;CCL14;EPHA4;NRP1;RRAS;GPER1;FN1;PDGFA;OPRM1;PDE8A;RASGRP1
nuclear import (GO:0051170),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,NUP50;NUP62;BACH2
organelle membrane fusion (GO:0090174),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,SYT4;STX6;SYTL2
cellular response to fibroblast growth factor stimulus (GO:0044344),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,PTBP1;POLR2F;FRS2;GTF2F2
glycoprotein metabolic process (GO:0009100),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,GCNT1;ST8SIA6
interstrand cross-link repair (GO:0036297),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,ERCC4;ATR
pattern recognition receptor signaling pathway (GO:0002221),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,TLR9;BCL10
Fc receptor signaling pathway (GO:0038093),8/183,0.7007406269620085,1,0,0,0.8743169398907104,0.31092237355176994,PSMA6;PDPK1;GRAP2;PSME3;BTK;PSME1;PIK3R1;BCL10
response to metal ion (GO:0010038),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,MT1A;SLC30A1;CRIP1
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,PSMA6;PSME3;PSME1
regulation of fat cell differentiation (GO:0045598),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,CCDC85B;GPER1;RORC
"transcription, DNA-templated (GO:0006351)",16/356,0.7052645996976561,1,0,0,0.898876404494382,0.3138716654959475,CREBZF;POU1F1;GTF2A2;TAF10;MTERF4;GLIS3;GTF2H3;GTF2F2;BACH2;ELL3;IRF3;ERCC3;TRPS1;NUP62;POLR2F;HIVEP2
positive regulation of Wnt signaling pathway (GO:0030177),6/140,0.7067393435253332,1,0,0,0.8571428571428571,0.29750859485229647,PSMA6;PSME3;RUVBL1;PSME1;ILK;RSPO3
positive regulation of signal transduction (GO:0009967),9/206,0.7074277339148102,1,0,0,0.8737864077669902,0.3024347745654844,POGLUT1;ADAMTS3;GPER1;TLR9;RSPO3;ILK;PIK3R1;DLL1;AGPAT2
transmembrane transport (GO:0055085),17/378,0.7082114889541371,1,0,0,0.8994708994708994,0.31032871870891837,GABRA2;GABRA1;GABRP;CHRNA4;SLC33A1;AQP6;WWP1;HTR3B;ATP2C1;GABRR3;PSMA6;MFSD14B;PSME3;PSME1;CASQ1;ATP6V1D;ATP6V1C1
positive regulation of histone methylation (GO:0031062),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,BRCA1
positive regulation of microtubule polymerization (GO:0031116),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CAV3
positive regulation of neutrophil chemotaxis (GO:0090023),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,DAPK2
dendritic spine organization (GO:0097061),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ZNF365
positive regulation of immune effector process (GO:0002699),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HLA-DMB
cellular lipid catabolic process (GO:0044242),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CYP1B1
negative regulation of protein localization to membrane (GO:1905476),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,LRRC15
negative regulation of cytoskeleton organization (GO:0051494),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CAV3
regulation of chromosome organization (GO:0033044),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RMI2
ear morphogenesis (GO:0042471),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SIX1
Golgi to plasma membrane protein transport (GO:0043001),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,C16ORF70
positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GPER1
negative regulation of developmental growth (GO:0048640),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,EPHA4
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PSMA6
drug catabolic process (GO:0042737),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CYP2C19
regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SOCS4
positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CAV3
eosinophil chemotaxis (GO:0048245),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CCL14
DNA geometric change (GO:0032392),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ZRANB3
regulation of transmembrane transport (GO:0034762),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,KCNJ16
negative regulation of oxidative stress-induced cell death (GO:1903202),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PDE8A
cellular senescence (GO:0090398),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,KAT6A
negative regulation of endothelial cell apoptotic process (GO:2000352),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PDPK1
eosinophil migration (GO:0072677),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CCL14
mucosal immune response (GO:0002385),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,IFNL2
regulation of neuronal synaptic plasticity (GO:0048168),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NETO1
mammary gland development (GO:0030879),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,FOXB1
actin nucleation (GO:0045010),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ARPC3
regulation of cardiac muscle cell action potential (GO:0098901),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CAV3
proteoglycan biosynthetic process (GO:0030166),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GAL3ST3
cGMP biosynthetic process (GO:0006182),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GUCY1B2
cAMP metabolic process (GO:0046058),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PDE4A
organic cation transport (GO:0015695),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RHD
calcium ion transport (GO:0006816),5/118,0.7088473515444491,1,0,0,0.847457627118644,0.29162294635276975,CHRNA4;CATSPER4;CACNA1A;PSEN1;ATP2C1
cytosolic transport (GO:0016482),5/118,0.7088473515444491,1,0,0,0.847457627118644,0.29162294635276975,EHD3;CCDC91;ANKRD27;HEATR5A;STX6
post-translational protein modification (GO:0043687),16/357,0.7093891620355143,1,0,0,0.8963585434173669,0.30776561515627743,RAB2A;FN1;ASB12;FBXL16;APOA5;KLHL41;DCAF6;PSMA6;BPIFB2;PSME3;PSME1;UBXN7;RAB38;CCDC22;DCAF10;ARSD
lipid homeostasis (GO:0055088),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,ACOX2;APOA5
positive regulation of protein modification process (GO:0031401),7/163,0.7121164303112548,1,0,0,0.8588957055214724,0.29160699221433833,HDAC3;GPER1;ILK;RAB3GAP2;PDE8A;RASGRP1;ATG7
positive regulation of protein metabolic process (GO:0051247),4/96,0.7134178055156833,1,0,0,0.8333333333333333,0.28140670641508325,WWP1;PSEN1;ATG7;TRIM32
ciliary basal body-plasma membrane docking (GO:0097711),4/96,0.7134178055156833,1,0,0,0.8333333333333333,0.28140670641508325,NPHP1;CDK1;HAUS3;CEP97
protein N-linked glycosylation (GO:0006487),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,ALG5;MOGS;DDOST
regulation of protein complex assembly (GO:0043254),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,SENP6;GSN;FBLIM1
canonical Wnt signaling pathway (GO:0060070),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,FZD4;FZD10;PSEN1
positive regulation of proteasomal protein catabolic process (GO:1901800),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,KCNE2;STUB1;TRIB1
cytokine-mediated signaling pathway (GO:0019221),29/633,0.7144212798413314,1,0,0,0.9162717219589257,0.30812611130155976,CCL14;LRRC15;IFNA1;TRADD;RORC;ILK;PIK3R1;TNFRSF13C;IFNA8;CSF2RA;IFNL2;TNFRSF8;SOCS4;TNFSF18;FN1;OPRM1;LRRC66;HLA-E;PSMA6;IRF3;PSME3;TCP1;CSNK2B;PSME1;NANOG;XAF1;HLA-DQB2;CRLF1;TRIM34
RNA export from nucleus (GO:0006405),5/119,0.7157855087234404,1,0,0,0.8403361344537815,0.2809871644732814,NXF2;NUP210;NUP50;NUP62;PHAX
positive regulation of phosphorylation (GO:0042327),9/208,0.7180363845543978,1,0,0,0.8653846153846153,0.28664570453451166,EPHA4;NRP1;HDAC3;GPER1;ILK;BCL10;PSEN1;PDE8A;RASGRP1
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),6/142,0.7194862015133059,1,0,0,0.8450704225352113,0.2782123358209349,PTPRT;CDH10;CDH15;CLDN16;ATP2C1;MPZL2
negative regulation of viral genome replication (GO:0045071),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,APOBEC3C;TRIM6
neurogenesis (GO:0022008),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,RITA1;SIX1
receptor internalization (GO:0031623),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,CAV3;LDLRAP1
response to tumor necrosis factor (GO:0034612),4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,CCL14;GPER1;BRCA1;TRIM32
protein localization to organelle (GO:0033365),4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,SIX1;ATP6V1D;LACRT;UBAC2
positive regulation of epithelial cell migration (GO:0010634),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,NRP1;DOCK5;CLASP2
glucose homeostasis (GO:0042593),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,CAV3;RPS6;PIK3R1
macromolecular complex assembly (GO:0065003),5/120,0.7226056756270708,1,0,0,0.8333333333333333,0.2707430048728052,CSNK2B;PDE4DIP;MDM4;NDUFAF1;WASF3
negative regulation of growth (GO:0045926),5/120,0.7226056756270708,1,0,0,0.8333333333333333,0.2707430048728052,MT1A;CCDC85B;SERTAD2;MT1M;ING1
negative regulation of wound healing (GO:0061045),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CLASP2
regulation of centrosome duplication (GO:0010824),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PKHD1
regulation of voltage-gated calcium channel activity (GO:1901385),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CACNB1
regulation of telomere maintenance (GO:0032204),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ERCC4
glial cell differentiation (GO:0010001),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PLP1
"negative regulation of gene expression, epigenetic (GO:0045814)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CREBZF
potassium ion homeostasis (GO:0055075),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SLC12A6
positive regulation of interleukin-12 production (GO:0032735),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TLR9
in utero embryonic development (GO:0001701),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,LMX1B
positive regulation of nuclear division (GO:0051785),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NUP62
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ATR
positive regulation of filopodium assembly (GO:0051491),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NRP1
"RNA splicing, via transesterification reactions (GO:0000375)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SF3B1
positive regulation of glucose transport (GO:0010828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PIK3R1
regulation of glucose metabolic process (GO:0010906),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,RORC
positive regulation of interleukin-1 beta secretion (GO:0050718),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NLRP7
negative regulation of cellular protein localization (GO:1903828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,CAV3
cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,NRP1
regulation of viral release from host cell (GO:1902186),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TRIM32
ncRNA 3'-end processing (GO:0043628),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,EXOSC6
long-chain fatty-acyl-CoA metabolic process (GO:0035336),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TECR
positive regulation of neutrophil migration (GO:1902624),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DAPK2
protein depolymerization (GO:0051261),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DSTN
negative regulation of locomotion (GO:0040013),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TRIM32
regulation of nervous system development (GO:0051960),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DLL1
regulation of vascular smooth muscle cell proliferation (GO:1904705),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GPER1
regulation of cellular protein localization (GO:1903827),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,RAB11FIP5
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TRIM6
regulation of protein import into nucleus (GO:0042306),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,WWTR1
regulation of mitotic cell cycle (GO:0007346),7/165,0.7238641717074015,1,0,0,0.8484848484848485,0.2741891619820413,SBK2;MAEA;ERCC3;NUP62;CDK1;MAP3K4;PTPN3
positive regulation of neuron differentiation (GO:0045666),4/98,0.7284348779278988,1,0,0,0.8163265306122448,0.25865881578997496,MMD;ZC4H2;NKX2-5;TRIM32
negative regulation of cell migration (GO:0030336),5/121,0.7293078982314523,1,0,0,0.8264462809917356,0.26087543733110413,ARHGDIB;CYP1B1;TRIB1;PBLD;CLASP2
regulation of inflammatory response (GO:0050727),7/166,0.7296137574922477,1,0,0,0.8433734939759036,0.2658650469053982,PSMA6;NLRP7;GPER1;RORC;TLR9;PYDC2;NLRC3
retinoid metabolic process (GO:0001523),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,AKR1B10;RHO;CYP1B1
negative regulation of cellular amide metabolic process (GO:0034249),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,GRB7;MEX3D;CNOT9
C-terminal protein lipidation (GO:0006501),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,GP2;LYPD2;ATG7
regulation of actin cytoskeleton organization (GO:0032956),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,ARHGDIB;PDGFA;FZD10
peptidyl-tyrosine modification (GO:0018212),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,EPHA4;BTK
coenzyme metabolic process (GO:0006732),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,ACSM6;PPCDC
ubiquitin-dependent protein catabolic process (GO:0006511),15/341,0.7314400682781942,1,0,0,0.8797653958944281,0.2751378226788873,WWP1;TNFAIP1;PCNP;PSMA6;UBE2W;MAEA;MTA1;RMND5A;UBE2S;PSME3;PSME1;CDK1;STUB1;UBAP1L;TRIM32
protein complex assembly (GO:0006461),8/189,0.7339397778044255,1,0,0,0.8465608465608465,0.261865227785484,TRAPPC6A;TRADD;RUVBL1;FN1;HACL1;BCL10;RASGRP1;CTSC
neuron projection development (GO:0031175),7/167,0.7352803017726739,1,0,0,0.8383233532934131,0.25778735647850953,LGI1;EPHA4;ANKRD27;CTTN;PLP1;APOA5;ZNF365
positive regulation of glucose import (GO:0046326),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PIK3R1
response to gamma radiation (GO:0010332),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ATR
monovalent inorganic cation homeostasis (GO:0055067),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,SLC12A6
lipid modification (GO:0030258),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PLPPR3
regulation of centrosome cycle (GO:0046605),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PKHD1
nucleotide biosynthetic process (GO:0009165),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GUCY1B2
positive regulation of granulocyte chemotaxis (GO:0071624),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,DAPK2
response to ketone (GO:1901654),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CATSPER4
negative chemotaxis (GO:0050919),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PDGFA
positive regulation of cAMP metabolic process (GO:0030816),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GPER1
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PCNA
regulation of cardiac muscle cell contraction (GO:0086004),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CAV3
regulation of muscle contraction (GO:0006937),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TNNT3
regulation of microtubule-based process (GO:0032886),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CLASP2
regulation of viral entry into host cell (GO:0046596),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GSN
phosphatidylethanolamine acyl-chain remodeling (GO:0036152),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PLBD1
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GPER1
snRNA 3'-end processing (GO:0034472),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,EXOSC6
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ERCC4
regulation of hematopoietic stem cell differentiation (GO:1902036),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,PSMA6;PSME3;PSME1
nucleic acid-templated transcription (GO:0097659),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,CREBZF;NUP62;POLR2F
positive regulation of apoptotic signaling pathway (GO:2001235),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,GSN;GPER1;BCL10
response to interleukin-1 (GO:0070555),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,CCL14;USP10;NLRP7
positive regulation of proteolysis (GO:0045862),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,TRIM32;CTSC
plasma membrane bounded cell projection morphogenesis (GO:0120039),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,ANKRD27;CTTN
positive regulation of secretion by cell (GO:1903532),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,GPER1;CLASP2
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),4/100,0.7428559954663433,1,0,0,0.7999999999999999,0.23780245442692988,NXF2;NUP210;NUP50;NUP62
protein deubiquitination (GO:0016579),11/257,0.7433475644492396,1,0,0,0.8560311284046692,0.2538916063956462,PSMA6;USP10;PSME3;ACTR5;TAF10;RUVBL1;PSME1;CDK1;MDM4;BRCA1;EIF3F
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,PDPK1;STUB1;PBLD
positive regulation of cytoskeleton organization (GO:0051495),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,NRP1;CTTN;STAP1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,PSMA6;PSME3;PSME1
cellular protein modification process (GO:0006464),46/1001,0.7473117995668617,1,0,0,0.919080919080919,0.2677032530333697,PTPRT;WDR45B;PTPRO;ILK;ALOX12B;ASB12;DUSP16;DCAF6;LCE1A;PTAR1;PPP3CC;FUT7;SERP1;RPS6KA2;ZNF747;UBXN7;PI3;DCAF10;ARSD;ATG7;RAB2A;PDPK1;DAPK2;ALG5;FN1;FBXL16;APOA5;DDOST;KLHL41;PSMA6;ERN2;LCE2C;BPIFB2;PRKAR1B;SDHAF2;UBE2S;LCE4A;PSME3;CDK3;PSME1;BTK;CDK1;RAB38;CCDC22;IVL;PTPN3
cilium organization (GO:0044782),8/192,0.7495638014323878,1,0,0,0.8333333333333333,0.24021986644642068,PKHD1;EHD3;GSN;RILPL1;UNC119;POC1B;ATP6V1D;TTC17
phosphatidylinositol phosphorylation (GO:0046854),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PIK3R1
regulation of cilium assembly (GO:1902017),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CEP97
response to hexose (GO:0009746),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,SLC2A5
peptidyl-glutamic acid modification (GO:0018200),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,VKORC1
negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CLASP2
cardiac muscle cell development (GO:0055013),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,NKX2-5
regulation of double-strand break repair via homologous recombination (GO:0010569),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ZNF365
modulation by host of viral transcription (GO:0043921),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,POU2F3
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,EYA2
negative regulation of cell-matrix adhesion (GO:0001953),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CLASP2
negative regulation of osteoblast differentiation (GO:0045668),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,GDF10
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TRADD
regulation of protein transport (GO:0051223),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,DNAJC1
protein targeting to vacuole (GO:0006623),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TMEM50B
regulation of blood vessel diameter (GO:0097746),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,GPER1
muscle fiber development (GO:0048747),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,KLHL41
protein localization to chromosome (GO:0034502),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ATR
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,GPER1;PDGFA
embryonic organ development (GO:0048568),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,PDGFA;NKX2-5
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,GNG2;GPER1;DRD1
sensory perception of mechanical stimulus (GO:0050954),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,COL2A1;CEACAM16;MARVELD2
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,PSMA6;PSME3;PSME1
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",5/125,0.7549416651407419,1,0,0,0.7999999999999999,0.2248918379459466,CNR2;CNR1;DRD1;OPRM1;WASF2
RNA modification (GO:0009451),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,MEPCE;FTSJ1
cellular response to nutrient levels (GO:0031669),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,SREBF1;ATG7
negative regulation of supramolecular fiber organization (GO:1902904),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,CAV3;CLASP2
mRNA processing (GO:0006397),12/283,0.7608347028834079,1,0,0,0.8480565371024735,0.23180705734297768,PTBP1;ERCC3;SYF2;DHX35;PCBP1;ZMAT5;AKAP8L;POLR2F;GTF2H3;SF3B1;GTF2F2;U2SURP
protein polyubiquitination (GO:0000209),12/283,0.7608347028834079,1,0,0,0.8480565371024735,0.23180705734297768,PSMA6;UBE2W;UBOX5;UBE2S;PSME3;PSME1;WWP1;BLMH;STUB1;BRCA1;FBXL16;TRIM32
regulation of G2/M transition of mitotic cell cycle (GO:0010389),6/149,0.7610356577983485,1,0,0,0.8053691275167785,0.21992622742208362,PSMA6;PSME3;CDK3;PSME1;CDK1;HAUS3
negative regulation of endocytosis (GO:0045806),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,UNC119
neuron projection extension (GO:1990138),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NRP1
cellular response to ketone (GO:1901655),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GNG2
cellular response to hydrogen peroxide (GO:0070301),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CYP1B1
hydrogen ion transmembrane transport (GO:1902600),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ATP6V1C1
acute inflammatory response (GO:0002526),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,KLK2
cellular amino acid biosynthetic process (GO:0008652),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CDO1
"synaptic transmission, cholinergic (GO:0007271)",1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CHRNA4
negative regulation of response to DNA damage stimulus (GO:2001021),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,TRIM32
regulation of mRNA processing (GO:0050684),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,JMJD6
regulation of receptor internalization (GO:0002090),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ATAD1
aerobic respiration (GO:0009060),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,MTFR1
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,DRD1
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,WWTR1
negative regulation of JNK cascade (GO:0046329),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HDAC3
positive regulation of calcium-mediated signaling (GO:0050850),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,LACRT
neural crest cell migration (GO:0001755),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NRP1
triglyceride homeostasis (GO:0070328),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,APOA5
cGMP metabolic process (GO:0046068),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GUCY1B2
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,HLA-E
regulation of defense response to virus by virus (GO:0050690),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,DOCK2
ventricular septum development (GO:0003281),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,NKX2-5
calcium ion import (GO:0070509),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CACNA1A
negative regulation of mitotic cell cycle phase transition (GO:1901991),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,PSMA6;PSME3;PSME1
peptidyl-tyrosine phosphorylation (GO:0018108),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,EPHA4;GRAP2;BTK
cellular response to interleukin-1 (GO:0071347),6/150,0.7665835594153122,1,0,0,0.7999999999999999,0.2126492578971434,CCL14;PSMA6;NLRP7;USP10;PSME3;PSME1
regulation of cellular catabolic process (GO:0031329),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,USP10;DAPK2
positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,GPER1;BLID
long-chain fatty acid metabolic process (GO:0001676),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,CYP1B1;ALOX12B
regulation of axonogenesis (GO:0050770),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,EPHA4;CTTN
mRNA transport (GO:0051028),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,NXF2;NUP210;NUP50;NUP62
positive regulation of vasculature development (GO:1904018),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,RRAS;PDPK1;CYP1B1;BRCA1
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,GPER1;PDGFA;NLRC3
NIK/NF-kappaB signaling (GO:0038061),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,PSMA6;PSME3;PSME1
regulation of mRNA stability (GO:0043488),5/128,0.7729447333197296,1,0,0,0.78125,0.20120916351791152,PSMA6;EXOSC6;PSME3;PSME1;MEX3D
keratan sulfate biosynthetic process (GO:0018146),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PRELP
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,IRF3
vacuolar transport (GO:0007034),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,TMEM50B
regulation of neutrophil chemotaxis (GO:0090022),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,DAPK2
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,HSF4
positive regulation of interleukin-1 secretion (GO:0050716),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,NLRP7
coenzyme biosynthetic process (GO:0009108),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PPCDC
negative regulation of epithelial cell apoptotic process (GO:1904036),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PDPK1
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CNOT9
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,BTK
semaphorin-plexin signaling pathway (GO:0071526),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,NRP1
skeletal muscle organ development (GO:0060538),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SIX1
respiratory system development (GO:0060541),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SMCHD1
striated muscle tissue development (GO:0014706),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SIX1
mRNA export from nucleus (GO:0006406),4/105,0.7763456159434972,1,0,0,0.761904761904762,0.192881886919067,NXF2;NUP210;NUP50;NUP62
regulation of secretion by cell (GO:1903530),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,DNAJC1;CPLX3
ribosome assembly (GO:0042255),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,MTERF4;BRIX1
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,TRADD;PYDC2
protein import (GO:0017038),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,NUP50;NUP62
epidermis development (GO:0008544),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,ATP2C1;DLL1;POU2F3
negative regulation of cell death (GO:0060548),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,NUP62;AGR2;PDE8A
sensory perception of sound (GO:0007605),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,COL2A1;CEACAM16;MARVELD2
positive regulation of protein catabolic process (GO:0045732),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,WWP1;ATG7;TRIM32
protein autophosphorylation (GO:0046777),7/175,0.7776256494974995,1,0,0,0.7999999999999999,0.20120803273201993,EPHA4;PDPK1;GRAP2;DAPK2;EIF2AK1;BTK;ATR
transcription from RNA polymerase II promoter (GO:0006366),21/485,0.782261577058012,1,0,0,0.8659793814432989,0.21265517665534756,NOTCH3;WWTR1;GTF2A2;POU1F1;TAF10;RORC;GLIS3;PHAX;GTF2H3;MED15;GTF2F2;BACH2;ELL3;NR6A1;MED30;IRF3;ERCC3;TRPS1;CDK1;POLR2F;HIVEP2
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),38/848,0.782515992684663,1,0,0,0.8962264150943395,0.21979138952731936,NOTCH3;GTF2A2;CSRNP3;SETD3;ZNF350;HDAC3;CRTC1;AKAP8L;RORC;GLIS3;SIX1;PIK3R1;BRCA1;DUX4;DLL1;DCAF6;GPER1;CCNL2;NKX2-5;KDM6B;WWTR1;SREBF1;MYOCD;POU1F1;EBF1;ZNF76;GTF2F2;POU2F3;ELL3;RAX2;IRF3;ERCC3;LHX3;TLR9;NANOG;LMX1B;PAXBP1;CCDC62
"DNA-templated transcription, termination (GO:0006353)",4/106,0.7826130830889017,1,0,0,0.7547169811320754,0.1849938504751301,ERCC3;MTERF2;POLR2F;GTF2H3
regulation of anatomical structure morphogenesis (GO:0022603),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,POGLUT1;DLL1;CLASP2
positive regulation of protein secretion (GO:0050714),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,GPER1;CLEC6A;HLA-E
"retrograde transport, endosome to Golgi (GO:0042147)",3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,EHD3;HEATR5A;STX6
C-terminal protein amino acid modification (GO:0018410),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,GP2;LYPD2;ATG7
cellular respiration (GO:0045333),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,MTFR1;ETFB
protein homotetramerization (GO:0051289),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,ACACB;CBR4
response to retinoic acid (GO:0032526),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,FZD4;FZD10
ribosomal large subunit assembly (GO:0000027),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,BRIX1
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PPP3CC
negative regulation of stress-activated MAPK cascade (GO:0032873),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,HDAC3
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,SRPX2
beta-catenin-TCF complex assembly (GO:1904837),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RUVBL1
hippo signaling (GO:0035329),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,WWTR1
acylglycerol catabolic process (GO:0046464),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,APOA5
cellular response to drug (GO:0035690),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,KCNE2
activation of protein kinase B activity (GO:0032148),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PDPK1
cyclic purine nucleotide metabolic process (GO:0052652),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GUCY1B2
regulation of cell adhesion mediated by integrin (GO:0033628),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CYP1B1
MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,IRF3
positive regulation of cation channel activity (GO:2001259),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,CASQ1
phosphatidylinositol 3-kinase signaling (GO:0014065),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PIK3R1
artery morphogenesis (GO:0048844),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,NRP1
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,PPP3CC
regulation of blood coagulation (GO:0030193),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,FAP
positive regulation of B cell proliferation (GO:0030890),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TLR9
CENP-A containing nucleosome assembly (GO:0034080),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RUVBL1
CENP-A containing chromatin organization (GO:0061641),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RUVBL1
regulation of intracellular signal transduction (GO:1902531),18/422,0.7887228411543117,1,0,0,0.8530805687203792,0.2024703968139338,GDF10;RMI2;SETD9;RFC2;PDPK1;DAPK2;TAF10;BRCA1;PKHD1;SBK2;RRAS;NLRP7;ERCC4;KAT6A;CSNK2B;ARHGDIB;MDM4;ATR
negative regulation of nucleic acid-templated transcription (GO:1903507),19/444,0.7894376191303879,1,0,0,0.8558558558558558,0.20235381843731465,CREBZF;ATF7IP;HEXIM2;ZNF350;HDAC3;ZHX3;MSX2;WWP1;UBP1;BRCA1;RIPPLY1;DMBX1;ERN2;CCDC85B;DEAF1;KAT6A;LRRFIP1;NKX2-5;ZNF423
positive regulation of ERK1 and ERK2 cascade (GO:0070374),8/201,0.7925273344506804,1,0,0,0.7960199004975124,0.18509714022296506,CCL14;EPHA4;NRP1;GPER1;PDGFA;OPRM1;PDE8A;RASGRP1
response to lipopolysaccharide (GO:0032496),6/155,0.7928910635542,1,0,0,0.7741935483870968,0.1796666627233374,TRIM6;NLRP7;NFKBIL1;TNFRSF8;STAP1;TRIB1
negative regulation of gene expression (GO:0010629),27/618,0.7929711018136918,1,0,0,0.8737864077669902,0.20269092198771083,CREBZF;GRB7;ZNF350;HDAC3;UBP1;BRCA1;DMBX1;PTBP1;TRIM6;CCDC85B;DEAF1;GPER1;LRRFIP1;NKX2-5;ZNF423;ATF7IP;HEXIM2;ZHX3;MSX2;WWP1;MEX3D;PARP9;RIPPLY1;ERN2;SHQ1;KAT6A;CNOT9
phospholipid transport (GO:0015914),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,CPTP;APOA5
receptor metabolic process (GO:0043112),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,EHD3;LDLRAP1
tRNA modification (GO:0006400),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,TRMT13;FTSJ1
integrin-mediated signaling pathway (GO:0007229),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,NRP1;ILK
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,NRP1;DOCK5
post-Golgi vesicle-mediated transport (GO:0006892),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,EXOC5;CCDC22
monocarboxylic acid metabolic process (GO:0032787),4/108,0.7947283904475327,1,0,0,0.7407407407407407,0.1701887925469081,MCCC1;ALKBH7;SLC16A3;ACACB
negative regulation of cell-cell adhesion (GO:0022408),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MAD2L2
positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,UBE2S
negative regulation of blood vessel endothelial cell migration (GO:0043537),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CSNK2B
regulation of glucose import (GO:0046324),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PIK3R1
organelle transport along microtubule (GO:0072384),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,UXT
renal water homeostasis (GO:0003091),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PRKAR1B
skeletal system morphogenesis (GO:0048705),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,SIX1
regulation of protein export from nucleus (GO:0046825),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,AKAP8L
anterograde axonal transport (GO:0008089),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MGARP
positive regulation of viral genome replication (GO:0045070),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,TOP2A
regulation of protein autophosphorylation (GO:0031952),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PDGFA
cofactor biosynthetic process (GO:0051188),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PPCDC
positive regulation of interleukin-1 beta production (GO:0032731),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,NLRP7
nucleobase-containing small molecule interconversion (GO:0015949),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,GSR
regulation of cytokine secretion (GO:0050707),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CLEC6A
protein destabilization (GO:0031648),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,GSN
proton transport (GO:0015992),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ATP6V1C1
positive regulation of supramolecular fiber organization (GO:1902905),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,CTTN;CAV3;PSEN1
protein modification process (GO:0036211),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,SERP1;UBE2S;ATG7
regulation of cell cycle G2/M phase transition (GO:1902749),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,CDK3;CDK1;HAUS3
cellular response to molecule of bacterial origin (GO:0071219),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,NLRP7;NFKBIL1;STAP1
negative regulation of cellular process (GO:0048523),23/534,0.7988486889896014,1,0,0,0.8614232209737828,0.1934616371736454,APOBEC3C;MYOCD;POU1F1;TES;CAV3;OPRM1;ING1;DUX4;DLL1;PKHD1;CCDC85B;SERTAD2;RPS6KA2;GPER1;CSNK2B;ARHGDIB;NUP62;AGR2;CYP1B1;TNFRSF8;MDM4;PDE8A;ENPP7
regulation of Wnt signaling pathway (GO:0030111),4/109,0.8005792983505415,1,0,0,0.7339449541284404,0.1632438094873767,ANKRD10;RSPO3;PSEN1;CXXC4
positive regulation of cytosolic calcium ion concentration (GO:0007204),5/133,0.8006749703651704,1,0,0,0.7518796992481203,0.1671430030702634,CAV3;PLCZ1;GPER1;CACNA1A;DRD1
renal system development (GO:0072001),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,PKHD1;SIX1
mitotic cytokinesis (GO:0000281),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,JTB;UNC119
macroautophagy (GO:0016236),4/110,0.8062945339593786,1,0,0,0.7272727272727272,0.1565863101665403,MTMR14;CSNK2B;ATG13;ATG7
cellular response to insulin stimulus (GO:0032869),4/110,0.8062945339593786,1,0,0,0.7272727272727272,0.1565863101665403,PDPK1;PIK3R1;ATP6V1D;ATP6V1C1
negative regulation of calcium ion transmembrane transporter activity (GO:1901020),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,TLR9
cellular response to amino acid stimulus (GO:0071230),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,UBR1
positive regulation of dendrite development (GO:1900006),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,PSEN1
central nervous system neuron differentiation (GO:0021953),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ZC4H2
chromatin remodeling at centromere (GO:0031055),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RUVBL1
cyclic-nucleotide-mediated signaling (GO:0019935),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,GUCY1B2
negative regulation of receptor activity (GO:2000272),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SOCS4
positive regulation of TOR signaling (GO:0032008),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,HDAC3
mitochondrial transmembrane transport (GO:1990542),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ACACB
endodermal cell differentiation (GO:0035987),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,FN1
regulation of cell-cell adhesion (GO:0022407),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,SIRPB1
G2 DNA damage checkpoint (GO:0031572),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,BRCA1
positive regulation of telomere maintenance (GO:0032206),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,MAP3K4
aminoglycan catabolic process (GO:0006026),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CHIA
vasculogenesis (GO:0001570),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,NKX2-5
nucleosome assembly (GO:0006334),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,HIRA;ASF1A
membrane lipid biosynthetic process (GO:0046467),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,SAMD8;ST8SIA6
toll-like receptor signaling pathway (GO:0002224),3/86,0.8106028254070419,1,0,0,0.6976744186046511,0.14649563666446674,TLR9;BTK;BCL10
regulation of peptidyl-serine phosphorylation (GO:0033135),3/86,0.8106028254070419,1,0,0,0.6976744186046511,0.14649563666446674,MAD2L2;TRIM6;CNOT9
mitochondrial transport (GO:0006839),5/135,0.8109917200733027,1,0,0,0.7407407407407407,0.15518328477497187,DNAJC19;GRPEL1;PAM16;SLC25A32;MGARP
"regulation of transcription, DNA-templated (GO:0006355)",73/1598,0.8112098988824289,1,0,0,0.9136420525657071,0.1911599045336612,CREBZF;GTF2H2C;RHOXF1;SETD3;RORC;ILK;UBP1;SIX1;BRCA1;DACH2;BACH2;PHF8;UXT;DMBX1;ING2;ZNF728;RUVBL1;NUP62;LRRFIP1;ZNF600;ZNF565;ZFP37;SREBF1;ZNF19;MYOCD;POU1F1;ZHX3;MSX2;PARP9;RIPPLY1;ERN2;ETV3L;KAT6A;ZNF317;MAPRE3;LMX1B;CASZ1;PCNA;ZNF350;HDAC3;ZNF2;PSEN1;BCL10;BARX1;TCEAL8;HIRA;MED30;CCDC85B;DEAF1;HSF4;ZNF286B;ZNF789;GPBP1L1;HIVEP2;ZNF423;NKX2-5;ATF7IP;HEXIM2;WWTR1;FOXB1;FZD4;ZNF76;WWP1;TRERF1;POU2F3;MAD2L2;ZNF33A;NR6A1;LHX3;LHX2;NANOG;SP8;RCOR2
cellular response to oxygen-containing compound (GO:1901701),11/274,0.8122111565206551,1,0,0,0.802919708029197,0.16700322658038597,GNG2;FZD4;NLRP7;NFKBIL1;GPER1;MPV17L;RORC;STAP1;FZD10;DRD1;CCDC62
negative regulation of MAP kinase activity (GO:0043407),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,CAV3;DUSP16
positive regulation of cellular amide metabolic process (GO:0034250),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,EPHA4;UPF3A
glycogen metabolic process (GO:0005977),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GYS1
axonemal dynein complex assembly (GO:0070286),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,DNAI1
positive regulation of cell-cell adhesion (GO:0022409),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,SIRPB1
negative regulation of neurogenesis (GO:0050768),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,DLL1
entry into host cell (GO:0030260),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,WWP1
negative regulation of mitochondrion organization (GO:0010823),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,MPV17L
stem cell differentiation (GO:0048863),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,ELL3
positive regulation of calcium ion transport (GO:0051928),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,FFAR1
positive regulation of cell-matrix adhesion (GO:0001954),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,NRP1
intra-Golgi vesicle-mediated transport (GO:0006891),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,COG5
embryonic organ morphogenesis (GO:0048562),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,SIX1
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,EXOSC6
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,PIK3R1
regulation of interleukin-12 production (GO:0032655),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,TLR9
positive regulation of cellular component biogenesis (GO:0044089),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,SRPX2;SLITRK2;ATR
phosphatidylinositol metabolic process (GO:0046488),4/112,0.8173248241169633,1,0,0,0.7142857142857142,0.14408477257015773,RUFY1;MTMR14;PLBD1;PIK3R1
regulation of mitotic cell cycle phase transition (GO:1901990),7/184,0.8190265473514379,1,0,0,0.7608695652173914,0.15189907273273576,PSMA6;ERCC3;PSME3;CDK3;PSME1;CDK1;HAUS3
positive regulation of macromolecule metabolic process (GO:0010604),11/276,0.8193212421558144,1,0,0,0.7971014492753622,0.1588456075843277,ATAD1;GSN;RHOXF1;GPER1;FN1;TLR9;AGR2;STAP1;ALOX12B;BRCA1;DRD1
regulation of transcription from RNA polymerase II promoter (GO:0006357),67/1478,0.8200207438366136,1,0,0,0.9066305818673883,0.17989875497564062,GTF2H2C;CSRNP3;SETD3;CRTC1;AKAP8L;RORC;UBP1;SIX1;BRCA1;DUX4;DCAF6;UXT;GPER1;TRPS1;RUVBL1;CCNL2;LRRFIP1;KDM6B;SREBF1;MYOCD;POU1F1;ZHX3;MSX2;EBF1;PARP9;RIPPLY1;ETV3L;IRF3;TLR9;LMX1B;GTF2A2;ZNF350;HDAC3;GLIS3;PIK3R1;PSEN1;BARX1;DLL1;TCEAL8;HIRA;DEAF1;HSF4;NKX2-5;E2F6;IRX1;GDF10;HEXIM2;WWTR1;FOXB1;SLC33A1;RITA1;ZNF76;GTF2H3;TRERF1;POU2F3;ELL3;RAX2;MAD2L2;NR6A1;ERCC3;LHX3;NANOG;MDM4;SP8;PAXBP1;RCOR2;CCDC62
gene expression (GO:0010467),17/411,0.8218705718362436,1,0,0,0.827250608272506,0.16228369711320814,MRPS17;CREBZF;NUP210;MRPS33;RPS6;RPS3A;TSPAN33;GSPT2;MRPS6;YARS2;NXF2;RPS15A;DHX35;NUP50;NUP62;POLR2F;STUB1
positive regulation of kinase activity (GO:0033674),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,EPHA4;MMD;JTB;MAPRE3
regulation of stem cell differentiation (GO:2000736),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,PSMA6;PSME3;PSME1
negative regulation of translation (GO:0017148),3/88,0.8227310669841436,1,0,0,0.6818181818181818,0.1330403886090264,GRB7;MEX3D;CNOT9
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),24/565,0.8230725514197683,1,0,0,0.8495575221238938,0.16541813298430433,IRX1;HEXIM2;ZNF350;HDAC3;ZHX3;MSX2;RORC;GLIS3;RITA1;PSEN1;PARP9;RIPPLY1;UXT;MAD2L2;DNAJB1;NR6A1;DEAF1;TRPS1;MDM4;LRRFIP1;NKX2-5;PAXBP1;E2F6;RCOR2
diterpenoid metabolic process (GO:0016101),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,AKR1B10;RHO
regulation of actin filament-based process (GO:0032970),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,PDGFA;FZD10
establishment of protein localization to organelle (GO:0072594),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,NUP50;NUP62
regulation of T cell proliferation (GO:0042129),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,TNFSF18;HLA-DMB
cellular response to cytokine stimulus (GO:0071345),19/456,0.8242479819232588,1,0,0,0.8333333333333333,0.16106987117726593,CCL14;LRRC15;IFNA1;USP10;FN1;RORC;PIK3R1;BRCA1;OPRM1;LRRC66;IFNA8;CSF2RA;TRIM6;IFNL2;NLRP7;GPER1;NANOG;CRLF1;SOCS4
epithelial tube morphogenesis (GO:0060562),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CSNK2B
regulation of double-strand break repair (GO:2000779),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,ZNF365
regulation of interleukin-8 production (GO:0032677),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TLR9
positive regulation of leukocyte migration (GO:0002687),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TNFSF18
ncRNA metabolic process (GO:0034660),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,MEPCE
keratan sulfate metabolic process (GO:0042339),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PRELP
positive regulation of exocytosis (GO:0045921),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CLASP2
response to peptide (GO:1901652),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CACNA1A
positive regulation of DNA binding (GO:0043388),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TRIM6
bone development (GO:0060348),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,VKORC1
ventricular cardiac muscle tissue morphogenesis (GO:0055010),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,NKX2-5
negative regulation of endothelial cell migration (GO:0010596),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CSNK2B
macromolecule catabolic process (GO:0009057),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,PRSS16
response to cytokine (GO:0034097),5/138,0.8256627743834776,1,0,0,0.7246376811594203,0.13881800889973492,TMEM102;XAF1;TRIM32;TIMP4;DDOST
positive regulation of intracellular signal transduction (GO:1902533),20/479,0.8269016708800515,1,0,0,0.8350730688935282,0.15872191198374538,EPHA4;HDAC3;GOLT1B;TRADD;CARD9;PDGFA;ILK;FRS2;ALOX12B;BCL10;PIK3R1;ATP2C1;FAM110C;CLEC6A;GPER1;NUP62;TLR9;CCDC22;LACRT;TRIM32
synapse assembly (GO:0007416),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,FARP1;DRD1
kidney development (GO:0001822),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,PKHD1;SIX1
vesicle coating (GO:0006901),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TRAPPC6A;CTSC
COPII vesicle coating (GO:0048208),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TRAPPC6A;CTSC
carbohydrate homeostasis (GO:0033500),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,CAV3;RPS6
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TRAPPC6A;CTSC
regulation of proteolysis (GO:0030162),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,DNAJC1;TRIM32
ribosomal large subunit biogenesis (GO:0042273),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,BRIX1;RRP15
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,EXOSC6;CNOT9
neuron differentiation (GO:0030182),5/139,0.8303434515247903,1,0,0,0.7194244604316546,0.13375242213240954,ERCC3;FZD4;UNC119;FZD10;LMX1B
antigen receptor-mediated signaling pathway (GO:0050851),10/257,0.8325414497299947,1,0,0,0.7782101167315175,0.14262433377551237,RFTN2;PSMA6;PDPK1;PSME3;GRAP2;BTK;PSME1;PIK3R1;BCL10;HLA-DQB2
negative regulation of cell growth (GO:0030308),4/115,0.832896768257819,1,0,0,0.6956521739130435,0.12719691976114322,EPHA4;CCDC85B;SERTAD2;ING1
cellular response to oxidative stress (GO:0034599),4/115,0.832896768257819,1,0,0,0.6956521739130435,0.12719691976114322,PYROXD1;MPV17L;GSR;PRDX6
positive regulation of RNA metabolic process (GO:0051254),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PIK3R1
lipid phosphorylation (GO:0046834),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PIK3R1
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,GADD45A
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,ILK
antibacterial humoral response (GO:0019731),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,HLA-E
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,EXOSC6
regulation of microtubule polymerization (GO:0031113),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CAV3
negative regulation of epithelial cell migration (GO:0010633),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PBLD
positive regulation of ATPase activity (GO:0032781),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,DNAJB1
membrane protein proteolysis (GO:0033619),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PSEN1
carbohydrate catabolic process (GO:0016052),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,NAGA
positive regulation of osteoblast differentiation (GO:0045669),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,ZHX3
sulfur compound catabolic process (GO:0044273),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,PRELP
cell-matrix adhesion (GO:0007160),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,SGCE;CTTN;ILK
protein tetramerization (GO:0051262),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,HSD17B8;ACACB;CBR4
regulation of Ras protein signal transduction (GO:0046578),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,ARHGDIB;NUP62;RASGRP1
positive regulation of protein polymerization (GO:0032273),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,CTTN;CAV3
positive regulation of cellular protein metabolic process (GO:0032270),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,UPF3A;ATG7;TRIM32
cellular response to lipopolysaccharide (GO:0071222),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,NLRP7;NFKBIL1;STAP1
protein-DNA complex assembly (GO:0065004),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,ERCC3;GTF2H3;ASF1A
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",9/236,0.839759149258675,1,0,0,0.7627118644067796,0.13320011847344498,PTBP1;SYF2;DHX35;PCBP1;ZMAT5;POLR2F;SF3B1;GTF2F2;U2SURP
negative regulation of apoptotic process (GO:0043066),20/485,0.8421485706602619,1,0,0,0.8247422680412371,0.14168975718759164,TNFSF18;EPHA4;FOXB1;TNFAIP8;HDAC3;SIX1;DHCR24;RPS3A;PIK3R1;PSEN1;DLL1;PKHD1;MAEA;NUP62;CDK1;CASP2;NKX2-5;LACRT;RETREG1;CRLF1
histone exchange (GO:0043486),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,RUVBL1
muscle cell differentiation (GO:0042692),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MYOCD
regulation of smoothened signaling pathway (GO:0008589),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,PTCH2
endoderm formation (GO:0001706),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,FN1
regulation of filopodium assembly (GO:0051489),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NRP1
regulation of response to DNA damage stimulus (GO:2001020),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ING2
mRNA catabolic process (GO:0006402),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NBDY
regulation of blood circulation (GO:1903522),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,CAV3
zymogen activation (GO:0031638),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,KLK2
centromere complex assembly (GO:0034508),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,RUVBL1
regulation of cell morphogenesis involved in differentiation (GO:0010769),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,EPHA4
cardiac muscle tissue morphogenesis (GO:0055008),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NKX2-5
axonal transport (GO:0098930),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MGARP
negative regulation of blood coagulation (GO:0030195),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,PDGFA
glutamate receptor signaling pathway (GO:0007215),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,HOMER3
spermatid development (GO:0007286),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ING2
chromatin assembly (GO:0031497),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,GATAD1;ASF1A
cellular response to reactive oxygen species (GO:0034614),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,MPV17L;CYP1B1
negative regulation of apoptotic signaling pathway (GO:2001234),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,PSME3;MPV17L
defense response to Gram-positive bacterium (GO:0050830),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,KRT6A;HLA-E
positive regulation of macromolecule biosynthetic process (GO:0010557),5/142,0.8437741668121552,1,0,0,0.704225352112676,0.11962703877312425,PCNA;TLR9;PDGFA;RAB3GAP2;UPF3A
mitochondrion organization (GO:0007005),6/167,0.8466850339939437,1,0,0,0.7185628742514969,0.11958791438036045,DNAJC19;MTFP1;SIRT5;RAB38;MTFR1;MGARP
plasma membrane bounded cell projection organization (GO:0120036),4/118,0.8473458741803346,1,0,0,0.6779661016949152,0.11230258687470465,LGI1;CTTN;PLP1;TTC17
positive regulation of protein serine/threonine kinase activity (GO:0071902),4/118,0.8473458741803346,1,0,0,0.6779661016949152,0.11230258687470465,PDGFA;MAPRE3;CCNL2;RASGRP1
regulation of cell cycle (GO:0051726),8/215,0.8480666942392859,1,0,0,0.7441860465116279,0.12263888179781321,SBK2;RPS15A;MAEA;GADD45A;RPS6KA2;CDK1;TRIM32;MAP3K4
negative regulation of epithelial cell proliferation (GO:0050680),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,NLRC3;PBLD
sphingolipid biosynthetic process (GO:0030148),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,SAMD8;ALOX12B
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),3/93,0.8501804853980194,1,0,0,0.6451612903225806,0.10471394598415903,GPER1;DHCR24;BLID
protein monoubiquitination (GO:0006513),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,UBE2W
myelination (GO:0042552),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PLP1
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PPP3CC
positive regulation of axonogenesis (GO:0050772),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,NTN1
regulation of peptidyl-threonine phosphorylation (GO:0010799),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,TRIM6
positive regulation of stress fiber assembly (GO:0051496),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,NRP1
negative regulation of Ras protein signal transduction (GO:0046580),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,TNFAIP1
regulation of metal ion transport (GO:0010959),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,NKAIN1
regulation of neuron projection development (GO:0010975),4/119,0.851921877903696,1,0,0,0.6722689075630252,0.10773811694664917,EPHA4;PTPRO;TNFRSF8;ZNF365
cellular protein complex assembly (GO:0043623),5/144,0.8522318406648981,1,0,0,0.6944444444444444,0.11103935813369432,TCP1;FCHO2;NDUFAF1;CASQ1;TMEM170A
positive regulation of endothelial cell proliferation (GO:0001938),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,NRP1;PDPK1
regulation of cardiac conduction (GO:1903779),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,CASQ1;NKX2-5
vesicle fusion (GO:0006906),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,SYT4;STX6;SYTL2
respiratory electron transport chain (GO:0022904),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,SDHAF2;ETFB;NDUFAF1
peptidyl-serine phosphorylation (GO:0018105),5/145,0.8563159481665291,1,0,0,0.689655172413793,0.10697646387244193,PDPK1;DAPK2;CDK1;PSKH1;ATR
T cell differentiation (GO:0030217),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,NHEJ1
muscle filament sliding (GO:0030049),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,TNNT3
regulation of cellular amide metabolic process (GO:0034248),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,SAMD8
actin-myosin filament sliding (GO:0033275),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,TNNT3
regulation of cellular pH (GO:0030641),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,SLC4A10
chemical homeostasis (GO:0048878),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,ACOX2
regulation of heart contraction (GO:0008016),3/95,0.86007960317269,1,0,0,0.631578947368421,0.09519810454070905,CAV3;CASQ1;NKX2-5
interleukin-1-mediated signaling pathway (GO:0070498),3/95,0.86007960317269,1,0,0,0.631578947368421,0.09519810454070905,PSMA6;PSME3;PSME1
COPII-coated vesicle budding (GO:0090114),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,TRAPPC6A;CTSC
positive regulation of T cell activation (GO:0050870),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,HLA-DMB;SIRPB1
positive regulation of MAPK cascade (GO:0043410),11/289,0.8606759332603792,1,0,0,0.7612456747404844,0.11421519203659355,CCL14;EPHA4;NRP1;GPER1;CARD9;TLR9;PDGFA;ALOX12B;OPRM1;PDE8A;RASGRP1
protein localization to nucleus (GO:0034504),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,NUP50;NUP62;SIX1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,PTBP1
purine ribonucleoside monophosphate metabolic process (GO:0009167),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,PDE6A
positive regulation of peptide hormone secretion (GO:0090277),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,GPER1
positive regulation of reactive oxygen species metabolic process (GO:2000379),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,GADD45A
inositol lipid-mediated signaling (GO:0048017),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,PIK3R1
positive regulation of hydrolase activity (GO:0051345),6/172,0.8654695388328904,1,0,0,0.6976744186046511,0.10080216269543664,CCL14;AFDN;DNAJB1;FZD10;ARHGAP27;RASGRP1
regulation of endothelial cell migration (GO:0010594),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,NRP1;PRCP
regulation of osteoblast differentiation (GO:0045667),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,GDF10;ZHX3
response to organic cyclic compound (GO:0014070),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,CHRNA4;CYP1B1
mitotic cell cycle phase transition (GO:0044772),8/221,0.8679315264827178,1,0,0,0.7239819004524887,0.10254657301295306,POLA2;UBE2S;CDK3;CDK1;HAUS3;PHF8;MCM2;CLASP2
positive regulation of endothelial cell migration (GO:0010595),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,NRP1;PDPK1
stress-activated protein kinase signaling cascade (GO:0031098),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,SBK2;MAP3K4
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,STUB1;TRIB1
cytoskeleton-dependent cytokinesis (GO:0061640),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,JTB;UNC119
Rab protein signal transduction (GO:0032482),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,RAB2A;RAB38
negative regulation of developmental process (GO:0051093),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,ARHGDIB;DLL1
negative regulation of TOR signaling (GO:0032007),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,UBR1
positive regulation of epithelial to mesenchymal transition (GO:0010718),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,WWTR1
regulation of protein dephosphorylation (GO:0035304),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PPP1R14D
sensory organ development (GO:0007423),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SMCHD1
positive regulation of mitotic nuclear division (GO:0045840),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NUP62
positive regulation of Ras protein signal transduction (GO:0046579),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,RASGRP1
positive regulation of mitotic cell cycle phase transition (GO:1901992),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,CDK1
negative regulation of cytokine secretion (GO:0050710),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,FN1
response to peptide hormone (GO:0043434),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,GPER1
negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,GPER1
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,TAS2R4
regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,GPER1
neuron migration (GO:0001764),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,NRP1
phosphatidylinositol biosynthetic process (GO:0006661),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,RUFY1;MTMR14;PIK3R1
regulation of insulin secretion (GO:0050796),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,GPER1;CACNA1A;FAM3D
Golgi vesicle transport (GO:0048193),10/271,0.8756026805587208,1,0,0,0.7380073800738007,0.09803900512300928,EHD3;TMED9;TRAPPC6A;MIA;COG5;CTAGE9;TEX261;EXOC5;SPTAN1;CTSC
recombinational repair (GO:0000725),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,ERCC4;BRCA1
positive regulation of lymphocyte proliferation (GO:0050671),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,HLA-DMB;TLR9
response to insulin (GO:0032868),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,PDPK1;PIK3R1
regulation of stress-activated MAPK cascade (GO:0032872),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CARD9
spliceosomal complex assembly (GO:0000245),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,SF3B1
sensory perception of bitter taste (GO:0050913),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,TAS2R4
regulation of cell growth (GO:0001558),7/201,0.8805619416668193,1,0,0,0.6965174129353233,0.08859353598323239,MAD2L2;LGI1;SERTAD2;CCDC85B;ING1;TRIM32;EIF4G2
lysosomal transport (GO:0007041),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,EHD3;CCDC91
regulation of neuron death (GO:1901214),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,RILPL1;DHCR24
Rho protein signal transduction (GO:0007266),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,SBK2;NTN1
positive regulation of intracellular protein transport (GO:0090316),5/152,0.8823360987788662,1,0,0,0.6578947368421052,0.08235673104394964,LRRC46;RUVBL1;ACSM6;ATG13;OR13C4
protein stabilization (GO:0050821),5/152,0.8823360987788662,1,0,0,0.6578947368421052,0.08235673104394964,EPHA4;TCP1;MDM4;PIK3R1;CCT8
glycolipid biosynthetic process (GO:0009247),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,ST8SIA6
positive regulation of protein kinase B signaling (GO:0051897),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,FAM110C;PDGFA;FRS2;PIK3R1
regulation of apoptotic process (GO:0042981),34/815,0.885092079599594,1,0,0,0.8343558282208589,0.10184447160245914,TOP2A;TNFAIP8;CSRNP3;HDAC3;TRADD;PIK3R1;BRCA1;PSEN1;BCL10;PKHD1;MAEA;GPER1;RPS6KA2;NUP62;TNFRSF8;CYP1B1;CASP2;NKX2-5;ATG7;MAP3K4;PHLDA3;TNFSF18;GDF10;EPHA4;GADD45A;DAPK2;RPS6;DHCR24;RPS3A;SBK2;SHQ1;ERCC3;CDK1;LACRT
regulation of immune response (GO:0050776),9/251,0.885573985210392,1,0,0,0.7171314741035857,0.08714529562675144,KLRK1;SIGLEC9;COL2A1;NLRP7;LILRA1;TREM1;MICA;HLA-E;ULBP3
regulation of protein ubiquitination (GO:0031396),3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,STUB1;BCL10;BRCA1
cellular protein metabolic process (GO:0044267),19/484,0.8888085053636707,1,0,0,0.7851239669421487,0.09254528731475549,MRPS17;GSN;MRPS33;RPS6;FN1;RPS3A;PSEN1;APOA5;GSPT2;MRPS6;YARS2;CSF2RA;DLL1;BPIFB2;RPS15A;SERP1;UBE2S;ATG7;ITM2B
regulation of B cell proliferation (GO:0030888),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,TLR9
mitotic metaphase plate congression (GO:0007080),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,NUP62
negative regulation of ERBB signaling pathway (GO:1901185),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PTPN3
male gonad development (GO:0008584),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,ING2
eye development (GO:0001654),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PRSS56
response to hydrogen peroxide (GO:0042542),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,CYP1B1
positive regulation of interleukin-6 production (GO:0032755),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,TLR9
nucleobase-containing compound catabolic process (GO:0034655),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,TATDN2
digestive tract development (GO:0048565),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,AGR2
mitotic spindle organization (GO:0007052),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,TUBGCP3;CLASP2
MAPK cascade (GO:0000165),10/278,0.8935099822519456,1,0,0,0.7194244604316546,0.08100559163077616,PSMA6;PSME3;PSME1;PDGFA;PEBP1;ILK;FRS2;SPTAN1;CSF2RA;RASGRP1
protein import into nucleus (GO:0006606),3/103,0.8941493670111881,1,0,0,0.5825242718446602,0.06517423722567385,TRPS1;NUP50;NUP62
negative regulation of phosphorylation (GO:0042326),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,WWTR1;STAP1
regulation of defense response (GO:0031347),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,PSMA6;NLRP7
gland development (GO:0048732),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,SIX1;NKX2-5
purine ribonucleotide biosynthetic process (GO:0009152),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,GUCY1B2;PPCDC
cAMP-mediated signaling (GO:0019933),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,GPER1;DRD1
protein transport (GO:0015031),12/326,0.8951669725779485,1,0,0,0.7361963190184049,0.08153007354707799,RUFY1;RAB2A;C16ORF70;TMED9;CTTN;STX6;UNC119;RAB3GAP2;RAB38;TBC1D12;ATP6V1D;ATP6V1C1
ribonucleoprotein complex assembly (GO:0022618),5/156,0.8953149759712675,1,0,0,0.641025641025641,0.07088441933337168,GRB7;SHQ1;MTERF4;BRIX1;SF3B1
lymphocyte chemotaxis (GO:0048247),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CCL14
positive regulation of viral life cycle (GO:1903902),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,TOP2A
regulation of dendrite morphogenesis (GO:0048814),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,EPHA4
regulation of smooth muscle cell proliferation (GO:0048660),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,TRIB1
microtubule cytoskeleton organization involved in mitosis (GO:1902850),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CLASP2
regulation of intracellular pH (GO:0051453),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,SLC4A10
metaphase plate congression (GO:0051310),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,NUP62
positive regulation of actin filament bundle assembly (GO:0032233),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,NRP1
myeloid cell differentiation (GO:0030099),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,KAT6A
sensory perception of chemical stimulus (GO:0007606),12/327,0.8973498113544849,1,0,0,0.7339449541284404,0.0794932210877048,OR2L8;OR5H1;OR1E1;OR2G2;OR2AG2;OR2M5;OR51B6;OR6N1;BEST2;OR10A3;OR4S2;OR13C4
double-strand break repair via homologous recombination (GO:0000724),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,ERCC4;BRCA1
transforming growth factor beta receptor signaling pathway (GO:0007179),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,GDF10;CGN
nucleus organization (GO:0006997),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,TMEM170A
negative regulation of ossification (GO:0030279),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,GDF10
activation of protein kinase activity (GO:0032147),8/233,0.9013119870284132,1,0,0,0.6866952789699571,0.0713502584023664,SBK2;PRKAR1B;GADD45A;PDPK1;CDK1;FRS2;ATG13;MAP3K4
regulation of cytokinesis (GO:0032465),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,CXCR5;TAS1R2
positive regulation of cellular biosynthetic process (GO:0031328),5/159,0.9042193482148154,1,0,0,0.6289308176100629,0.0633228340831324,SREBF1;PCNA;PDGFA;UPF3A;APOA5
regulation of cell proliferation (GO:0042127),30/740,0.9044918456717375,1,0,0,0.8108108108108109,0.08139080227761071,CCL14;TES;CDCA7L;PDGFA;BRCA1;DUX4;DLL1;PKHD1;RPS15A;GRAP2;RPS6KA2;GPER1;NUP62;CYP1B1;TNFRSF8;NKX2-5;ENPP7;KRT6A;WWTR1;MYOCD;POU1F1;FN1;OPRM1;KLHL41;CDK3;CSNK2B;BTK;MDM4;LACRT;CRLF1
response to endoplasmic reticulum stress (GO:0034976),3/106,0.9048723287754362,1,0,0,0.5660377358490566,0.05658193494921566,ERN2;PDILT;PIK3R1
interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,TCP1
cartilage development (GO:0051216),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,COL2A1
pyruvate metabolic process (GO:0006090),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,SLC16A3
cellular response to interleukin-12 (GO:0071349),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,TCP1
mitotic spindle assembly (GO:0090307),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,TUBGCP3
regulation of cellular component movement (GO:0051270),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,PKHD1
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,NDUFAF1
regulation of DNA metabolic process (GO:0051052),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,GPER1
regulation of nucleic acid-templated transcription (GO:1903506),24/607,0.9060852294595902,1,0,0,0.7907742998352553,0.07798766796373331,WWTR1;ZNF19;POU1F1;ZNF350;RHOXF1;SIX1;ZNF2;DACH2;BACH2;ZNF33A;ING2;NR6A1;ZNF728;ZNF317;HSF4;ZNF286B;ZNF789;NANOG;GPBP1L1;ZNF600;HIVEP2;LMX1B;ZNF565;ZFP37
negative regulation of cell communication (GO:0010648),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,EPHA4;OPRM1
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),4/134,0.9076913178913244,1,0,0,0.5970149253731343,0.0578214426562523,CNR1;GPER1;DRD1;WASF2
"mRNA splicing, via spliceosome (GO:0000398)",9/261,0.9096703260461426,1,0,0,0.689655172413793,0.0652917408140208,PTBP1;SYF2;DHX35;PCBP1;ZMAT5;POLR2F;SF3B1;GTF2F2;U2SURP
response to glucose (GO:0009749),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,GPER1
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),2/79,0.9107606472852537,1,0,0,0.5063291139240506,0.047329191130890166,TRADD;CASP2
"negative regulation of transcription, DNA-templated (GO:0045892)",33/813,0.9130438997365217,1,0,0,0.8118081180811807,0.07385125332000525,CREBZF;ZNF350;HDAC3;RORC;GLIS3;UBP1;BRCA1;PSEN1;UXT;DMBX1;CCDC85B;DEAF1;TRPS1;LRRFIP1;ZNF423;NKX2-5;E2F6;ATF7IP;IRX1;HEXIM2;ZHX3;MSX2;RITA1;WWP1;PARP9;MAD2L2;RIPPLY1;ERN2;NR6A1;KAT6A;MDM4;PAXBP1;RCOR2
receptor-mediated endocytosis (GO:0006898),6/188,0.9131597476168598,1,0,0,0.6382978723404255,0.0579858151181627,CD163;CTTN;FCHO2;ARHGAP27;LDLRAP1;DLL1
RNA transport (GO:0050658),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,NXF2;NUP62
regulation of protein serine/threonine kinase activity (GO:0071900),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,GADD45A;TRIB1
cellular response to hormone stimulus (GO:0032870),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,GPER1;MGARP
negative regulation of MAPK cascade (GO:0043409),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,CAV3;GPER1
regulation of cell motility (GO:2000145),3/109,0.9146032191683431,1,0,0,0.5504587155963303,0.049136668628761794,ADGRG3;NTN1;TRIM32
Wnt signaling pathway (GO:0016055),3/109,0.9146032191683431,1,0,0,0.5504587155963303,0.049136668628761794,FZD4;FZD10;PSEN1
endosome to lysosome transport (GO:0008333),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,LYST
cellular macromolecule catabolic process (GO:0044265),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,TATDN2
positive regulation of transferase activity (GO:0051347),4/137,0.9162983017532836,1,0,0,0.583941605839416,0.05104426883901789,EPHA4;RFC2;TCP1;MAP3K4
muscle contraction (GO:0006936),4/137,0.9162983017532836,1,0,0,0.583941605839416,0.05104426883901789,CAV3;TNNT3;TLN1;KLHL41
regulation of gene expression (GO:0010468),43/1037,0.9173702056632489,1,0,0,0.8293153326904532,0.07152361608374638,RHOXF1;ZNF350;AKAP8L;SIX1;ZNF2;ALOX12B;BRCA1;DACH2;CRIP1;BACH2;TRIM6;ING2;MTA1;ZNF728;NLRP7;GPER1;AGR2;HSF4;ZNF286B;ZNF789;STAP1;GPBP1L1;HIVEP2;DRD1;ZNF600;ZNF565;ZFP37;RBM38;WWTR1;ZNF19;POU1F1;GSN;FN1;PARP9;CLK4;ZNF33A;NR6A1;CDK3;ZNF317;CDK1;TLR9;NANOG;LMX1B
negative regulation of programmed cell death (GO:0043069),15/408,0.9174436227276661,1,0,0,0.7352941176470588,0.06335599085270593,TNFSF18;EPHA4;TNFAIP8;HDAC3;DHCR24;RPS3A;PIK3R1;PSEN1;PKHD1;MAEA;NUP62;CDK1;CASP2;NKX2-5;LACRT
BMP signaling pathway (GO:0030509),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,GDF10;SLC33A1
positive regulation of binding (GO:0051099),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,PSEN1;PARP9
protein catabolic process (GO:0030163),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,PSMA6;PRSS16
protein homooligomerization (GO:0051260),6/190,0.9179445909739374,1,0,0,0.631578947368421,0.054074683325986896,EHD3;TAF10;BCL10;TMCC1;ACACB;CBR4
regulation of vesicle-mediated transport (GO:0060627),4/138,0.9190038309457114,1,0,0,0.5797101449275363,0.0489652104536948,RUFY1;NRP1;UNC119;TBC1D12
glutathione metabolic process (GO:0006749),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,GSR
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,KRT6A
cilium movement (GO:0003341),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,DNAI1
RNA metabolic process (GO:0016070),6/191,0.9202496036129625,1,0,0,0.6282722513089004,0.05221591882399562,PTBP1;PCNA;DHX35;PCBP1;POLR2F;GTF2F2
modulation of chemical synaptic transmission (GO:0050804),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,LGI1;CPLX3
positive regulation of GTPase activity (GO:0043547),6/192,0.9224978058129646,1,0,0,0.625,0.050418925995509435,CCL14;AFDN;FZD10;TBC1D12;ARHGAP27;RASGRP1
fatty acid oxidation (GO:0019395),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,HACL1
blood circulation (GO:0008015),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ELN
heart morphogenesis (GO:0003007),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,NKX2-5
regulation of programmed cell death (GO:0043067),9/268,0.9238602448208192,1,0,0,0.6716417910447761,0.05319031498242689,GDF10;SBK2;DAPK2;TRADD;NUP62;TNFRSF8;CASP2;BRCA1;MAP3K4
response to lipid (GO:0033993),4/140,0.9241810645107653,1,0,0,0.5714285714285714,0.04505558244276368,TRIM6;TNFRSF8;FFAR1;TRIB1
regulation of cellular component organization (GO:0051128),4/140,0.9241810645107653,1,0,0,0.5714285714285714,0.04505558244276368,RUFY1;MAD2L2;GSN;UNC119
negative regulation of signaling (GO:0023057),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,EPHA4;OPRM1
negative regulation of endopeptidase activity (GO:0010951),2/83,0.9243958207118659,1,0,0,0.4819277108433735,0.03788670924051055,SERPINB10;TIMP4
RNA processing (GO:0006396),6/193,0.9246902847033436,1,0,0,0.6217616580310881,0.04868171495418062,PTBP1;NWD1;DHX35;MTERF4;ZMAT5;AKAP8L
regulation of exocytosis (GO:0017157),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,CLASP2
activation of GTPase activity (GO:0090630),2/84,0.9274839879498789,1,0,0,0.47619047619047616,0.035847499197840214,TBC1D12;RASGRP1
regulation of mitotic nuclear division (GO:0007088),2/84,0.9274839879498789,1,0,0,0.47619047619047616,0.035847499197840214,NUP62;CEP97
mitochondrial ATP synthesis coupled electron transport (GO:0042775),2/85,0.9304527474425885,1,0,0,0.47058823529411764,0.03392187580644571,SDHAF2;NDUFAF1
chemokine-mediated signaling pathway (GO:0070098),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,CCL14
positive regulation of ossification (GO:0045778),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,ZHX3
positive regulation of mitotic cell cycle (GO:0045931),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,NUP62
regulation of DNA binding (GO:0051101),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,CSNK2B
calcium ion transmembrane transport (GO:0070588),2/86,0.9333063042418757,1,0,0,0.46511627906976744,0.032103177510297835,CACNA1A;ATP2C1
Ras protein signal transduction (GO:0007265),7/223,0.9333684881308107,1,0,0,0.6278026905829596,0.043290264071117746,RAB2A;SBK2;RIT1;RRAS;GRAP2;RAB38;NTN1
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),4/144,0.9336516399151867,1,0,0,0.5555555555555555,0.03813993714585849,GDF10;SLC33A1;STUB1;CGN
chromatin remodeling (GO:0006338),3/116,0.9338791037872658,1,0,0,0.5172413793103448,0.035383597412689746,KDM6B;TOP1MT;RUVBL1
neutrophil chemotaxis (GO:0030593),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,CCL14
cellular response to BMP stimulus (GO:0071773),2/87,0.9360487418513352,1,0,0,0.45977011494252873,0.03038516286569491,GDF10;SLC33A1
regulation of cellular macromolecule biosynthetic process (GO:2000112),24/631,0.9372438077094339,1,0,0,0.7606973058637084,0.04930218466665792,WWTR1;ZNF19;POU1F1;ZNF350;RHOXF1;SIX1;ZNF2;DACH2;BACH2;ZNF33A;ING2;NR6A1;ZNF728;ZNF317;HSF4;ZNF286B;ZNF789;NANOG;GPBP1L1;ZNF600;HIVEP2;LMX1B;ZNF565;ZFP37
positive regulation of immune response (GO:0050778),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,HLA-DMB
membrane fusion (GO:0061025),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,ATG7
rRNA metabolic process (GO:0016072),6/200,0.9385668961689758,1,0,0,0.6,0.038040687368497916,EXOSC6;ERN2;EMG1;RPS15A;RPS6;RPS3A
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),2/88,0.9386840239616273,1,0,0,0.45454545454545453,0.028761981412220677,STUB1;TRIB1
fat cell differentiation (GO:0045444),1/55,0.9406924613791231,1,0,0,0.3636363636363636,0.022232368682920493,TRIM32
positive regulation of cellular process (GO:0048522),19/519,0.9413323926200773,1,0,0,0.7321772639691715,0.044266682050055114,CCL14;LGI1;WWTR1;CDCA7L;FN1;PDGFA;ACACB;DLL1;PKHD1;RPS15A;ACOX2;CDK3;GPER1;NKX2-5;LACRT;TRIM32;CRLF1;EIF4G2;KRT6A
regulated exocytosis (GO:0045055),4/148,0.9420378113831829,1,0,0,0.5405405405405406,0.032275603102025825,FN1;PDGFA;TLN1;RAB11FIP5
rRNA processing (GO:0006364),6/202,0.9420900584935459,1,0,0,0.594059405940594,0.035438260680691364,EXOSC6;EMG1;RPS15A;RPS6;RPS3A;RRP15
positive regulation of multicellular organismal process (GO:0051240),6/202,0.9420900584935459,1,0,0,0.594059405940594,0.035438260680691364,WWTR1;DOCK5;ALOX12B;APOA5;AGPAT2;CLASP2
regulation of cell cycle process (GO:0010564),2/90,0.9436483877912323,1,0,0,0.4444444444444444,0.025778512347182387,RMI2;GPER1
chromosome organization (GO:0051276),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,TOP2A
granulocyte chemotaxis (GO:0071621),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,CCL14
regulation of BMP signaling pathway (GO:0030510),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,ZNF423
organonitrogen compound catabolic process (GO:1901565),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,PRSS16
phosphatidylinositol-mediated signaling (GO:0048015),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,PIK3R1
cellular iron ion homeostasis (GO:0006879),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,HEPH
glycosaminoglycan catabolic process (GO:0006027),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,PRELP
cellular response to acid chemical (GO:0071229),2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,FZD4;FZD10
phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,OPRM1;DRD1
positive regulation of cell death (GO:0010942),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,ACOX2
sulfur compound biosynthetic process (GO:0044272),3/122,0.9471194166855288,1,0,0,0.4918032786885246,0.026719718243249837,PRELP;CHST14;CDO1
negative regulation of signal transduction (GO:0009968),9/283,0.9479450306278001,1,0,0,0.636042402826855,0.034002040056752544,EPHA4;NOTCH3;NFKBIL1;PTCH2;TLR9;RITA1;TRIB1;LACRT;CXXC4
neutrophil migration (GO:1990266),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,CCL14
platelet degranulation (GO:0002576),3/124,0.9509542388487732,1,0,0,0.48387096774193544,0.024333549956038612,FN1;PDGFA;TLN1
negative regulation of macromolecule metabolic process (GO:0010605),3/124,0.9509542388487732,1,0,0,0.48387096774193544,0.024333549956038612,TRIM6;GPER1;PARP9
dicarboxylic acid metabolic process (GO:0043648),1/59,0.95172205472190885,1,0,0,0.3389830508474576,0.01677364276098951,SLC25A32
cell chemotaxis (GO:0060326),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,NRP1
positive regulation of protein binding (GO:0032092),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,PSEN1
response to reactive oxygen species (GO:0000302),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,MPV17L
regulation of cytoskeleton organization (GO:0051493),2/95,0.9544392929248489,1,0,0,0.42105263157894735,0.019634205791927362,PDGFA;FZD10
cytoskeleton organization (GO:0007010),3/126,0.9545283679114202,1,0,0,0.47619047619047616,0.022160912418275697,FGD6;TLN1;WASF3
vesicle organization (GO:0016050),3/127,0.9562226890751985,1,0,0,0.47244094488188976,0.021148561272512884,SYT4;STX6;SYTL2
cell cycle G2/M phase transition (GO:0044839),3/127,0.9562226890751985,1,0,0,0.47244094488188976,0.021148561272512884,AKAP8L;CDK1;HAUS3
regulation of vesicle fusion (GO:0031338),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,TBC1D12
positive regulation of T cell proliferation (GO:0042102),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,HLA-DMB
regulation of cell migration (GO:0030334),10/316,0.9573784698045901,1,0,0,0.6329113924050633,0.027567399031011415,ADGRG3;GRB7;LRRC15;CARMIL2;FAM110C;GPER1;CYP1B1;PDGFA;DRD1;TRIM32
mRNA metabolic process (GO:0016071),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,PTBP1;AKAP8L
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,HLA-DMB;HLA-DQB2
antigen processing and presentation of exogenous peptide antigen (GO:0002478),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,HLA-DMB;HLA-DQB2
mitochondrial respiratory chain complex assembly (GO:0033108),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,SDHAF2;NDUFAF1
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,TRIM32
stress-activated MAPK cascade (GO:0051403),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,TRIB1
tRNA processing (GO:0008033),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,FTSJ1
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),2/98,0.9599334606764933,1,0,0,0.4081632653061224,0.01669033008887676,HLA-DMB;HLA-DQB2
defense response to bacterium (GO:0042742),7/241,0.960039090830733,1,0,0,0.5809128630705394,0.023690367646265958,TLR9;DEFB107A;LACRT;LYST;MICA;HLA-E;KRT6A
negative regulation of protein modification process (GO:0031400),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,WWTR1
iron ion homeostasis (GO:0055072),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,HEPH
positive regulation of cell projection organization (GO:0031346),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,CARMIL2
glycosaminoglycan biosynthetic process (GO:0006024),2/99,0.9616193258375976,1,0,0,0.40404040404040403,0.015812774876077424,PRELP;CHST14
NADH dehydrogenase complex assembly (GO:0010257),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFAF1
mitochondrial respiratory chain complex I biogenesis (GO:0097031),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFAF1
mitochondrial respiratory chain complex I assembly (GO:0032981),1/64,0.9626730196391721,1,0,0,0.3125,0.011887958847229707,NDUFAF1
protein phosphorylation (GO:0006468),16/470,0.9629587435964748,1,0,0,0.6808510638297872,0.025698525713879893,EPHA4;PDPK1;DAPK2;EIF2AK1;ILK;GTF2H3;ERN2;PRKAR1B;CDK3;RPS6KA2;CSNK2B;CDK1;BTK;TLR9;PSKH1;ATR
intracellular protein transport (GO:0006886),11/347,0.9632001881383757,1,0,0,0.6340057636887608,0.023771417873967762,RAB2A;TMED9;CTTN;XPO6;NUP50;NUP62;STX6;RAB3GAP2;HOMER3;RAB38;TBC1D12
cellular response to metal ion (GO:0071248),2/100,0.9632369873558141,1,0,0,0.39999999999999997,0.014982321868347009,MT1A;MT1M
cellular response to transforming growth factor beta stimulus (GO:0071560),2/100,0.9632369873558141,1,0,0,0.39999999999999997,0.014982321868347009,GDF10;CGN
central nervous system development (GO:0007417),6/217,0.9632432419576695,1,0,0,0.5529953917050692,0.020709296613592415,DMBX1;WWP1;HAPLN3;DLL1;NHEJ1;PHF8
regulation of cell division (GO:0051302),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,DLL1
fatty acid catabolic process (GO:0009062),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,HACL1
regulation of kinase activity (GO:0043549),2/101,0.9647890418591292,1,0,0,0.396039603960396,0.014196360797659355,EPHA4;SPDYE5
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,ARPC3;PIK3R1;WASF2
positive regulation of cell proliferation (GO:0008284),14/424,0.9652439310582771,1,0,0,0.660377358490566,0.02336047349172523,CCL14;WWTR1;CDCA7L;FN1;PDGFA;DLL1;PKHD1;RPS15A;CDK3;GPER1;NKX2-5;LACRT;CRLF1;KRT6A
detection of chemical stimulus involved in sensory perception (GO:0050907),2/102,0.9662779974899206,1,0,0,0.39215686274509803,0.013452432976578837,OR1E1;OR4S2
JNK cascade (GO:0007254),1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,TRIB1
Fc-gamma receptor signaling pathway (GO:0038094),3/134,0.9665252718637258,1,0,0,0.4477611940298507,0.015245298295546113,ARPC3;PIK3R1;WASF2
Fc receptor mediated stimulatory signaling pathway (GO:0002431),3/135,0.9677952919812572,1,0,0,0.4444444444444444,0.014548750798032252,ARPC3;PIK3R1;WASF2
negative regulation of protein binding (GO:0032091),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,PTPRF
positive regulation of autophagy (GO:0010508),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,LACRT
peptide metabolic process (GO:0006518),2/104,0.9690762134019278,1,0,0,0.38461538461538464,0.0120815456087189,GSR;PSEN1
positive regulation of lymphocyte activation (GO:0051251),2/104,0.9690762134019278,1,0,0,0.38461538461538464,0.0120815456087189,TLR9;SIRPB1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,DHCR24
response to interferon-gamma (GO:0034341),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,CCL14
regulation of actin filament polymerization (GO:0030833),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,CTTN
nervous system development (GO:0007399),15/455,0.9700101559458084,1,0,0,0.6593406593406593,0.020076090654259738,LGI1;FARP1;ZC4H2;RITA1;SLC4A10;WWP1;BARX1;HAPLN3;DMBX1;TRIM3;PCDHA3;PCDHA2;DRD1;NHEJ1;ITM2B
ribosome biogenesis (GO:0042254),6/226,0.9722745936369446,1,0,0,0.5309734513274336,0.014929386199993113,EXOSC6;EMG1;RPS15A;MTERF4;RPS6;RPS3A
cellular response to growth factor stimulus (GO:0071363),3/139,0.9724341820362676,1,0,0,0.4316546762589928,0.012065993490628802,NRP1;PDPK1;PDE8A
neuropeptide signaling pathway (GO:0007218),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,OPRM1
cellular response to starvation (GO:0009267),2/107,0.9728581476955978,1,0,0,0.3738317757009345,0.01028672748442257,SREBF1;ATG7
positive regulation of epithelial cell proliferation (GO:0050679),2/107,0.9728581476955978,1,0,0,0.3738317757009345,0.01028672748442257,NRP1;LACRT
regulation of protein secretion (GO:0050708),2/107,0.9728581476955978,1,0,0,0.3738317757009345,0.01028672748442257,DNAJC1;CACNA1A
regulation of cell communication (GO:0010646),1/71,0.9739647545480367,1,0,0,0.28169014084507044,0.00743103163098366,NUP62
defense response to Gram-negative bacterium (GO:0050829),1/71,0.9739647545480367,1,0,0,0.28169014084507044,0.00743103163098366,TLR9
modification-dependent protein catabolic process (GO:0019941),3/141,0.9745089388889377,1,0,0,0.42553191489361697,0.010987909481436438,UBE2S;STUB1;TRIM32
negative regulation of cysteine-type endopeptidase activity (GO:2000117),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,DHCR24
positive regulation of inflammatory response (GO:0050729),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,TLR9
regulation of peptide hormone secretion (GO:0090276),1/73,0.9765118358730951,1,0,0,0.273972602739726,0.0065118926107079,CACNA1A
regulation of protein binding (GO:0043393),2/111,0.9772120066589167,1,0,0,0.36036036036036034,0.008306901937342228,PSEN1;LDLRAP1
positive regulation of defense response (GO:0031349),1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,TLR9
regulation of signal transduction (GO:0009966),6/233,0.9778331891991421,1,0,0,0.5150214592274678,0.01154481717730623,EPHA4;CAV3;NUP62;RSPO3;ILK;DLL1
regulation of angiogenesis (GO:0045765),4/177,0.9791925960289664,1,0,0,0.4519774011299435,0.009503696496085842,RRAS;PDPK1;CYP1B1;BRCA1
heart development (GO:0007507),3/149,0.981416039698096,1,0,0,0.40268456375838924,0.007553883933884644,MYOCD;NKX2-5;CRIP1
positive regulation of translation (GO:0045727),1/78,0.9818427613794292,1,0,0,0.2564102564102564,0.004698488267500739,UPF3A
nucleosome organization (GO:0034728),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,ASF1A
regulation of endothelial cell proliferation (GO:0001936),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,NRP1
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",1/80,0.9836196507462239,1,0,0,0.25,0.004128997611953673,TMED9
positive regulation of B cell activation (GO:0050871),2/119,0.9839830371412186,1,0,0,0.3361344537815126,0.005427435548267131,BTK;TLR9
brain development (GO:0007420),2/119,0.9839830371412186,1,0,0,0.3361344537815126,0.005427435548267131,DMBX1;PHF8
cellular protein localization (GO:0034613),9/327,0.9845420100908343,1,0,0,0.5504587155963303,0.008575436870251073,RAB2A;TMED9;CTTN;WDR45B;STX6;RAB3GAP2;RAB38;TBC1D12;ATG13
positive regulation of homeostatic process (GO:0032846),1/83,0.9859645609779344,1,0,0,0.24096385542168675,0.0034059921056594548,C2CD2L
inflammatory response (GO:0006954),6/252,0.9881395520189202,1,0,0,0.47619047619047616,0.005681592488558233,CCL14;ADGRE5;NLRP7;TNFRSF8;KLK2;CDO1
G2/M transition of mitotic cell cycle (GO:0000086),2/126,0.9882689055470334,1,0,0,0.31746031746031744,0.0037461735428357327,CDK1;HAUS3
negative regulation of response to stimulus (GO:0048585),2/127,0.9887816352200313,1,0,0,0.31496062992125984,0.0035533118886497796,EPHA4;NLRP7
ncRNA processing (GO:0034470),5/227,0.9898527655650302,1,0,0,0.44052863436123346,0.004492981746761008,EXOSC6;EMG1;RPS15A;RPS6;RPS3A
positive regulation of response to external stimulus (GO:0032103),1/90,0.9902133488804308,1,0,0,0.2222222222222222,0.002185523367001884,TLR9
endocytosis (GO:0006897),6/263,0.9918333872894163,1,0,0,0.45627376425855515,0.003741509733074818,CD163;HEATR5A;CTTN;CAV3;ARHGAP27;LDLRAP1
regulation of B cell activation (GO:0050864),1/95,0.9924358915832194,1,0,0,0.21052631578947367,0.0015984971305800805,TLR9
positive regulation of neuron projection development (GO:0010976),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,SYT4
cellular response to organonitrogen compound (GO:0071417),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,BRCA1
negative regulation of cell motility (GO:2000146),1/97,0.993176581718741,1,0,0,0.20618556701030927,0.001411712214835502,CYP1B1
regulation of small GTPase mediated signal transduction (GO:0051056),2/140,0.9937514842124622,1,0,0,0.2857142857142857,0.0017908912764511386,ARHGDIB;NUP62
neuron development (GO:0048666),2/144,0.9947887375101383,1,0,0,0.27777777777777773,0.001451357910531423,LGI1;PLP1
plasma membrane invagination (GO:0099024),1/103,0.9949913632524948,1,0,0,0.19417475728155337,9.749945649443491e-4,GSN
B cell receptor signaling pathway (GO:0050853),1/104,0.9952429552680097,1,0,0,0.19230769230769232,9.169991309490005e-4,BTK
"phagocytosis, engulfment (GO:0006911)",1/104,0.9952429552680097,1,0,0,0.19230769230769232,9.169991309490005e-4,GSN
positive regulation of cellular catabolic process (GO:0031331),1/106,0.9957088736018097,1,0,0,0.18867924528301885,8.113886235340445e-4,APOA5
circulatory system development (GO:0072359),1/109,0.9963236252556655,1,0,0,0.1834862385321101,6.758071960977404e-4,CRIP1
positive regulation of developmental process (GO:0051094),1/113,0.9970085519676813,1,0,0,0.17699115044247787,5.302533373988125e-4,AGR2
positive regulation of cell differentiation (GO:0045597),3/194,0.9970841047537141,1,0,0,0.30927835051546393,9.031406446467312e-4,WWTR1;ZHX3;CDH15
endosomal transport (GO:0016197),4/229,0.9971524222410082,1,0,0,0.34934497816593885,9.962060512597052e-4,EHD3;ANKRD27;HEATR5A;STX6
phosphorylation (GO:0016310),9/386,0.997490134369023,1,0,0,0.46632124352331605,0.0011718749023356674,ERN2;PRKAR1B;PDPK1;DAPK2;CDK3;RPS6KA2;CDK1;BTK;ILK
activation of MAPK activity (GO:0000187),1/117,0.997565873640774,1,0,0,0.17094017094017094,4.165972070020412e-4,CDK1
regulation of protein processing (GO:0070613),1/128,0.9986191297313574,1,0,0,0.15625,2.1591008571631521e-4,NLRP7
vesicle-mediated transport (GO:0016192),9/410,0.9988601923047916,1,0,0,0.4390243902439024,5.006887770818962e-4,SYT4;EHD3;HEATR5A;MIA;CAV3;CTAGE9;STX6;CCZ1;SYTL2
cellular response to organic substance (GO:0071310),1/133,0.99893267616922,1,0,0,0.15037593984962405,1.6058553781593565e-4,CYP1B1
phagocytosis (GO:0006909),1/135,0.9990371293746406,1,0,0,0.14814814814814814,1.427162197126682e-4,GSN
